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Abstract
Coinfection by multiple species of parasite, including viruses, bacteria,
protozoa, fungal pathogens, and helminths, affects hundreds of millions of
people. Despite the potential for significant health effects, and important
implications for treatment of infections, relatively little is know about the
structure of coinfecting communities, the processes responsible for this
structure, and the consequences for host health. This lack of knowledge
limits the extent to which treatment of infection can account for coinfec-
tion.
The four original research chapters of this thesis include collation and
analyses of large databases of coinfection information collected from pub-
lished papers, analyses of coinfection data in a large database of death
certificates, and analyses of the behaviour of a theoretical model of two
coinfecting parasites.
Coinfection information in previously published literature indicates
that coinfection tends to enhance parasite abundance and harm human
health. The same literature shows that interactions among coinfecting
parasites are likely to involve shared resources, as opposed to being medi-
ated via the immune system.
Analysis of death certificates showed that the proportion of deaths at-
tributed to coinfection was greatest in early adulthood, and that, positive
associations between pairs of coinfections on death certificates were more
common than negative associations.
The theoretical model of two coinfecting parasites revealed that indi-
rect effects of treatment on untreated parasites may be predictable given
information about the direction of interspecific interactions among para-
sites.
In sum, these findings indicate that coinfection in humans involves hun-
dreds of different species combinations, that these communities are likely
to be structured by bottom-up rather than top-down processes, and that
coinfection can present a serious health risk. Furthermore, a better un-
derstanding of interspecific interactions among parasites could be used to
improve treatment outcomes. Further research could show where specific
treatments indirectly suppress more parasites than currently estimated.
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Chapter 1
Introduction
Over the last century, vaccines and antibiotics have improved the preven-
tion and treatment of many infectious diseases, and, in the case of small-
pox, even enabled eradication (Winslow, 1980). These interventions have
significantly reduced deaths from infection so that by the 1970s human life
expectancy in countries like the USA, UK, and Sweden was more limited
by chronic, degenerative diseases like heart disease and cancer (Finch and
Crimmins, 2004; Horiuchi, 2000; Omran, 1971; Rosenberg, 2009). In fact,
between 1990 and 2010 the global health burden switched from mainly
infectious to noninfectious causes (Murray et al., 2013).
However, in the 21st century infectious diseases remain a large chal-
lenge for individual health, in terms of morbidity and mortality, on a
global scale. While many countries have relatively little infectious disease
mortality, the economic burdens are substantial; in 2003 influenza cost
the USA over $87 billion in disease prevention, healthcare, and lost pro-
ductivity (Molinari et al., 2007). In many poorer countries the majority of
human deaths are still caused by infectious disease (Sanders et al., 2008).
Many twentieth century efforts to locally eliminate or globally eradicate
infections were very costly, and not always successful (Hopkins, 2013).
One of the difficulties in treating or preventing morbidity (illness) and
mortality (death) from infectious disease is that existing interventions
often ignore the potential for different infections to affect one another
(Ameisen, 1999; Singer, 2009; Singer and Clair, 2003). Health services
are faced by many infection-related challenges including sexually trans-
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mitted infectious diseases (Eng and Butler, 1997; Forhan et al., 2009),
hospital-acquired infections (Curtis, 2008; Meyer et al., 2011; Sandora
and Goldmann, 2012), and children missing multiple vaccines (Duckworth
et al., 2012), all of which increase the chances for infections to co-occur
within individuals. To improve global health, health burdens from in-
fectious diseases must be tackled, and to do this effectively interactions
among infectious agents need to be considered (Wilson, 1995). This thesis
aims to better understand how different infectious diseases interact within
humans, and to determine what the consequences of these interactions are
for effective treatment. To achieve this important goal, we need to under-
stand the distribution and impact of coinfection in human populations.
What is known about coinfection in humans
Coinfection is the simultaneous infection of an individual by more than
one type of parasite. Although the effects of coinfection on human health
are rarely assessed (King, 2010; Pullan and Brooker, 2008), and there is
no estimate of the number of coinfected individuals worldwide, studies
of particular taxa and groups of individuals suggest that coinfection is
extremely widespread. Over three billion individuals have parasitic worm
(helminth) infections (Drake and Bundy, 2001), one billion of whom are
coinfected with multiple helminth species (Crompton, 1999). One study
in the Ivory Coast found that 75% of villagers were heavily coinfected
with between three and ten intestinal parasite species (Raso et al., 2004).
Beyond helminths, over 10 million individuals are coinfected with HIV
and tuberculosis (World Health Organization, 2012). Bacterial coinfection
has also been identified as a major cause of death among pandemic and
seasonal influenza patients because the virus enables more bacteria to
colonise and cause more severe infection than would occur in patients with
just a bacterial infection (Chertow and Memoli, 2013; Dushoff et al., 2006;
Finelli et al., 2008; Morens et al., 2008; World Health Organization, 2010).
Marginalised groups within human populations are the most likely to be
coinfected, due to high exposure, and inadequate prevention or treatment
options (Boraschi et al., 2008). These groups include the global poor
8
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(Bonds et al., 2010; Buck et al., 1978a; Lustigman et al., 2012; Steinmann
et al., 2010), sex workers and injecting drug users (Singer, 2009; Singer and
Clair, 2003), and men who have sex with men (Guo et al., 2009; Keystone
et al., 1980).
Taken together, these studies suggest that coinfection is commonplace
in humans and involves parasites of different taxa, transmission routes,
and pathologies. How these patterns of coinfection arise and how they
differ by parasite types is unknown because data on human coinfections
have not yet been synthesised. Before attempting such a synthesis we
must first consider the kinds of parasites that infect humans, and then
consider what defines coinfection.
Parasites that infect humans
Across all taxa and ecosystems, more than half the species on earth, in-
cluding the most abundant species (Zhao et al., 2013), are parasitic. These
parasites live in and rely on the organism they infect (their host) for nu-
trition and survival during their life cycle (Begon et al., 2006; Brooks and
Hoberg, 2000). “Parasite” is used broadly here to include viruses, bacte-
ria, fungal parasites, protozoa, and helminths (i.e. micro-parasites - often
called pathogens - and macroparasites sensu Anderson and May (1992)).
Humans are infected by many different parasites (Anderson, 1990); a
comprehensive search published in 2001 counted 1, 415 disease-causing
(pathogenic) species reported as infecting humans (Taylor et al., 2001).
The number of parasites of humans will likely increase as further sampling
and better diagnostic tests reveal previously undiscovered parasites, and
as new parasites invade the human population (Henderson and Morse,
1993), recent examples being influenza A (H1N1) in 2009, SARS in 2002,
and Nipah virus in 1999 (Tabish, 2010).
Non-human hosts are also infected by various parasites, and coinfec-
tion is commonplace in domesticated animals including livestock and pets
(Nieto and Foley, 2009), wild buffalo (Budischak et al., 2012; Ezenwa et al.,
2010), rodents (Behnke et al., 2001; Telfer et al., 2010), and Soay sheep
(Craig et al., 2008). There are growing concerns about how these parasite
species may interact within animal hosts, as these interactions may affect
9
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treatment and parasite dynamics (Lello et al., 2004; Telfer et al., 2010).
This thesis focuses on coinfection in humans because much is known about
the range of infectious diseases that are found to infect humans, as well
as their pathologies. The concepts, techniques, and findings regarding
coinfection in humans are likely to be relevant to other host systems.
Defining coinfection
This thesis defines coinfection as multiple pathogenic parasite species si-
multaneously infecting the same individual. In the literature, the term
“coinfection” has various meanings, from parasites of different taxonomic
kingdoms, to a mix of pathogenic and non-pathogenic parasites, to even
multiple strains of the same parasite species. Some papers discuss coin-
fection of bacteriophages (Mills et al., 2013; Refardt, 2011), and prions
(Leblanc et al., 2012). These groups are relatively little studied and are
not considered in this thesis. By including viruses, bacteria, protozoa,
fungi, and helminths in the definition of coinfection, the effects of a range
of parasites on human health can be explored.
Commensal organisms are like parasites because they derive energy
from their host, though they are not normally pathogenic. Commensals
can be difficult to distinguish from mutualists or pathogens because their
relationship with the host varies over time and under different conditions
(Mims et al., 2000). While commensals are thought to affect the suscep-
tibility, immunity to (Abt and Artis, 2013; Naik et al., 2012; Stecher and
Hardt, 2008), and virulence (Lysenko et al., 2010) of parasites co-occurring
in their host, these commensals also confer benefits to host physiology
(Turnbaugh et al., 2008). While not addressed in this thesis, the role
of commensals in coinfection is an important area for future study. For
this thesis a pathogenic definition of coinfection seems reasonable since
the aim is to understand the effects of coinfection on human health, and
pathogenic organisms directly damage human health while commensals
generally do not.
Some authors use coinfection to refer to multiple subspecies, like differ-
ent malarial strains (De Roode et al., 2005), or genotypes of a trematode
species (Karvonen et al., 2012). Across infection publications, 11% re-
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port conspecific strains (Balmer and Tanner, 2011). This thesis does not
consider co-occurring subspecies as coinfections because multi-genotype
coinfections can involve different processes from multi-species infections
(Louhi et al., 2013), such as viral recombination only occurring with su-
perinfection of a conspecific strain (Blackard et al., 2002). This distinction
is complicated by the fact that the differences between multi-genotype and
multi-species infections often depends on the taxonomic group (Alizon
et al., 2013). While further research is needed into how parasite species
or subspecies differ and what the biological implications are (Alizon et al.,
2013), before we can make such a comparison, we first need to establish
the general patterns of coinfection when the line is drawn at each scales.
Since differences within species are likely to be smaller, this thesis focuses
on interactions between species to enable the breadth of interactions in
coinfected humans to be studied more efficiently. Comparisons with multi-
genotype research are an important subject for future research. Having
defined coinfection as simultaneous infections of multiple pathogenic par-
asite species in the same host, the next step is to consider how coinfecting
parasite species interact.
How do coinfecting parasites interact?
An interaction is the effect of an individual of one species on an individual
of another species (Wootton and Emmerson, 2005). Parasites of different
species do not always interact; the species might be independent, but the
presence of multiple species in the same host can exert additive burdens
on host health (Brogden et al., 2005; Brooker et al., 2007). Coinfection
can also just be an association, for example two species may often coin-
fect humans if the same host characteristics are a risk factor for infection
by both parasite species (Sousa, 1994). There are also debates over which
statistical tools to use to detect parasite interactions (Cobey and Lipsitch,
2013; Fenton et al., 2010; Haukisalmi, 1994; Sousa, 1994), but they can
be classified by the biological processes between the two parasites. In-
teractions between parasite species can be direct or indirect, analogous
to the types of interspecific interactions found in free-living ecosystems.
Accordingly, indirect interactions between parasites are top-down when
11
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mediated by predators (the immune system), or bottom-up when me-
diated by a shared host resource (Graham, 2008; Pedersen and Fenton,
2007).
Direct interactions include viruses infecting bacteria (Flores et al.,
2011; Hanlon, 2007), helminths transmitting bacteria (Perkins and Fenton,
2006), and bacterial colonies releasing exoproducts that hinder other bac-
terial species (Hoffman et al., 2006). Indirect interactions that are medi-
ated by the immune response (Kasprowicz et al., 2008) can be opportunis-
tic coinfection by normally commensal bacteria when the immune system
is suppressed by another infection (Chonmaitree et al., 2008; Cox, 2001),
and trade-offs between different branches of host immunity (Bradley and
Jackson, 2008; Graham, 2001; Maizels and Yazdanbakhsh, 2003; Page
et al., 2006; Stewart et al., 1999). Lastly, examples of indirect interac-
tions involving host resources are competition between malarial parasites
for red blood cells (Antia et al., 2008; Read and Taylor, 2001), or influenza
infection creating more pneumococcal binding sites (Peltola et al., 2005).
There are many mechanisms by which parasites of different species in-
teract in a host (Dobson, 1985), and these can have positive or negative
effects (Brogden et al. (2005), also called synergistic or antagonistic) on the
abundance of coinfecting parasites, and, in turn, on host health. Whether
interactions are positive or negative, direct or indirect, they could affect
parasite community dynamics, and treatment outcomes (Jackson et al.,
2006; Lello et al., 2004).
Importance of coinfection for prevention and
treatment of infectious disease
Finding parasite species that interact strongly is urgent given the many,
and potentially large effects of parasite interactions on the outcomes of
treatment and prevention efforts. For example, immune-mediated inter-
actions can hinder preventative measures like vaccination. Generally, if
one parasite affects the immune response, then vaccines and certain diag-
nostic tests are less effective (Buck et al., 1978c; De Bruyn, 2010). Vaccines
that are less effective in individuals with other infections include helminths
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(Cooper et al., 2001; Geiger et al., 2011; Harris et al., 2009), HIV (van den
Berg et al., 2009), human papillomavirus (Pons-Salort et al., 2013), and
enteric viruses (Armah et al., 2010; Guerrant et al., 1990; Madhi et al.,
2010; Wang et al., 2012; Zaman et al., 2009, 2010). While these pre-
ventative measures are an important area for coinfection research, this
thesis focuses on treatments because these are administered to coinfected
individuals, whereas many of the aforementioned vaccine studies include
individuals with single-species infections.
As with vaccines, treatments targeted toward particular parasite species
can fail to improve the health of individuals who are infected by other
species. Treatment of infection using drugs can be impeded or counter-
productive because of interactions between coinfecting parasites (Behnke
et al., 2001). One otherwise successful treatment had such serious side
effects in coinfected patients that subsequent treatment programmes took
extra precautions in coinfected populations (Diggle et al., 2007). In this
case, treating onchocerciasis with a standard drug (ivermectin) triggered
severe, and sometimes lethal, encephalitis within three days in patients
with high burden Loa loa infections (Boussinesq et al., 1998, 2001; Chio-
dini, 2001; Gardon et al., 1997). This is thought to be because the drug
caused a high rate of nematode death behind the eyes (Gardon et al., 1997;
Twum-Danso, 2003). Thus, treatments can have reduced benefits for, and
even damaging effects on, individuals coinfected with other parasites.
Knowledge of how parasite species and existing treatments affect the
health of coinfected individuals is therefore needed to develop new, im-
proved treatment options. Knowledge of parasite interactions is not always
available and, where it is, its use in treatment programmes is just begin-
ning. The only treatment guidelines for coinfection are for patients with
Hepatitis B or C virus (HBV or HCV) or tuberculosis and HIV (Brook
et al., 2010; Daftary et al., 2006; England et al., 2009; Pozniak et al.,
2005), with prescription of existing drugs for both infections being the first
treatment option (Firnhaber and Ive, 2009). The recommended drugs fail
in two thirds of HCV-HIV coinfection cases, so new treatments are be-
ing developed that combine standard interferon with new HCV protease
inhibitors (Chary and Holodniy, 2011) or microRNA blockers (Janssen
13
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et al., 2013). Even for relatively well-studied hepatitis coinfection where
treatment guidelines are being developed, there is much scope to better
understand interactions between the viruses to improve treatment.
Treating coinfecting parasites simultaneously
Some treatment programmes are beginning to consider which parasites
co-occur in human populations. One approach is to use integrated treat-
ments that administer all available drugs together to tackle each infec-
tion (Molyneux et al., 2005; Zaman et al., 2009). Integrated treatment
programmes have begun in communities with high helminth coinfection
prevalence (Hotez, 2009; Hotez et al., 2007). Treating several helminth
infections in communities with many coinfected individuals can be highly
efficient and beneficial to health; the largest health improvements from
deworming school children have been found in populations where 96%
of children had hookworm and Trichuris coinfection (Stephenson et al.,
1993; Taylor-Robinson et al., 2012). However, the potential for interac-
tions between the drugs is poorly understood (Lammie et al., 2006), proper
evaluation of these programmes is rare (Parker and Allen, 2011; Yamey,
2009), and effects on non-target parasites are rarely monitored (Basa´n˜ez
et al., 2012; Eziefula and Brown, 2008; Righetti et al., 2012).
There is also integrated treatment in terms antiretroviral therapy for
HIV during tuberculosis therapy. This reduced patient mortality in a ran-
domised controlled trial (Abdool Karim et al., 2010), but the best time
for initiating the treatments is unclear (Abdool Karim et al., 2011). Sim-
ilarly for HIV-malaria coinfection it is unclear when integrated treatment
should be preferred (Skinner-Adams et al., 2008).
Although current treatment guidelines recommend it, integrated treat-
ment could be unnecessary if targeting a single infection indirectly reduces
the burden of other infections. For example, malaria elimination efforts
also bring reductions in cases of lymphatic filariasis (van den Berg et al.,
2013). Research into optimal coinfection treatment is in its infancy, and
other options besides integrated treatment are being considered.
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New treatments based on the direction of parasite interactions
Rather than administering separate drugs for each infection, recent studies
have suggested that treatments could be tailored to how parasites inter-
act within coinfected hosts (Pasman, 2012; Shrestha, 2011; Siqueira Jr
and Rocas, 2009). Traditionally, infection research studied each parasite
independently (Belia, 2009), and often ignored how different infections
affect one another (Kuramitsu et al., 2007). Understanding positive in-
teractions between particular pairs of parasites has led to novel methods
of infectious disease control, such as using antibiotics to kill the commen-
sal bacteria Wolbachia in various host species. While the Wolbachia do
not directly parasitise humans, antibiotics clear these commensals from
their adult filarial nematode hosts, such as Wuchereria bancrofti, which
are sterilised and die prematurely (Landmann et al., 2011; Slatko et al.,
2010; Tamarozzi et al., 2011; Taylor et al., 2010). I know of no exam-
ples where one pathogenic species was targeted in order to also suppress
another parasite species.
Treatments could also be improved by use of parasites that interact
negatively with other parasite species. For example, parasites like sym-
biotic bacteria that compete with more pathogenic organisms are given
to patients as probiotics after surgery or after antibiotics to reduce the
risk of subsequent infection by more pathogenic species (Khodadad et al.,
2013; Rayes et al., 2004). Viruses that delay progression of coinfection
are also being considered as potential vaccines, as with GBvC or HIV-2
that can produce some protective immunity against HIV-1 (Bagasra et al.,
2012; Esbjernsson et al., 2012). Introducing Wolbachia from Aedes aegypti
mosquitoes can reduce transmission of dengue among humans (Hoffmann
et al., 2011). Treatment of parasites that interact negatively with other
parasites should also be avoided since treating parasites that confer cross-
protective immunity to other parasites, as with Plasmodium falciparum
malaria in some age groups (Bruce et al., 2000; Smith et al., 1999), might
lessen the target infection and exacerbate non-target infections.
Appropriate manipulation of interactions among coinfecting parasites
could improve treatment for millions of coinfected individuals worldwide
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(Brogden et al., 2005; Costello et al., 2012; Cox, 2001). It is possible to
make general statements about treatment of coinfection based on parasite
interactions. For instance, if one parasite, like a helminth, induces anti-
inflammatory immune responses then treatment could exacerbate coinfec-
tions (Jackson et al., 2004; Kamal and El Sayed Khalifa, 2006; Smith et al.,
2011). However, altering treatments based on likely negative interactions
does not necessarily improve patient health; randomised trials show that
treating immunosuppressive parasites like helminths does not delay pro-
gression of other immunosuppressive parasites like HIV (Whitaker et al.,
2012). A general theory of coinfection in humans would need to explain
why non-target parasites respond to treatment in sometimes unexpected
ways. This thesis aims to contribute to such a general perspective, and
various approaches are available for this research.
Approaches to coinfection research
From pairs of parasites to whole communities
Most of the above studies only consider a few coinfecting species, but
humans encounter a more diverse parasite community. There are also
many concurrent within-host processes that may affect treatment success.
Whether there are general rules governing how certain types of parasite
species interact within the same host, and how these interactions can be
manipulated to improve human health, is an open question, and one this
thesis seeks to address.
Spanning multiple disciplines and scales
Parasite communities within individual hosts have been discussed previ-
ously, including a 1950s description of ecological understanding of para-
sitism and host immunology (Cameron, 1956), a 1986 chapter on helminth
communities (Holmes and Price, 1986), and a 1992 symposium on ecolog-
ical studies of immune responses to infection (Wassom, 1993). Nowadays
coinfection is studied by many specialisms, including parasitologists, mi-
crobiologists, and public health practitioners. Just as knowledge of inter-
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actions at the protein level requires a mix of biology, chemistry, and physics
(Kastritis and Bonvin, 2013), so too is cross-disciplinary research of par-
asites needed to improve coinfection treatment (Fincham et al., 2003).
In this thesis I therefore use a variety of relevant tools in an “antedisci-
plinary” endeavour (Eddy, 2005) in order to identify interspecific parasite
interactions, and test their impact on health and treatment outcomes.
Not only are there multiple parasite species involved in coinfection, but
processes occur at various biological scales to affect individual health. Par-
asite interactions occur at levels from the cellular level within coinfected in-
dividuals (Durmus¸ Tekir and U¨lgen, 2013; Schneider and Klabunde, 2013;
Zengler and Palsson, 2012), to migration through multiple organ systems,
up to the human population level where complex, multi-stage diseases
are currently a major medical challenge (Auffray et al., 2009; Tappenden,
2011; West, 2012). To help research this multi-scale problem, concepts
and techniques normally applied to free-living communities can be use-
ful for studying the community of parasites within coinfected individuals
(Costello et al., 2012; Gonzalez et al., 2011; Meyer and Leveau, 2012;
Pedersen and Fenton, 2007; Roche et al., 2012; Siqueira Jr and Rocas,
2009).
Making the most of existing data
Broad studies will most efficiently find how best to control complex dis-
eases like coinfection (Baraba´si et al., 2011; Wolfram, 2002) and patterns
of interaction among coinfecting parasites. Holistic understanding comes
from combining knowledge of individual components (Pavlopoulos et al.,
2011; Wilson, 1998), and published findings spanning cellular processes
up to whole organ systems offer a good start for beginning to build up
knowledge of interactions among the parasite community of humans. By
bringing together specific insights from studies that each focused on a few
parasite species, we can develop a systems level understanding of complex
host organisms and their parasites (Moulin, 2005). This thesis will at-
tempt to collate and describe these interactions using recently published
reports of coinfected humans. Given the wealth of expert knowledge on
the wide array of human parasites, it would be prudent to use existing
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publications to gain an overview of the parasites and health of coinfected
individuals. Data from these publications could reveal, for the first time,
the types of parasites known to coinfect humans, and differences between
the health status of coinfected individuals and those with single infections.
In this thesis I present a systematic survey of a full year of publications on
coinfection in humans to seek to fill these large gaps in current knowledge
about coinfection.
Another way to collate existing data on coinfection is to construct a
network from known parasite interactions. Finding out how parasites, re-
sources, and immune system components interact in coinfected humans
would improve mechanistic understanding of parasite community struc-
ture. Food webs are networks that have been used to study the structure
of trophic (feeding) relationships among free-living organisms. Parasites
are increasingly being included in these networks by describing the host
species fed on by different parasite species, predominantly in marine or
estuarine ecosystems (Hechinger et al., 2007; Kuris et al., 2008; Lafferty
and Kuris, 2009; Lafferty et al., 2006, 2008; Lima Jr et al., 2012).
Applying these network ideas to coinfection, we can view parasitism as
a trophic interaction within a host, where a parasite is the consumer and
cells of the host are the resources, and where the host’s immune system is
the predator (Wassom, 1993). Were a network of trophic relationships of
parasites within humans to be constructed, it would reveal the potential
way for coinfecting parasites to interact (Pedersen and Fenton, 2007). This
thesis will assemble such a network to understand the types of interaction
that structure the parasite community of humans, the first network of its
kind for any host species.
Further data on many infections in human populations are routinely
collected by many organisations. Some datasets contain information on
concurrent infections of individuals, but to my knowledge these have not
yet been used to study coinfection. For example, in the constituent coun-
tries of the UK, every human death is recorded with its cause or causes.
These causes of death can include infectious diseases. Accessing such data
would provide unique insight into the kinds of parasites involved in human
mortality. This thesis will analyse the relative proportions of single and
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coinfection deaths in these data to infer how strongly one infection affects
the odds of other infections being reported as a cause of death.
Testing the implications of parasite interactions using theoret-
ical models
Developing a network to describe interactions in coinfected humans, analysing
reports of the effects of coinfection from recent publications, and analysing
a national dataset on causes of death to understand the odds of coinfec-
tion death, will provide suggestive evidence of how parasite interactions
affect human health. Understanding how interactions affect each parasite
species’ abundance over time is also vital if treatment outcomes are to
be improved. Coinfection has been recognised among many human com-
munities for decades, but its effects are unclear and coinfecting parasites
are rarely monitored by treatment programmes targeting particular in-
fections (Buck et al., 1978d; Keusch and Migasena, 1982). One could do
field experiments in humans to assess interactions, and do clinical trials of
different treatments to infer how treatment affects the abundance of coin-
fecting parasites. Some such studies are underway, but besides the few
examples highlighted above where treatments are known to be affected
by interspecific parasite interactions, we have no general understanding of
how treatments targeting particular species affect non-target parasites.
Theoretical models can test the effects of treatment on coinfecting par-
asites and host health in parasite communities across a range of various
interaction types and strengths. Developing a general, theoretical model
could also show effects of drug treatment over multi-year programmes
using a range of scenarios more quickly, efficiently, and at lower cost
than field trials (Westerhoff et al., 2009). Theoretical models also allow
for greater experimental control than real human treatment programmes
where ethical concerns make it difficult to conduct randomised, double-
blind, placebo-controlled trials.
Several models have been used to study the dynamics of simultaneous
infections for particular pairs of parasites, such as gonorrhoea and HIV
coinfection (Mushayabasa et al., 2011), and malaria and trypanosomiasis
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(Nannyonga et al., 2012). However, the findings from such models are
relevant only to specific coinfections. More general models can show the
range of possible outcomes, for instance by varying the efficacy of treat-
ments or the types of coinfecting parasite. General theoretical models
have been used to show the effect of treatments of single-species infections
(Anderson and May, 1992). More recent general models relating to coin-
fection have explored the effects of species interactions on populations of
coinfecting bacteria (Eswarappa et al., 2012), and of vaccination and im-
mune interactions in a three-species helminth system (Lello et al., 2004).
The findings from these models are more widely relevant as they were not
created for specific parasites. However, I know of no models that measure
treatment outcomes amidst within-host parasite interactions of varying
type and strength in a heterogeneous host population. In this thesis, I
build this type of model to better understand how a village-sized human
population receiving treatment for one of two helminth infections will be
affected by interactions between the parasites.
Objectives of this thesis
The goal of this thesis is to better understand the effects of coinfection on
human health on a general level. I aim to study the effects of coinfection
on morbidity and mortality, interactions among coinfecting parasites, and
how these interactions affect treatment outcomes. To understand the type
and strength of interactions among the parasites community of humans,
I collected several novel sources of data on the parasite community of
humans and used various tools to describe the structure of this community
and study its implications for human health and treatment.
In Chapter 2 I systematically reviewed recent coinfection publications
and analysed the data they reported to find the taxonomic groups of par-
asites that coinfect humans, and their health effects. I compared the re-
ported coinfecting parasites with infectious diseases causing highest global
morbidity and mortality. The results suggest that coinfection often in-
volves micro-parasites, and is associated with higher parasite abundance
and worse host health when compared with single species infections. This
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is the first broad-scale test of whether coinfections have a higher health
burden than single infections.
In Chapter 3 I collated specific information about the within-host inter-
actions among coinfecting parasites reported in the publications reviewed
for Chapter 2. I assembled these interactions into the first ever network of
within-host interactions for any host species. This network suggests that
there are strong parallels between the structure of within-host parasite
communities and free-living communities of other organisms, and that in-
teractions involving shared host resources are the most common type of
interaction.
For Chapter 4 I compiled a dataset of reported causes of death from
England and Wales to test whether coinfection affects mortality risk. This
is another broad-scale analysis of the health effects of coinfection, but,
unlike in Chapter 2, I focus on mortality using cross-sectional, national
data. Results suggest that the odds of coinfection being reported on a
death certificate is not randomly distributed and that, when compared
with the occurrence of single infection deaths, the odds of coinfection
were higher than expected for many pairs of parasites.
In Chapter 5 I take a different approach again and develop a theoret-
ical model to test the effects of different parasite interactions, coinfection
prevalences, and treatment regimes on host health. This model includes
both immune- and resource-mediated interactions, and results show that
the direction of the effect of species-specific treatment on non-target par-
asites could be predictable if the direction of parasite interactions and
related within-host processes are understood.
Lastly, in Chapter 6, I conclude the thesis by discussing the results
of each of the four research chapters, and drawing together these find-
ings to address general patterns of coinfection in humans. I then discuss
the broader implications of my work, specifically how treatments could
be modified with knowledge of parasite interactions, and possible future
directions for coinfection research.
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Chapter 2
The nature and consequences
of coinfection in humans
Abstract
The kinds of parasites that coinfect humans, how frequently they occur,
and their human health impacts are poorly understood. One way to study
these patterns is to collate data from publications on coinfection in hu-
mans. In this chapter I systematically reviewed a recent sample of such
publications to find the parasites involved, their reported effects on host
health, and their reported effects on parasite abundance. I also compared
the proportion of coinfections involving these parasites with parasites caus-
ing the most global morbidity and mortality. Reported coinfections in-
cluded all kinds of parasites, but were most likely to contain viruses and
bacteria. Generally coinfected individuals had worse health (78% of pub-
lications, 40% of parasite pairs) and higher parasite abundance (57% of
publications, 37% of parasite pairs) than individuals with only one infec-
tion. The most commonly reported coinfections differed from infections
causing highest global mortality, with a lack of serious childhood infec-
tions. This suggests that coinfection tends to have deleterious effects on
human health, and often involves different parasites from those of highest
global health concern. The skew towards negative health effects, and un-
known levels of sampling or reporting biases in coinfection research should
prompt further collation and evaluation of human coinfection data.
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Introduction
The many parasites that infect humans (e.g., viruses, bacteria, protozoa,
fungal parasites, helminths) often co-occur within individuals (Brogden
et al., 2005; Cox, 2001; Esch et al., 1990; Petney and Andrews, 1998;
Rigaud et al., 2010). Helminth coinfections alone are thought to occur in
over 800 million individuals (Hotez et al., 2007), and are especially preva-
lent among the global poor (Boraschi et al., 2008; Hotez, 2009; Steinmann
et al., 2010). Other coinfections involve globally important diseases such
as HIV (Lawn, 2004), tuberculosis (Resende et al., 2007), malaria (Muturi
et al., 2006), hepatitis (Sagnelli et al., 2004), leishmaniasis (Alvar et al.,
2008), and dengue fever (Pancharoen and Thisyakorn, 1998). It seems
likely, therefore, that the true prevalence of coinfection exceeds one sixth
of the global population and often involves infectious diseases of pressing
human concern.
Improved understanding of coinfection prevalence is greatly needed
(Brooker et al., 2010), partly because coinfecting parasites can interact
either directly with one another or indirectly via the host’s resources or
immune system (Cox, 2001). Compared to infections of single parasite
species, these interactions within coinfected hosts can alter the transmis-
sion, clinical progression and control of multiple infectious diseases (Chio-
dini, 2001; Pedersen and Fenton, 2007; Sternberg et al., 2011). Establish-
ing the nature and consequences of coinfection requires data about the
various infections individuals have (Esch et al., 1990), but such data are
rare (Brooker and Utzinger, 2007; Pullan and Brooker, 2008; Steinmann
et al., 2010).
Coinfection involves a range of parasites and can have various effects
on host health (Cox, 2001). Studies in wild bats and Soay sheep suggest
positive interactions are dominant (Craig et al., 2008; Lotz et al., 1991),
though findings in wild mammals are highly variable (Marzal et al., 2008).
Reviews of coinfection emphasise the need for further research, especially
in humans (Cox, 2001; Holmes and Price, 1986; Petney and Andrews, 1998;
Pullan and Brooker, 2008), where coinfection outnumbers single infection
in many communities (Petney and Andrews, 1998; Raso et al., 2004), and
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where helminth coinfections appear to worsen human health (Pullan and
Brooker, 2008). There are many individual studies concerning coinfec-
tion, but these use different methods and are often narrowly focused. To
gain a coherent picture of the nature and consequences of coinfection in
humans the published literature was systematically reviewed for coinfect-
ing parasites and their effects on other infecting organisms and human
health. Coinfections involve a huge variety of parasites, and most stud-
ies report negative effects on host health. However, current coinfection
research rarely focuses on parasites with highest global mortality.
Methods
Literature search
Published studies of coinfection in humans were found using the largest on-
line citation database, Scopus (Elsevier Ltd.). Many disciplines study in-
fectious diseases and various terms are used to describe coinfection. Search
terms were: coinfection, co-infection, concomitant infection, concurrent
infection, multiple infection, simultaneous infection, double infection bi-
infection, bystander infection, polyparasitism, or multiple parasitism in
the Title, Abstract, or Keywords of publications from 1995 up to 2010.
An equivalent search on an alternative online citation database, Web of
Science (Thomson Reuters), yielded similar trends in publications through
time, but fewer results (grey vs. black dots, Fig. 2.1).
Due to the large number of publications matching the search terms,
further study focused on publications from 2009. Publications about non-
human hosts, non-infectious diseases or multiple genotypes of only one par-
asite species were excluded. A separate search for “infection” in the Title,
Abstract, or Keywords of publications on Scopus was done to compare
publication trends with the background trend in infection publications
(triangles, Fig. 2.1).
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Fig. 2.1: Annual publications (log10 ) from a search for all coinfection
terms in Scopus (black dots), and Web of Science (grey dots), and for
infection in Scopus (black triangles).
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Data collection
Data collected from each publication were: coinfecting parasites, jour-
nal, study type, and maximum number of parasite species per individual.
Study types included experiments to find the effects of treating each infec-
tion, observational studies, and reviews or meta-analyses. Observational
studies were either case notes on particular patients, studies of patient
groups, or epidemiological surveys of human communities, most of which
involved treatment.
Many publications reported the stated effect of one parasite on coin-
fecting parasite abundance (i.e. proxies for the intensity of infection, e.g.
from measures of viral load, faecal egg counts, antibody response, bacte-
rial cultures etc.) and/or host health (e.g. survival time, anaemia, liver
fibrosis, immune cell counts). These effects of coinfection are relative to
conditions observed under infections of single parasite species. Where
these effects were reported the pair of coinfecting parasites, quality of
measurement (rated as low e.g. anecdotal, adequate e.g. correlation, and
high i.e. full reporting of appropriate statistical test supported by theo-
retical mechanisms), and other data (see below) were recorded. Data from
review-type publications, case notes, and from publications not mention-
ing the effects of coinfection (93 publications for parasite abundance and
83 for host health) were excluded to avoid double counting, undue in-
fluence of individual cases, and the inclusion of irrelevant publications.
Reported effects based on low quality evidence were also omitted (e.g.
anecdotal or single patient data, 10 publications for parasite abundance,
24 for host health).
There was heterogeneity in the reporting of coinfection effects, both
in the response variable (e.g. cell counts, biomarkers, survival rates), and
the quantitative measure given (e.g. odds ratios, adjusted odds ratios,
p-values, hazards ratios, raw comparisons). Many publications gave only
qualitative statements of effect direction. Further study therefore focused
on the direction of reported effects (positive, negative and no-effect) to
maximise the data available. Reported directions of the effects on both
parasite abundance and host health for each pair of coinfecting parasites
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was coded +1 for positive effect, 0 for neutral, −1 for negative effects,
and NA if no information about effect direction was given. The resulting
dataset includes some repeated measures because some publications re-
ported multiple pairs of coinfecting parasites and some coinfections were
reported in multiple publications.
Analysis
I created two independent datasets containing the mean effect direction
(i) per publication, and (ii) per coinfection to eliminate these sources of
pseudoreplication. A negative mean implied a predominance of negative
effects; a positive mean implied a dominance of positive effects. A mean
close to 0 could result from either many neutral effects (parasite con-
sistently had no discernible effect) or nearly equal numbers of positive
and negative effects (parasite had different, possibly context-dependent
effects). In either case, there is no clear indication of these parasites
having a consistent effect on each other (or on host health), so conser-
vatively I infer that there is no effect. These means were converted into
three categories: negative (−1 to − 1
3
), neutral (−1
3
to + 1
3
) and posi-
tive (+1
3
to + 1). Chi-squared tests (Bushman, 1994) based on double
log-likelihood values (Crawley, 2007; Sokal and Rohlf, 1981) were done
to establish whether totals in each category differed from those expected
from two different null hypotheses (random and no-effect). The random
null model had equal proportions of positive, neutral, and negative effects,
while the no-effect null model was that coinfecting parasites do not inter-
act, allowing for a 5% error rate (hence 2.5% negative, 2.5% positive, and
95% neutral reported effects). This follows a recommended vote-counting
method using continuous response variables and 95% confidence intervals
(Hedges and Olkin, 1985).
I explored the potential influence of missing data (NAs) on the analy-
sis of coinfection effects (56 for parasite abundance, 47 for host health).
These values represent reported coinfections where the effect on either
parasite abundance or host health was not reported, despite the possibil-
ity that these coinfecting parasites did interact with each other or altered
host health. I therefore assessed how potential interactions from these
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unreported effects may alter the overall patterns of coinfection effects. To
determine their potential impact, NAs were assigned one of three values
with equal probability (+1, 0,−1). The mean effect was then calculated
per publication or coinfection pair as before, and a grand mean taken
across all publications or coinfection-pairs. The grand mean represents an
estimate of overall effect of coinfection on either host health or parasite
abundance across either publications or coinfections, given a particular
random assignment of −1, 0,+1 to NAs. Repeating this random assign-
ment 1000 times produced a distribution of grand means.
Whether recent coinfection research focuses on the parasites causing
the highest global mortality is considered in the discussion. Global totals
for the number of deaths for each infection were reported by the World
Health Organisation for the closest year available, 2008 (obtained from the
Global Health Observatory website, World Health Organization (2009)).
The ten categories causing the highest percentage of global deaths were
compared with the percentage of reports of coinfection from 2009 involv-
ing these infections, and with their morbidity (years of life lost to disability,
again for the closest year available, 2010, obtained from IHME (2012)).
Analyses were done in R version 2.15.1 (R Development Core Team,
2012).
Results
Hundreds of publications on coinfection are published annually and the
numbers increased from 389 publications in the first year of search results
to 1407 publications in 2009 (Fig. 2.1). This rate of increase has been
almost double the rate of overall infection publications (linear regression
log10 (search results) year slope= 0.041 for coinfection, slope= 0.023 for
infection, compare black dots with black triangles on the log-linear plot
Fig. 2.1). These search results include studies of human and non-human
hosts, and in vitro experiments. Of the 1407 publications retrieved for
2009, 253 reported multiple parasite species coinfecting humans. Publi-
cations came from 152 journals, but many journals (46, 30.3%) published
a single coinfection article in 2009.
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The majority of relevant publications from 2009 were observational
studies (191 of 253, 75.5%), of which 126 (65.9%) involved patient
groups, 46 (24.1%) were case notes and 17 (8.9%) surveyed a popu-
lation. Two observational studies (1.0%) analysed death records. Fifty-
seven publications (22.5%) were reviews or meta-analyses. Five publi-
cations (2.0%) were experimental, whereby treatment and controls were
applied to both singly infected and coinfected groups. A majority of the
relevant publications concerned coinfection by two parasite species (204
of 253, 80.6%), but more parasite species per individual were occasion-
ally reported; a maximum of six parasites was reported once (Peng et al.,
2009).
A total of 207 parasite taxa were reported in coinfection publications
from 2009 across 677 reports of coinfections comprising 447 different
pairs of coinfecting parasite taxa. All parasite types (viruses, bacteria,
protozoa, fungal parasites, helminths) were reported in coinfections; the
most common parasite group were viruses (796 viruses of 1354 coinfect-
ing parasites [58.7%]), then bacteria (320, 23.6%), protozoa (107, 7.9%),
helminths (78, 5.8%), fungal parasites (27, 2.0%), and undisclosed infec-
tions (26, 1.9%). In terms of specific parasites, HIV and hepatitis viruses
featured highly in reported coinfections. The most frequently reported
coinfections were: Hepatitis C (HCV) and HIV (82 reports of 677 total
coinfections, 12.1%), Hepatitis B (HBV) and HIV (31, 4.6%), HBV and
HCV (30, 4.4%), HIV and Human Papillomavirus (HPV, 27, 4.0%), and
HIV and Mycobacterium tuberculosis (27, 4.0%).
Reported effects of coinfection
Effects of coinfection on parasite abundance and host health were sampled
across 146 suitable publications according to parasite abundance and host
health for 444 coinfections, involving 119 parasites. Among these coin-
fections, 191 (43.0%) measured the size or direction of effects on parasite
abundance and 172 (38.7%) measured the size or direction of effects on
host health. The remainder of coinfections had no effects reported.
Overall, positive effects of coinfection on parasite abundance were the
most common reported across publications (6 negative, 14 neutral, 27
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positive reports across 47 publications; Fig. 2.2A). Among specific pairs of
coinfecting parasites neutral effects exceeded positive effects (7 negative,
91 neutral, 66 positive across 164 unique parasite pairs; Fig. 2.2C). In
both cases these patterns were strongly significantly different from the ran-
dom null model (grey line on Fig. 2.2, by publication [X2 = 14.7, d.f. =
2, p < 0.001], by coinfection [X2 = 88.8, d.f. = 2, p < 0.001]), and
from the no-effect null model (black line on Fig. 2.2, by publication
[X2 = 156.4, d.f. = 2, p < 0.001], by coinfection [X2 = 276.4, d.f. =
2, p < 0.001]).
Regarding the impact of coinfection on host health, there was a much
greater number of negative effects reported in publications than either
positive, neutral, or NA categories (46 negative, 10 neutral, 3 positive
across 59 publications; Fig. 2.2B). When data were aggregated by spe-
cific parasite pairs the neutral effects exceed the negative effects (45 neg-
ative, 74 neutral, 4 positive across 123 unique parasite pairs; Fig. 2.2D).
In both cases these patterns were significantly different from the ran-
dom null model (grey line, by publication [X2 = 53.4, d.f. = 2, p <
0.001, Fig. 2.2B], by coinfection [X2 = 77.2, d.f. = 2, p < 0.001,
Fig. 2.2D]), and from the no-effect null model (black line, by publi-
cation [X2 = 286.3, d.f. = 2, p < 0.001, Fig. 2.2A], by coinfection
[X2 = 176.0, d.f. = 2, p < 0.001, Fig. 2.2C]).
It is unlikely that these patterns of the effects of coinfection would
be changed by knowledge of the unreported effects (the NAs in Fig. 2.2).
Even after NA values were assigned predominantly to the neutral category
(i.e. under the no-effect null model), the distribution of the grand mean
effect was positive for the effects on parasite abundance (Fig. 2.3A and
C), and negative for effects on host health (Fig. 2.3B and D). None of the
distributions of grand means overlapped zero (Fig. 2.3).
Reported coinfections compared with infections of global health
importance
There were differences between the most commonly reported coinfecting
parasites and the infections causing most global health burden (Fig. 2.4).
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Fig. 2.2: Direction of reported effects of coinfection on the abundance
of infecting parasites and host health averaged across publications and
coinfections published in 2009. Horizontal lines indicate expected values
of null hypotheses (black=no-effect, grey=random).
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Fig. 2.3: Distribution of grand mean effects of coinfection including simu-
lations of missing values according to the random (grey line) and no-effect
(black line) null models. Lines generated by a Gaussian kernel estimator
(smoothing bandwidths: random = 5.1× 10−3 , no-effect = 1.2× 10−3 ).
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Respiratory infections causing the most (40.5%) infection deaths, with
the next greatest causes, diarrhoea and HIV/AIDS, causing half as many
deaths. Other important infections by global mortality are tuberculo-
sis, malaria, and predominantly childhood infections (measles, meningitis,
pertussis, and tetanus).
Comparing the infections causing highest global mortality, global in-
fectious disease morbidity, measured by years of disability caused by infec-
tion, are proportionately lower for respiratory infections and HIV/AIDS,
but higher for diarrhoea and tuberculosis (compare grey and white bars
on Fig. 2.4).
The tenth biggest infectious cause of mortality worldwide, HBV, is the
only hepatitis virus featuring in the top ten infectious causes of mortality,
causing 1.1% of infectious disease deaths, and 0.4% of years of disability
from infection. In comparison, hepatitis viruses featured in one third of
reported coinfections (220 of 677, 32.5%, fourth black bar from the left
in Fig. 2.4)).
The top ten parasite species reported in coinfections were HIV (in 266
[39.3%] of 677 coinfections), HCV (20.4%), HBV (12.3%), M. tubercu-
losis (5.9%), Cytomegalovirus (CMV, 5.2%), Hepatitis D (HDV, 3.8%),
unidentified bacterial infections (2.8%), Herpes Simplex virus (HSV, 2.7%),
HPV (2.51%), and unidentified helminth infections (2.51%). While five
of these viruses (CMV, HCV, HDV, HPV, and HSV) are among the most
common reported coinfecting parasites, they contribute relatively little to
global infection mortality. Four of the globally most common infectious
causes of mortality received no, or very few, reports of coinfection in 2009
publications (all of them childhood infections: meningitis [0.15% of re-
ports], tetanus [0.08% reports], pertussis [no reports], and measles [no
reports]).
Discussion
Interest in coinfection has increased in recent years, with publications on
human coinfection involving hundreds of parasite taxa across all major
parasite groups. Recent publications show that negative effects of coinfec-
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tion on human health are more frequent than no effect or positive effects.
The most commonly reported coinfecting parasites are not the infections
causing highest global mortality. These results raise questions concerning
the occurrence and study of coinfection in humans and their implications
for effective infectious disease management.
The overall consequence of reported coinfections was poorer host health
and enhanced parasite abundance, compared with single infections. This
is strongly supported by differences in the reported direction of effects
(p < 0.001) from expectations of either no-effect or of random distribu-
tions, by the robustness of these trends to missing values, and by the
diverse publications in which these coinfections were reported. The ten-
dency for positive effects on parasite abundance also corroborates the neg-
ative effects on host health because larger infections are a mechanism by
which disease can be exacerbated. The consistency of these detrimental
coinfection effects across a wide range of parasites suggests a general ten-
dency towards positive interspecific interactions. In publications about
leprosy and tuberculosis coinfections there has been a recent turn away
from antagonistic interactions toward more synergistic theories (Hohmann
and Voss-Bo¨hme, 2013). A majority of positive interactions is also seen
in the animal coinfection literature (Manenti, 2011), and in Tanzanian
children (Lello et al., 2013).
The reported coinfection effects could have at least two explanations.
First, coinfection may be more likely to occur or be detected in individuals
of poor health, which in turn leads to poorer prognosis among coinfected
cases. The failure to always undertake a full-range of initial diagnostic
tests and the relative paucity of experimental studies of coinfection in
humans means sampling bias towards individuals of poorer health is pos-
sible, though there may be recall bias in the opposite direction because
coinfected patients are less likely to take part in follow-up observations
(Nansera et al., 2012). Such biases were difficult to account for in my
analyses. The second explanation is that coinfecting parasites interact
synergistically with each other, for example via the host’s immune sys-
tem, so that the presence of one enhances the abundance or virulence of
the other. A clear example of this is HIV, which causes immunosuppres-
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sion, increases the likelihood of additional infections, and occurred in two
fifths of reported coinfections (Fig. 2.4).
Differences between reported coinfections and global mortality figures
also suggest interactions between coinfecting parasites. Coinfections that
were more commonly reported than their relative contribution to global
mortality may involve particular synergistic parasite-parasite interactions,
such as herpes viruses like CMV or HSV infection enhancing the risk of
HPV coinfection (Baldauf et al., 1996). Conversely, infections that cause
high mortality but had relatively few reports of coinfection could result
from antagonistic interactions, reducing the likelihood of such coinfections
occurring and being reported, like Pseudomonas aeruginosa exoproduct
limiting Staphylococcus aureus colony formation (Hoffman et al., 2006).
An alternative, and possibly more likely, explanation of the discrepan-
cies between reported coinfections and global mortalities from infections
could be greater funding availability (e.g. HIV/AIDS research), higher
interests of virologists in coinfection and/or easier observations or more
routine screening compared with other parasite types, for instance the
greater difficulty of detecting intestinal helminths to the species level in a
living patient. The lack of coinfection publications reporting on major in-
fectious causes of childhood mortality remains unexplained. While some
publications do consider childhood coinfection (Lello et al., 2013), and
coinfection appears to be more common in childhood (Plata-Nazar et al.,
2009), recently published coinfection research does not include the infec-
tions that kill the most infants globally. Fewer than 1 in 20 publications
reported coinfections involving helminths, despite hundreds of millions of
helminth coinfections globally (Hotez et al., 2007), which could arise from
limited published research on helminthiases. To what extent disparities
between global mortality data reflect real patterns, or biases in either re-
search attention or reporting, remains to be seen. Proper evaluation of
these potential biases is hindered by inadequate coinfection surveillance.
The disparity between infections that feature highly in global mortal-
ity statistics and those receiving most attention in published coinfection
studies poses a challenge to infectious disease research. A general under-
standing of the effects of coinfection is important for appropriate control
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Fig. 2.4: Ten infections causing most deaths globally in 2008 (grey bars,
World Health Organization (2009)), compared with percentage of times
those infections were reported in coinfections in 2009 publications (black
bars), and global estimates for the years of disability caused by those
infections in 2010 (white bars, IHME (2012)).
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of infectious diseases (Boraschi et al., 2008; Brogden et al., 2005; Hotez,
2009; Laserson and Wells, 2007). Poor or uncertain observational data
regarding coinfection hinders efforts to improve health strategies for infec-
tious disease in at-risk populations (Steinmann et al., 2010). For example,
global infectious disease mortality data (World Health Organization, 2009)
report only single causes of death, even if comorbidities were identified.
If health statistics better represented coinfection, published coinfection
research could be better evaluated. True patterns of coinfection remain
unknown (Brooker and Utzinger, 2007), but my results suggest that it
may differ from existing data on important infectious diseases.
Recently published reports of coinfection in humans show that coinfec-
tion tends to be detrimental to human health. Understanding the nature
and consequences of coinfection is vital for accurate estimates of infec-
tious disease burden. More holistic data on infectious diseases would help
to quantify the size of the human health effects of coinfection. Improved
knowledge of the factors controlling an individual’s risk of coinfection,
circumstances when coinfecting parasites interact, and the mechanisms
behind these parasite-parasite interactions, especially from experimental
studies, will also aid the design and evaluation of infectious disease man-
agement programmes. To date, most treatment programmes typically
treat each parasite species as if it were in isolation. If coinfecting parasites
tend to interact to worsen human health, as suggested here, treatments
may need to be more integrated and specialist treatments developed for
coinfection.
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Chapter 3
Parasites interact most via
shared resources in a summary
human coinfection network
Abstract
Coinfection can have negative effects on human health (Chapter 2). How
coinfecting parasites interact within a complex human host to produce
these effects is currently unknown. Understanding the mechanisms that
underly parasite interactions within a host could lead to improved coin-
fection treatments. In this chapter I use data from hundreds of published
studies of coinfected humans to assemble a summary within-host coinfec-
tion network comprising direct and indirect interactions among parasites,
resources, and host immune components. I then investigated the net-
works structure by quantifying parasite interaction types, and detecting
modules of closely interacting components. Interactions between pairs of
parasites were more often mediated indirectly through shared resources
than through immune components or other parasites. Furthermore, the
network comprised 10 groups of closely interacting parasites, resources
and immune components, eight of which were associated with particu-
lar body parts, and seven of which were dominated by parasite-resource
interactions. The summary network of reported coinfection in humans
had a compartmentalised structure, with physical location and bottom-
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up, resource-mediated processes most often influencing how, where, and
which coinfecting parasites interact. This shows the utility of networks for
understanding how coinfecting parasites interact, gives evidence for why
parasite communities in human populations may be resistant to treat-
ment, and provides hypotheses for how new treatments could modify the
processes within coinfected humans.
Introduction
More than 1400 parasite species, including viruses, bacteria, helminths,
protozoa, and fungi, infect humans (Taylor et al., 2001). Simultaneous in-
fection of humans by multiple species (coinfection) is commonplace (Brog-
den et al., 2005; Cox, 2001; Petney and Andrews, 1998); helminth coinfec-
tion alone affects 800 million individuals (Hotez et al., 2007). Coinfection
involves globally important diseases like HIV and tuberculosis (Fatken-
heuer et al., 1999), is concentrated among the poor (Boraschi et al., 2008;
Steinmann et al., 2010), and is often associated with worse host health
and higher parasite abundance (Chapter 2). Coinfection can also reduce
treatment efficacy (Chiodini, 2001; Cooper et al., 2001; Harris et al., 2009),
and increase treatment costs (Rizzardini et al., 2011). These phenomena
are likely driven by within-host interactions among coinfecting parasites.
Coinfecting parasites interact when individuals of one species affect in-
dividuals of another (an interspecific interaction, Wootton and Emmerson
(2005)). Interactions may be direct (Hoffman et al., 2006), or indirect, me-
diated by other parasites, host immunity (Bruce et al., 2000; Christensen
et al., 1987; Cox, 2001) or host resources (Antia et al. (2008), i.e. body
parts consumed, damaged, or inhabited by parasites). These bottom-up
resource-mediated and top-down immune-mediated interactions between
coinfecting parasites have been likened to how species interact in free-
living ecosystems (Pedersen and Fenton, 2007). Accordingly, treatment of
one species could result in unexpected changes to another non-target par-
asite (Bruce et al., 2000; Druilhe et al., 2005; Lello et al., 2004). However,
we currently know little about the frequency of these different interac-
tion types, or how they are distributed in the human body (Franco et al.,
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2003). Indeed, the potentially overwhelming diversity of coinfecting para-
site types, and their many possible interactions, means that understanding
the consequences of coinfection remains difficult.
Before the effects of treatment on coinfecting parasites can be pre-
dicted, we need to know how within-host parasite communities are struc-
tured. If parasite communities have consistent, non-random assembly
processes, these could be used to develop general treatment guidelines.
However, at present, we do not know the overall structure of the wider
parasite community because most studies of coinfection are typically re-
stricted to measuring interspecific interactions between pairs of parasites
(80% of publications reviewed in Chapter 2 reported a single species pair).
Here, I move beyond this pairwise view to study interspecific interactions
among the parasite community of humans.
Network structure can reveal the biological function of complex sys-
tems (Albert and Barabasi, 2002; Strogatz, 2001), and networks have fre-
quently been used to study free-living ecological communities. Summary
networks, comprising aggregated samples across multiple places or times,
are particularly useful for finding consistent forces influencing commu-
nity composition or interaction pathways among groups of components,
even when they are not directly measured from a single sample (Pimm,
2002). Researchers have begun to include parasites in ecosystem-wide net-
works (Lafferty et al., 2006), and in disease transmission networks (Danon
et al., 2011; Poulin, 2010). Networks are also being applied to complex
diseases (Cho et al., 2012), and within-host ecosystems, revealing relation-
ships between the host and single parasite infections (e.g. Mycobacterium
tuberculosis, Raman et al. (2010)), humans and their microbes (Thiele
et al., 2012), and a summary network of many parasites across many fish
species (Lima Jr et al., 2012). However, there has been no attempt to
construct a comprehensive within-host interaction network for a single
host species. Such a network could be constructed with three trophic lev-
els of parasites, resources consumed by them, and host immune defences
to show whether interactions among parasites are direct or indirect, or
are predominantly resource-mediated or immune-mediated (Pedersen and
Fenton, 2007). Understanding such community-wide patterns could in
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the future help understand and predict treatment responses in individual
coinfected patients.
Here I constructed the first summary network of within-host coinfec-
tion from published reports of coinfection in humans. The components
(nodes) of the network are parasites (e.g. HIV, Aspergillus, hookworm),
host immune system components (e.g. IgA, IL-10, macrophages), and
host resources (including nutrients or cells consumed and cells, bodily flu-
ids, tissues, organs, anatomic sites occupied or damaged by parasites). I
then analyzed (i) the structure of the full network in terms of the dis-
tribution of links (interactions between nodes), (ii) the frequency of par-
asite interaction types (direct, immune-mediated, resource-mediated, or
parasite-mediated), and (iii) how the network is arranged in modules of
highly-connected nodes (see Table 3.1 and Fig. 3.1). I found the structure
of interactions among parasites within coinfected humans to be similar to
other ecological networks and, contrary to expectations from other re-
search, to mainly be subject to bottom-up control.
Methods
Network development
A network of parasites, resources, and immune components (nodes) was
assembled from 316 articles on human hosts with established coinfections
published in 2009 (one year due to time constraints; see Chapter 2 for
inclusion and exclusion criteria). Analyses later in this chapter show that
results are unlikely to be affected by the restricted dataset (see accumu-
lation curves and effects of publication sampling in Fig. 3.7).
Interactions in the network are denoted by links between two nodes,
and all links in the network were binary (present or absent), since data for
interaction strengths were unavailable from most publications. Quantified
interaction strengths are useful when modelling network dynamics, and
when some interactions may only occur under certain conditions (e.g. at
particular points in the infection cycle, with plasticity of parasite pheno-
types (Mideo and Reece, 2012; Viney, 2001). However, a binary network
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Fig. 3.1: Illustrative diagrams of network analyses undertaken: (a) node
degree, (b) assortativity, (c) direct and indirect connections, and (d) mod-
ularity, where the modularity scores correspond to the maximum modu-
larity obtained by sequentially collapsing nodes into modules. The left
network in (d) was designed to have three modules and high modularity.
The right network in (d) is a random network with the same number of
nodes, links, and modules, but has lower peak modularity.
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Table 3.1: Network metrics used herein and their biological relevance for
understanding interactions among coinfecting parasites.
Measure Meaning Importance to coinfection Outline
Degree Number of nodes
linked to a given
node.
Reveals how interactive a node is. Fig. 1a
Assortativity Correlation of node
degree across all
pairs of linked
nodes.
Strong positive correlation indicates
polarisation between nodes with few
and many interactions; cliques of
highly interactive nodes may need
special treatment.
Fig. 1b
Direct
parasite
interactions
Number of parasites
linked to a given par-
asite.
Reveals coinfections where inte-
grated treatment may be advisable.
Fig. 1c
Indirect
parasite
interactions
Number of parasites
connected to each
parasite by two links
via an intermediary
node.
Reveals interactions between coin-
fecting parasites mediated by an-
other parasite or by host immunity
or resources, where treatment choice
may depend on host condition.
Fig. 1c
Modules Groups in the net-
work that have many
links within them
and fewer links to
other groups.
Reveals areas of highly connected
immune components, parasites & re-
sources. Could enable typing of coin-
fection cases.
Fig. 1d
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is sufficient for revealing the coarse topology of biotic interactions (see
Chapter 2 for a fuller discussion of the difficulty of quantifying interaction
strengths from this dataset).
Each individual publication reports only a subset of resource- and
immune-interactions relevant to that specific study. To understand the
wider potential for interactions among parasites I therefore combined in-
teractions from many publications into a summary network (also called a
community food web by Cohen (1978)), akin to many ecological networks
of free-living systems that aggregate all the possible links between nodes in
one ecosystem type (e.g. a freshwater stream, Woodward (2010)). Hence,
the full network does not represent an individual coinfected host, but re-
flects all potential within-host interactions reported among the parasite
community within humans.
Nodes
Nodes from reports collated across the sampled publications were named
consistently by aggregating closely related nodes. This aggregation helps
detect functionally similar interactions and is standard practice in net-
work science (Dunne, 2006). Following common use in genetics (Bard
and Rhee, 2004), I used an ontology (National Cancer Institute, 2011),
the Universal Medical Language Service (UMLS) semantic hierarchy (US
National Library of Medicine, 2010), and the following rules to ensure
consistent node aggregation: (i) immune and resource nodes aggregated
to cell type or above, except for components that interact directly with
parasites, (ii) substance nodes designated by the UMLS type were aggre-
gated by their biological function, and (iii) nodes relating to the human
reproductive system were classified into gender-specific classes (e.g. female
genitals, male genitals, and pregnancy), because differences between the
sexes and reproductive status have been biologically important in other
coinfection studies (Cattadori et al., 2008; Luong et al., 2010; Ned et al.,
2005). Accordingly, some nodes above the cellular level were subsets of
one another, such as knee and joint, gums and mouth, or colon and gas-
trointestinal. These nodes were not aggregated so as not to confound how
particular interaction patterns were counted, for example, the number of
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indirect links between parasites will increase as intermediary nodes are
aggregated. Many links would be unrealistic if two parasites occupying
very distinct parts of, for instance, the alimentary canal were linked to
the same, aggregated resource node. Relations between nested nodes (like
colon and gastrointestinal) are biologically important, and the module
analysis allows these nodes to cluster together.
Since the amount of node aggregation (e.g. taxonomic resolution of
nodes) can affect ecological network structure (Gilljam et al., 2011), I as-
sessed the effect of three different node aggregation methods on the con-
clusions: (i) no aggregation, where node names matched those reported in
publications, (ii) medium aggregation of cells into tissues, immune recep-
tors into functional groups (Th1/Th2), and parasites to genus level, and
(iii) high aggregation where tissues were aggregated into body parts, and
parasites were aggregated to the family level.
Links
Links between nodes were first derived from the same publications that
reported those nodes. Resource or immune links for some parasites were
not mentioned in the publications, but in many of these cases the re-
sources they consume and immune responses they triggered were known
so were assigned using an encyclopedia of infections (Topley, 2006). Each
link was classified in one of three ways according to the strength of ev-
idence: (1) co-occurrences (two nodes observed in the same individual,
(2) correlations (an association between two nodes is reported, without
a known biological mechanism), or (3) mechanistic links (connected by a
demonstrated biological process). While known mechanisms are a reliable
basis for an interaction, there are potential causal processes that remain
unknown, especially for poorly studied parasites. Establishing causality
over mere association is particularly problematic in humans where experi-
mentation is difficult. Two components found simultaneously in the same
individual could potentially interact, even if the connecting mechanisms
have not been identified or the interaction is so weak that it has not yet
been detected. Therefore three versions of the network were analysed
based on the link types described above: mechanistic links only, mecha-
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nistic and correlative links, and all three link types together. The three
versions cover a spectrum from a network with high degree of certainty
(mechanistic only) to one where the mechanism of interaction has not been
reported (all link types).
In most cases there was insufficient data to infer directionality between
parasites and their various linked host (resource and immune) components.
The presence of many undirected links, or ones where the direction of
energy flow is ambiguous (e.g. non-mechanistic links between parasites,
damage from migration through tissues, or immune interdependencies),
and the inability to compute a network with a mixture of directed and
undirected links means all three versions of the network were undirected.
Most of the metrics I used (assortativity, direct/indirect interactions, and
modularity) do not depend on link direction. Node degree can depend on
direction by counting links to or from a node (in- and out-degree), but for
this undirected network I used total degree.
A summary network
All the nodes and links across the time course of infections and across in-
dividuals form a summary network of coinfection in humans, akin to many
ecological networks of free-living systems that aggregate all the possible
links between nodes in one ecosystem type (Woodward, 2010). Hence,
the full network does not represent an individual coinfected host, but re-
flects all potential within-host interactions reported among the parasite
community within humans.
Network analysis
I analysed three structural features of each of the networks (Fig. 3.1
and Table 3.1): (i) how much the components interact with one another
(distribution of node degree, Fig. 3.1a-b), (ii) the relative importance
of different types of interaction between parasites (Fig. 3.1c), and (iii)
whether the network contains modules of tightly interacting nodes (Fig.
3.1d). While many other network structural features exist, I chose these
particular features because they reveal functionally important patterns
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regarding interactions in coinfected humans (see Table 3.1). Many other
analyses can be done to understand within-host networks of coinfection,
but I present a selection of results to highlight what a summary within-
host parasite network can reveal about coinfection. Analyses were done
in R version 2.15.1 (R Development Core Team, 2012).
Degree distribution
I summarised the overall network structure by calculating node degree.
A node’s degree is the number of nodes that are one link away (i.e. the
number of other nodes connected to each focal node). A networks degree
distribution reveals how links are distributed among nodes, can indicate
how resistant the network is to perturbation, and, being a commonly used
network metric, enables us to directly compare the within-host coinfec-
tion network with other networks. Parameter(s) for exponential, power-
law, Poisson, normal, and uniform degree distributions were estimated by
maximum likelihood and the coefficient of determination (R2 ) was calcu-
lated to find the model closest to the observed degree distribution (Dunne
et al., 2002).
I also analysed the tendency for well-connected (high degree) nodes
to be linked to other well-connected nodes (i.e. evidence for assortative
mixing, or assortativity). If highly linked nodes are also connected to
other highly linked nodes (high assortativity) there is greater potential for
perturbations to spread across the network (Maslov and Sneppen, 2002).
Assortativity was measured via Pearson’s correlation coefficient (r) of the
degree of each node either side of each link (Newman, 2003). Networks
with high assortativity have high positive values of r (close to +1) be-
cause high degree nodes are also likely to be linked to other high degree
nodes. Values of r close to 0 indicate a more even distribution of links,
similar to a random network. Negative values of r (close to −1) indi-
cate disassortativity whereby high degree nodes are dispersed across the
network and are typically connected to low degree nodes.
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Frequency of parasite interaction types
I counted the total number of direct and indirect links between every
pair of parasites to reveal the reported frequency of each type of parasite
interaction. Indirect links occur when two parasite nodes are linked via
an intermediate node (either a resource, parasite, or immune component).
The number of each type of parasite-parasite interaction was calculated
by isolating only the links relevant to a certain type of interaction, and
then counting the number of unique routes linking any parasite pair.
I compared the observed number of direct and indirect links with that
expected from chance using 1000 randomly rewired networks. I used a
constrained Poisson process to create random networks that had the same
number of nodes in each trophic level but each node had equal probability
of being linked to another node (Erdos-Renyi process of independent link
assignment, following Erdos and Re´nyi (1959); Strogatz (2001)). Many
networks deviate from such random distributions, but I used this null dis-
tribution to test whether the community of parasites coinfecting humans
was assembled by a neutral, independent process. Randomisations with
more biological detail could be explored in future, but as this is the first
summary network of parasites within humans I begin with a null model of
a Poisson distribution of links. I implemented the randomisation by reas-
signing the links from the upper triangle of the observed adjacency matrix
in random order. The total number of nodes and links was therefore equal
to the empirical network, though the redistribution of links meant that
individual node degrees differed (and hence the number of particular in-
teractions between certain nodes types in the network also differed). The
observed numbers of each type of interaction are significantly different
from the expected numbers of interactions if they lie beyond two stan-
dard deviations from the mean of the randomisation results. I calculated
p-values by comparing the observed number with the expected normal dis-
tribution using the mean and standard deviation from the randomisations
(at large means the Poisson tends toward a normal distribution). Ran-
domisations are an adequate significance test for frequency of interaction
types, but can fail to account for broader network structures like clusters
49
3. Coinfection interaction network
of nodes (Schwobbermeyer, 2007), which is why I also studied network
modularity.
Modules
Modules were found using three search algorithms (Fig. 3.7a): (i) by se-
quentially removing the most peripheral link (Newman and Girvan, 2004);
(ii) using statistical mechanics (the methodology of Reichardt and Born-
holdt (2006), iterated 100 times); and (iii) using short random walks (Pons
and Latapy, 2005). In brief, these algorithms search for classifications of
nodes into groups (modules) that maximize the modularity. One measure
of modularity, termed Q, ranges from 0 (no modular structure, many links
between modules) to 1 (strong modular structure, few links between mod-
ules, Newman and Girvan (2004)). I analysed the set of modules with peak
modularity (Q) for the mechanistic network, since this network makes a
conservative assumption about the presence of interactions and reveals
the strongest functional similarities (and differences) within the network.
For each module I recorded the type (parasite, resource, immune) and
identity of the node with highest within-module degree. These nodes con-
tribute strongly to modularity and reveal the defining characteristics of
each module.
I also looked within each module to test whether node types had more
within-module links than would be expected from chance. I compared the
observed number of within-module links to that expected from a binomial
distribution where the number of trials was the total number of links
to nodes of each type in the module. The number of observed links was
considered significantly different from expected if the number was less than
5% probability in a two-tailed binomial distribution (i.e. p < 0.025 or
p > 0.975). I repeated this test for two interaction types (immune-parasite
and resource-parasite). Parasite-parasite links were omitted because this
interaction type was very rare in the mechanistic network.
To test the robustness of the modularity analyses and results, specifi-
cally whether resource-dominated modules were also present in other pos-
sible module sets (identified by the same algorithms but having lower
modularity), I compared the optimal module set with alternative module
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sets. These alternatives had slightly lower Q values than the maximal
value found (i.e. for four module sets with next-highest Q-values where
0.469 < Q < 0.4695; see Results). Visually comparing the nodes in each
module in these other high modularity sets with the 10 modules described
above confirmed that all modules were consistently associated with bodily
locations and the node with highest within-module degree was a resource
node.
Results
The summary network of coinfected humans comprised 124 host resources,
305 parasite taxa, 98 immune system components, and 2922 links between
these components. The network was compiled from 316 published papers.
Most publications (256/316, 81%) reported data from multiple coinfected
patients. The majority of links (1578) were based on mechanistic evidence,
while 812 were from co-occurrence, and 532 from correlational evidence.
I derived three versions of the summary network from these different link
types: mechanistic links only, mechanistic and correlative links, and all
links. I primarily describe results for the mechanistic-only version because
these links have the greatest biological support. However, I also compare
these results with those from the two other network versions.
Degree distribution
I calculated the degree of each node (the number of connections that each
node has with other nodes; Fig. 3.1a, metrics defined in Table 3.1). The
degree distribution for the network containing only mechanistic links most
closely resembled an exponential distribution with the exponent 0.16 (s.d.
0.007, R2=0.87, p < 0.001, Fig. 3.2a). This means that most nodes (i.e.
parasites, resources or immune components) in the network were linked
to few other nodes, in fact 89.7% of nodes (456/508) had < 15 unique
links. Only 9 nodes (0.018%) had degree ≥ 35. These highly connected
nodes were blood (70 unique links), respiratory tract (47), skin (40),
lungs (39), HIV (37), IgG (37), macrophage (37), dental abscess (37),
and liver (36).
51
3. Coinfection interaction network
0 10 20 30 40 50 60 70
0.00
0.05
0.10
0.15
0.20
Degree
P
ro
po
rti
on
 o
f n
od
es
(a)
0.0 0.5 1.0 1.5 2.0
0.0
0.5
1.0
1.5
2.0
Log10 degree of each node 
Lo
g 1
0 
de
gr
ee
 o
f l
in
ke
d 
no
de
s 
(b)
Fig. 3.2: (a) Degree distribution for the network containing only mech-
anistic links. Thick black line corresponds to the observed proportion
of nodes with a degree greater than or equal to the value on the x-axis.
Dashed line indicates the best-fitting statistical model, the exponential
model (exponent 0.016, p < 0.001, R2 = 0.87). (b) Assortativity: the
degree of each node plotted against the degree of their linked nodes for all
unique links for a network with only mechanistic links (Pearsons correla-
tion r = −0.12, p < 0.001). Plotting symbols are transparent such that
ten overlaid data points are black.
There was generally weak assortativity across all three versions of the
summary within host network (r close to zero, ranging from −0.12 to
0.12, Fig. 3.3a, and Table 3.2), but significant disassortativity in the
mechanistic network (r = −0.12, p < 0.001, Fig. 3.2b). Hence, most
nodes were connected to a range of low, medium, and high degree nodes.
Frequency of parasite interaction types
Indirect interactions (i.e. paths of two links with an intermediate node,
Fig. 3.1c) between parasites were more common than direct links. The
ratio of indirect to direct links ranged from 1.09 times higher for parasite-
mediated interactions within mechanistic and correlative link networks,
to 829 times higher for resource-mediated interactions in the mechanistic-
only network (Fig. 3.4, Table 3.2). Indirect parasite interactions were
most often resource-mediated, and these were significantly more com-
mon than expected by chance (p < 0.001; rewiring randomisation test).
Immune-mediated indirect interactions were about half as common as
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Fig. 3.3: Degree of nodes plotted against the degree of their linked nodes
for all unique links. Plotting symbols are transparent such that 10 overlaid
data points are black. (a) For mechanistic and correlative links and (b)
all link types. The correlation for both networks was weak but significant,
p < 0.001.
Table 3.2: Node degree, assortativity, number of each type of interaction
between parasite species, and the number of modules for three versions
of the summary within-host coinfection network containing different link
types, with standard aggregation of node names. Indirect parasite inter-
actions are represented as: I = Immune mediated, P = parasite mediated,
and R = Resource mediated. *** denotes significantly different from ran-
domised values (p < 0.001)
Measure Mechanistic Mechanistic &
Correlative
All link types
Degree distribution Exponential
(λ=0.16,
R2 =0.866***)
Exponential
(λ=0.12,
R2 =0.874***)
Exponential
(λ=0.09,
R2 =0.895***)
Assortativity −0.12*** +0.07*** +0.12***
Direct interactions 9*** 128*** 875***
Indirect interactions P=1***,
R=7464***,
I=3652***
P=140***,
R=9408***,
I=5429***
P=4064***,
R=11492***,
I=5429***
Modules 10 9 8
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Fig. 3.4: The number of direct and indirect paths between parasites for
(a) all link types, (b) mechanistic and correlative links, and (c) mech-
anistic links only. Vertical black lines represent expected distributions
(2 sd, dot=mean) from 1000 simulations. All observed results devi-
ated significantly from expected values (tested against normal distribution
p < 0.001). Vertical axis scales for (a), (b), and (c) are identical.
resource-mediated interactions, though still significantly more common
than expected by chance (p < 0.001). Furthermore, 167 publications
(167/316, 53%) reported multiple parasite-resource interactions, but only
85 (27%) reported multiple parasite-immune interactions. The relative
frequency of reported resource- and immune-mediated interactions were
robust to the potential under-reporting of parasite-immune links (Fig.
3.5), and to the exclusion of publications relating to individual patients
(Fig. 3.6).
Most parasite-parasite links were based on co-occurrence; networks
excluding this type of evidence had relatively few direct or indirect in-
teractions involving only parasites (and fewer than expected by chance;
p < 0.001, Fig. 3.4b and c). The relative frequency of each type of
parasite-parasite interaction was qualitatively similar for all three network
versions (Fig. 3.4a-c, all p < 0.001; Table 3.2).
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Fig. 3.5: Number of direct and indirect paths between parasites, with par-
asites lacking immune links removed from the network. Vertical black lines
represent expected distributions from 1000 simulations (2 sd, point=mean,
see Methods). (Right) All link types, (middle) mechanistic and correla-
tive links, and (left) mechanistic links only. All observed results deviated
significantly from expected values (p < 0.001).
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Fig. 3.6: Number of direct and indirect paths between parasites, with
links from individual patients (case note publications) removed from the
network. Vertical black lines represent expected distributions from 1000
simulations (2 sd, point=mean, see Methods). (Right) All link types,
(middle) mechanistic and correlative links, and (left) mechanistic links
only. All observed results deviated significantly from expected values (p <
0.001).
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Modules
The mechanistic network contained a set of modules with highest mod-
ularity (peak Q value, illustrated in Fig. 3.1d) that best distinguished
clusters of dense interactions, and included 10 modules ranging in size
from 12 to 90 nodes (Q = 0.4695, Table 3.3, Fig. 3.7). Each of those
modules contained a mix of parasites, immune components and resources.
One module contained only bacterial parasites, however, all other modules
contained multiple parasite types. Parasites were the most common node
in 9 of the 10 modules (Table 3.3, except module 2 with 30 immune and
22 parasite nodes). All but two modules had more resource than immune
nodes (except module 2 with 30 immune and 15 resource nodes, and
module 4 with 25 immune and 9 resource nodes).
These 10 modules were associated with particular microhabitats within
the human body (Fig. 3.8, Table 3.3), and this association was also found
in other module sets with next highest modularity values. Visual in-
spection of these 10 modules showed associations with particular bodily
systems (Modules 3, 4, 7, 9), body parts (Modules 1, 8, 10), and tissues
(Module 6). Two modules were classified as mixed because they contained
several sites of infection including the liver, oesophagus, genitals, and eyes
(Module 2), and nose, skin, and urinary tract infections (Module 5). Re-
source nodes had the highest within-module degree for seven out of the 10
modules, and were more common than expected by chance in all modules
(Fig. 3.9, p < 0.001). Parasite-immune interactions dominated the struc-
ture of the remaining three modules where they were also more common
than expected by chance (p < 0.001). Of the three modules where non-
resource nodes had the highest within-module degree, two were immune
nodes (IgG and macrophages), and a parasite dominated the other (HIV).
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Figure S4: (a) Number of modules and modularity score for each set of modules generated
by diﬀerent algorithms from the mechanistic network (black line = sequential deletion of
the weakest link from each individual node having its own module to one large module
containing all nodes, light grey dots = statistical mechanics, and black dots = random
walks). Modularity (Q) is a measure of the strength of association within the proposed
modules and strength of division between diﬀerent modules. (b) Accumulation of nodes
and links in the network with each sampled 2009 publication. All nodes (red line, right
y-axis) resolved into immune (purple), resource (green), and parasite nodes (blue). Left
y-axis for all links (black line)
Fig. 3.7: (a) Number of modules and modularity score for ach set of
modules generated by different algorithms from the mechanistic network.
Black line = sequential deletion of the weakest link from each individual
n de having its wn module to one large module ontaini g all nodes,
light grey dots (indistinguishable from one another) = statistical mechan-
ics, and black dots (indistinguishable) = random walks. Modularity (Q)
is a measure of the strength of association within modules and division
between modules. (b) Accumulation of nodes and links in the network
with each sampled publication. All nodes (red line, right y-axis) resolved
into immune (purple), resource (green), and parasite nodes (blue). Left
y-axis for all links (black line).
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Table 3.3: Classification of each module in the module set with peak
modularity for the summary network containing only mechanistic links. I
describe the number of nodes of each type in each module, and the identity
and degree of the node with the highest number of links to other nodes
in that module and proportion of within-module links these represent. I
= immune, P = parasite, R = resource, GI = Gastrointestinal, UTI =
Urinary Tract Infection, LRT=Lower Respiratory Tract.
Module Name I P R Highest
degree
node
Degree % of
module
links
1 Throat 1 11 3 Tonsil 9 69
2 Mixed 30 22 15 HIV 23 16
3 GI 12 39 17 IgG 20 17
4 Genitals 25 30 8 Macrophage 18 12
5 UTI,
Skin
4 59 27 Urinary
tract
24 11
6 Mucosa 11 30 11 Respiratory
tract
19 18
7 Bowel 1 9 6 Colon 5 25
8 LRT 3 18 4 Lungs 15 45
9 Blood 1 29 10 Blood 24 42
10 Mouth 3 52 17 Dental
abscess
27 23
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Fig. 3.8: The within-human coinfection network comprising parasite
(blue), immune (green), and resource (pink) nodes connected by mech-
anistic links has ten modules, eight of which are associated with a par-
ticular bodily sites. Module numbers refer to Table 3.3. Grey and black
numbers and dotted lines are stylistic only; the different shades are used
to more clearly distinguish the lines corresponding to each module.
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Fig. 3.9: Number of within-module interactions between host immune
components and parasites, and between host resources and parasites in
each of the ten modules of the mechanistic network. Thick black lines
indicate 95% confidence intervals expected from the binomial test (see
Methods). Bars that do that overlap with black lines (immune-parasite
links for modules 1, 7, and 9) are not significantly different from random
distributions (p > 0.05). The number of within-module links for all other
modules and link types are significantly higher than expected by chance
(p < 0.001)
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Robustness of results
I tested whether measures of network structure were sensitive to the ag-
gregation of nodes and the sample of publications (Tables 3.4-3.6, Fig.
3.10-3.14). The key findings of exponential degree distributions (Fig.
3.10), weak (dis)assortativity (Fig. 3.11), the relative frequency of par-
asite interaction types (Fig. 3.12), and resource-mediated outnumbering
immune-mediated within-module interactions (Fig. 3.13) were all robust
to node aggregation. While the number of nodes and links in the net-
work increased linearly with each new publication (Fig. 3.7b), the ratio
of resource- to immune-mediated links levelled off once 40 publications
were sampled with resource-mediated interactions being dominant (Fig.
3.14a). The degree distribution exponent also reached an asymptote af-
ter 100 publications, but the R2 value was unchanged even with only 5
papers sampled (Fig. 3.14b). Assortativity became weakly positive with
a very low p-value, reaching an asymptote after 100 publications (Fig.
3.14c). The number of modules and the modularity score peaked once 50
publications were sampled, levelling off at lower values with fewer modules
with more sampling (Fig. 3.14d).
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Table 3.4: Summary of the results for number of nodes and links, node
degree, assortativity, number of each type of interaction between parasite
species, and the number of modules & associated Q value for different link
types in a version of the network where node names were not aggregated.
Indirect parasite interactions are represented as: I = Immune mediated,
P = parasite mediated, and R = Resource mediated. *** denotes signif-
icantly different from randomised values with p < 0.001, ** p < 0.01, *
p < 0.05, no asterisk means NS.
Measure Mechanistic Mechanistic &
Correlative
All link types
Nodes 612 644 664
Links 1651 2219 3073
Degree distribution Exponential
(λ=0.18,
R2=0.975***)
Exponential
(λ=0.14,
R2=0.976***)
Exponential
(λ=0.11,
R2=0.986***)
Assortativity −0.02* +0.05** +0.11***
Direct interactions 16 163 854
Indirect interactions P=5,
R=9538***,
I=3449***
P=177,
R=10749***,
I=5418***
P=934,
R=10698***,
I=5148***
Modules 10, Q = 0.507 12, Q = 0.458 13, Q = 0.499
Table 3.5: Summary of the results for the version of the network with
medium aggregation, i.e. node names were more aggregated than with
standard aggregation. Indirect parasite interactions are represented as: I
= Immune mediated, P = parasite mediated, and R = Resource mediated.
*** denotes significantly different from randomised values with p < 0.001,
** p < 0.01, * p < 0.05, no asterisk means NS.
Measure Mechanistic Mechanistic &
Correlative
All link types
Nodes 281 291 292
Links 1177 1606 2282
Degree distribution Exponential
(λ=0.12,
R2=0.887***)
Exponential
(λ=0.09,
R2=0.849***)
Exponential
(λ=0.06,
R2=0.887***)
Assortativity −0.06* +0.11*** +0.09***
Direct interactions 10 ∗ ∗ 124 ∗ ∗ 648∗
Indirect interactions P=3***,
R=7316***,
I=5009***
P=157***,
R=8482***,
I=6382***
P=6477,
R=8415***,
I=6382***
Modules 8, Q = 0.358 8, Q = 0.335 5, Q = 0.374
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Fig. 3.10: Degree distribution for networks with (top row; a-c) no aggrega-
tion of node names, (middle row; d-f) medium aggregation, and (bottom
row; g-i) high aggregation. Split by the link types in each network with
(left column; a, d, g) mechanistic links only, (middle column; b, e, h)
mechanistic and correlative links, and (right column; c, f, i) all link types.
Thick black line is the observed proportion of nodes with a degree greater
than or equal to the value on the x-axis. In all cases the best fitting
model for the degree distribution was the exponential model (dashed line,
see Tables 3.4-3.6- for statistics, all p < 0.01).
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Fig. 3.11: Assortativity: the degree of each node plotted against the degree
of their linked nodes for all unique links for networks with (top row; a-
c) no aggregation of node names, (middle row; d-f) medium aggregation,
and (bottom row; g-i) high aggregation. Split by the link types in each
network with (left column; a, d, g) mechanistic links only, (middle column;
b, e, h) mechanistic and correlative links, and (right column; c, f, i) all
link types. Plotting symbols are transparent such that ten overlaid data
points are black.
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Fig. 3.12: Number of direct and indirect interactions between parasites for
networks with (top row; a-c) no aggregation of node names, (middle row;
d-f) medium aggregation, and (bottom row; g-i) high aggregation. Split
by the link types in each network with (left column; a, d, g) mechanistic
links only, (middle column; b, e, h) mechanistic and correlative links, and
(right column; c, f, i) all link types. Vertical black lines represent expected
distributions (2 sd, point=mean) from 1000 simulations (see Methods).
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Fig. 3.13: Number of within-module interactions between parasites and
immune components or resources in the module sets with peak modularity
for networks with (top row; a-c) no aggregation of node names, (middle
row; d-f) medium aggregation, and (bottom row; g-i) high aggregation.
Split by the link types in each network with (left column; a, d, g) mecha-
nistic links only, (middle column; b, e, h) mechanistic and correlative links,
and (right column; c, f, i) all link types. Thick black lines indicate 95%
confidence intervals from the binomial distribution (see Methods). Bars
that overlap with CI lines are not significantly different from random dis-
tributions. Bar colours denote the type of nodes connected by a link: green
= immune-parasite, blue = parasite-immune, purple = parasite-resource,
pink bars = resource-parasite.
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(a) (b)
(c) (d)
Fig. 3.14: Robustness of network structure to sampling within 2009 coin-
fection publications. (a) Ratio of resource- to immune-mediated parasite-
parasite interaction frequency, (b) exponent and R2 of model fit to degree
distribution, (c) coefficient and p-value of Pearsons correlation between
node degrees (assortativity), and (d) number of modules and Q mod-
ularity score for module set with peak modularity. Networks had only
mechanistic links and standard aggregation of node names. Sampled from
five to 336 publications. Links from Topley and Wilsons encyclopedia
were broken down to reflect the average number of links reported in each
2009 paper, which increased the total number of publications to 337.
Vertical black lines represent two standard errors around the mean (small
horizontal black bar) from 50 simulations.
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Table 3.6: Summary of the results for the version of the network with
high aggregation, i.e. node names were much more aggregated than stan-
dard aggregation. Indirect parasite interactions are represented as: I =
Immune mediated, P = parasite mediated, and R = Resource mediated.
*** denotes significantly different from randomised values with p < 0.001,
** p < 0.01, * p < 0.05, no asterisk means NS.
Measure Mechanistic Mechanistic &
Correlative
All link types
Nodes 163 167 167
Links 837 1187 1685
Degree distribution Exponential
(λ=0.09,
R2=0.877***)
Exponential
(λ=0.07,
R2=0.856***)
Exponential
(λ=0.06,
R2=0.887***)
Assortativity −0.10** +0.09*** +0.08***
Direct interactions 32 ∗ ∗∗ 118** 462***
Indirect interactions P=32***,
R=5815***,
I=3490***
P=218***,
R=6753***,
I=4571***
P=2798***,
R=6680***,
I=4571***
Modules 6, Q = 0.269 6, Q = 0.253 4, Q = 0.289
Discussion
I developed a summary network of human coinfection from published re-
ports of coinfecting parasites, the resources they consumed or inhabited,
and immune components reacting with them. Although the summary
within-host coinfection network is complex, it contains several clear struc-
tural patterns. First, most components interact with few other compo-
nents, although some parasite species were highly interactive, e.g. HIV,
Staphylococcus aureus and Hepatitis C virus each interacted with dozens of
other nodes. Second, of all possible interactions between pairs of parasites,
most were indirect. While many studies highlight immune-modulation by
parasites (Bradley and Jackson, 2008; Lijek and Weiser, 2012; Maizels
et al., 2004), I found twice as many interactions via shared resources than
through shared immune responses. Finally, interactions were clustered
around particular locations of the human body, suggesting that the para-
site community of humans may be divided into microhabitat modules.
These findings indicate that the human summary coinfection network
is similar to many free-living ecological communities, confirming prior
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suggestions that coinfection can be understood using ecological concepts
(Bruce et al., 2000; Graham, 2008; Pedersen and Fenton, 2007). In partic-
ular, assortative and disassortative processes were found in the summary
coinfection network, similar to directed ecological networks (Foster et al.,
2010; Hao and Li, 2011). This suggests that, while well-connected parasite
species tend to interact with one another, other well-connected resource
and immune nodes tend to interact with poorly-connected components.
This feature may limit how far perturbations are likely to spread across
the network (Maslov and Sneppen, 2002). Furthermore, the exponen-
tial degree distribution that I observed in the summary within-human
network matches that of many food webs (Camacho et al., 2002; Dunne
et al., 2002). The summary networks modularity (Q = 0.469) was within
the range seen for many food webs (range 0.15 to 0.6) (Guimera` et al.,
2010), suggesting that well-connected nodes are somewhat isolated and,
again, restricting the wider effects of perturbations and maintaining net-
work robustness (Alca´ntara and Rey, 2012; Krause et al., 2003; Maslov and
Sneppen, 2002). Overall, therefore, many structural aspects of the sum-
mary coinfection network suggest it is robust to perturbations, such that
treatment or vaccination of a particular parasite may have little impact on
the remaining network. This finding is consistent with observations from
treatment programmes in human communities where parasite populations
rapidly return to pretreatment levels, and secondary effects on other par-
asites are rarely reported (Basa´n˜ez et al., 2012). Perturbation studies
of parasite communities in other host species, more extensive monitoring
of human treatment programmes, and dynamic coinfection networks are
needed to more fully determine stability of parasite communities.
Resource- and immune-mediated indirect interactions between para-
sites were more common than expected by chance in the summary network.
Coinfecting parasites were most likely to interact indirectly through shared
resources than via the immune system, and network modules tended to
be associated with microhabitats rather than immune phenotypes. The
dominance of indirect effects matches other ecological systems and could
be another reason why controlling parasites in coinfected populations is
difficult (Borrett et al., 2010). While much coinfection research has fo-
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cussed on immune-mediated interactions, and interactions between para-
sites are often apparently presumed to be immunological (e.g. du Plessis
et al. (2012)), the role of resource-mediated interactions has received less
attention (Tompkins et al., 2011). However, host resources control the
within-host dynamics of various taxa: red blood cell density affects malaria
intensity in lab mice and in humans (Antia et al., 2008; Graham, 2008),
associations among microbiota (Faust et al., 2012), exclusion of another
hepatitis virus or Trypanosoma strain from certain tissues (Amaku et al.,
2013; Franco et al., 2003), and microhabitat associations in parasite com-
munities of nonhuman hosts (Lello et al., 2004; Stock and Holmes, 1988).
My results indicate that resources may be more widely involved in struc-
turing parasite interactions in humans than currently appreciated.
Such bottom-up control of the summary network could be produced by
either facilitation or competition among parasites. In the case of facilita-
tion, infection by one parasite encourages coinfection of the same resource,
as with polymicrobial wound infection (Dalton et al., 2011). Conversely,
ecological guilds of parasites may compete for particular resources (Lello
and Hussell, 2008; Pedersen and Fenton, 2007). We need further stud-
ies of the relative contributions of competition, facilitation, and how best
to manipulate these interactions to improve treatment of coinfected pa-
tients. If coinfecting parasites do interact more via resources, then new
treatments could be developed that disrupt parasite colonisation, feed-
ing, or reproduction using resources shared by coinfecting parasites. For
instance, if certain dietary constituents like cranberry juice prevent ad-
herence of bacteria to epithelial cells (Raz et al., 2004), do they prevent
bacterial coinfection to the same extent? Within the recent specialism of
nutritional and environmental medicine, research into how nutrients affect
infection, let alone coinfection, has so far been relatively scant (Downing,
2009).
The apparent lesser influence of top-down immune control in the net-
work suggests that either a strong immune response involving a few key
components may prevent coinfection, or that the immune system tends
to have weak interactions with specific parasites. Studies that consider
both resource- and immune-mediated interactions are rare (see Chouvenc
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et al. (2012) for an example in termites), so the relative contribution of
immune and resource control on coinfecting parasite populations needs
further study.
As with any analysis of literature-derived data, the results may be in-
fluenced by observational and reporting biases (as detailed in Chapter 2).
In this analysis I attempted to address these issues where possible (see
Fig. 3.10-3.14). Beyond this evaluation of the sensitivity of the results to
possible biases, there may also be reporting biases in the sampled publica-
tions, for example toward describing infections in terms of the parasite’s
resource (Loscalzo, 2011). In addition, the publications may be subject to
detection biases, for instance where establishing immune mechanisms may
be relatively more difficult in humans than, say, in vivo experiments. Fur-
ther research could identify whether individual networks assembled from
particular coinfected patients are also resource dominated, could test for
physiological or genomic shifts and biomarkers of coinfection, and com-
pare networks from different patients and points in the infection cycle to
measure the health consequences of particular topologies and dynamics.
Such focused efforts would allow interaction strength and direction to be
measured to enable probabilistic module detection (Tsuda and Georgii,
2013; Yang et al., 2013), and to help predict patient-specific treatment
effects.
Reported interactions were most often indirect, and this result was
robust to node aggregation and sampling of publications. It is therefore
important to understand how treating one parasite species indirectly af-
fects the community of coinfecting parasites. Given the growing interest in
integrated control strategies where multiple species are treated simultae-
nously (Hotez et al., 2007; Lammie et al., 2006), we need to test whether
knowledge of parasite interactions could improve treatment outcomes in
human populations where coinfection is prevalent. Whilst the complexity
of the parasite community of humans makes this process somewhat daunt-
ing, the summary network and analyses presented herein make this prob-
lem more tractable. In particular, the modules resolve interactions into
potentially more manageable clusters of taxa. Some studies suggest that
modules are a general biological pattern with evolutionary underpinnings
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(Clune et al., 2012). Whether coevolution of host and parasite communi-
ties has resulted in resource-related modules because of increased stability
or biological constraints like human physiology remains to be seen. With
better understanding of the ecological interactions structuring parasite
communities, the effects of treatment on the wider parasite community
and on patient health could perhaps be predicted.
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Chapter 4
Coinfection mortality in
England and Wales from 2005
to 2008
Abstract
The parasites that tend to coinfect and cause death are unknown for any
host species. Causes of human deaths, including infectious causes, are
registered in many countries, and offer a unique but hitherto unexploited
opportunity to study coinfection mortality.
I analysed a cross-sectional dataset of reported deaths from infectious
causes in England and Wales. I tested whether the proportion of deaths
from infectious causes involving coinfection differed across age and sex
cohorts, and whether the number of infectious causes was randomly dis-
tributed across death certificates. I used two-way contingency tests to find
the odds of each pair of infectious causes causing death from coinfection,
and then analysed whether the strength of association between each pair
was related to the similarity of the pair of infectious causes across four
biological characteristics.
The proportion of deaths from certain infectious causes that involved
coinfection peaked in adults in their 30s, and was higher in males. Death
certificates contained between one and six infectious causes, and there were
more death certificates with one or two infectious causes than expected
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from a Poisson distribution. The reporting of most pairs of infectious
causes were not associated with co-occurrence on death certificates (54%),
but 39% of pairs were positively associated. The strength of these associ-
ations was not related to the similarity of the pair of infectious causes in
the four characteristics tested.
These results indicate that coinfection causes many deaths in England
and Wales, especially among younger adults, and that there is a tendency
for infectious causes to co-occur on death certificates with higher odds
than expected.
Introduction
Infectious diseases are the main cause of death of one in four individuals
worldwide; for example, respiratory infectious disease caused 4.26 million
deaths in 2008, diarrhoea caused 2.16 million, and HIV/AIDS caused 2
million (World Health Organization, 2009). Although HIV-tuberculosis
caused 350, 000 deaths worldwide in 2008 (World Health Organization,
2012), the number of deaths involving other coinfections is unknown on a
global or even national level.
Some coinfections increase the risk of death in humans, such as tu-
berculosis and HIV (Ditiu et al., 2011), HCV and HIV (Branch et al.,
2012), and bacterial pneumonia with influenza (Chertow and Memoli,
2013; Dushoff et al., 2006; Finelli et al., 2008; Morens et al., 2008; Palacios
et al., 2009; Rothberg et al., 2008; von Baum et al., 2011; World Health
Organization, 2010). In contrast, some coinfections may decrease mor-
tality rates, such as GBvC coinfection slowing HIV disease progression
(Bagasra et al., 2012). Apart from these few examples, relatively little is
know about which coinfections are associated with increased or decreased
mortality risk, or indeed if there is a general pattern of coinfection in
causes of death data.
One way to study the general associations between coinfection and
death (or lack thereof) is to analyse a composite dataset of causes of death
that were recorded on death certificates. Infectious diseases were the un-
derlying cause of 1.2% of deaths in England and Wales between 2001 and
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2011 (Office for National Statistics, 2011). While this level of infectious
disease mortality may be relatively low compared with global levels, these
data provide a national dataset of the distribution of infections recorded
at death. These data enable tests of hypotheses about coinfection that
are relevant to public health in England and Wales, and to understanding
of coinfection in humans in general.
While coinfection could be an important determinant of human mor-
tality, characteristics of coinfected individuals such as age and sex can also
be important. These can be important risk factors for helminth coinfection
status (Buck et al., 1978b), though not among the children from Zanzibar
studied by Lello et al. (2013) where infection by a species of gastrointesti-
nal helminth was the only consistent risk factor for coinfection. The role
of age and sex in deaths from coinfecting helminths or other parasite types
has, to my knowledge, never been studied. Older individuals are likely to
be more susceptible to infectious disease (Weinberger et al., 2008), and
less responsive to vaccines (Goodwin et al., 2006) as their immune sys-
tem deteriorates. Health differences between the sexes are commonplace
and are most likely attributable to biological and social factors (Arber
and Ginn, 1993; Macintyre et al., 1996; Rieker and Bird, 2005; Verbrugge,
1989). These may also contribute to sex differences in coinfection deaths,
but whether there is a consistent difference between males and females is
unclear. For instance, hospitalised females have higher pneumonia mor-
tality rates than males (Crabtree et al., 1999), and most fatal cases of
measles are from viral or bacterial coinfection, especially in young females
(Beckford et al., 1985; Dabbagh et al., 2009; Garenne, 1994; Griffin et al.,
2012). In contrast, sepsis mortality rates are higher in males than females
(Melamed and Sorvillo, 2009; Wehren et al., 2003).
To better understand how coinfections affect human mortality, it is
also important to measure whether parasite species tend to co-occur, and
what types of infectious disease are associated with this. The chance of
a particular pair of infectious causes co-occurring could be higher if they
are similar. For instance, it has been suggested that taxonomically similar
parasite species may coinfect a host more often than expect by chance, due
to similarities in life cycles, resource use, or immune responses (Pedersen
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and Fenton, 2007). The immune response to two coinfecting species of
different taxonomic groups may stimulate divergent and weaker immune
responses that limit damage to the host that would otherwise occur in
single infected individuals (Graham, 2001). For example, anaemia was less
severe in mice with malaria and helminth coinfection than in mice with
just malaria (Fairlie-Clarke, 2011). Shared transmission routes may also
increase the risk of coinfection, disease, and possibly death, e.g. blood-
borne viral infections often coinfect injecting drug users (Chu and Lee,
2008; Singer, 2009). Similarly, having two infectious diseases that share a
resource (i.e. have the same tropism) may exacerbate the health burden.
For instance, hepatitis viruses A and C compete strongly in the livers
of coinfected patients and this enhances pathology (Amaku et al., 2013).
Coinfection by infections with the same timescale may also co-occur often.
For instance, two chronic infections may have more of a chance for a serious
interaction or complication to arise, and acute coinfection may enhance the
risk of death because of severe stress exerted by two short-lived, virulent
infections. Here, I test whether these characteristics are significant risk
factors in reported coinfection death.
Other factors besides the age and sex of the individual, and the char-
acteristics of infections reported on death certificates may well affect mor-
tality rates. While further data were unavailable (see Methods), I consider
other potential influences in the Discussion.
Infections often reported as causes of death may also be common but
often mild infections, as opposed to rare but often deadly infections. It is
therefore important to also test for a relationship between the number of
individuals infected in the wider population, and the number of reported
deaths caused by that infection.
Hypotheses
Using death certificate data on infectious causes of death from a recent
four-year time period from England and Wales, and separate data on the
numbers of reported infections in the same population and time period, I
tested five hypotheses:
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1. The number of deaths with a single infectious cause are positively
correlated with the number of those infections reported in the pop-
ulation.
2. The proportion of deaths attributed to multiple infectious causes (as
opposed to a single infectious cause) is related to age and sex.
3. The distribution of the number of different infections reported on
death certificates is not random, indicating that infectious causes of
death are not independent.
4. The occurrence on death certificates of a particular pair of infections
is different from that expected given the occurrence of each infectious
cause in isolation.
5. Associations between pairs of infections are positively related to sim-
ilarity (or lack thereof) in their biological characteristics (i.e., taxo-
nomic group, transmission route, tropism, or timescale).
Methods
Dataset
Death certificates in England and Wales report one underlying cause of
death and up to 15 contributory factors; these are coded by the Interna-
tional Classification of Diseases (ICD, World Health Organization (1992)).
The 139, 459 death certificates used here were registered from 2005 to
2008, contained at least one infectious disease and followed the coding
system for causes of death in ICD-10 version 2005 (World Health Organi-
zation, 2005). Data were obtained via the Office for National Statistics.
In ICD-10 infectious diseases are coded in categories A and B, and
numbers within these can indicate a parasite’s genus (e.g. B68 Taenia)
or species (e.g. B51 Plasmodium falciparum). Coinfection is indicated
by multiple infectious causes reported on the death certificate, i.e. the
doctor signing the death certificate attributed the death to more than
one infectious cause. In addition, one specific code indicated coinfection
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(B20, which denotes other infections arising from HIV infection). Any
other code in isolation was assumed to be a single infection. This is a
conservative assumption since other infections may have contributed to
death but were not identified and so were not reported. The Discussion
considers some possible implications of this assumption. Hereafter, the
term “single infection death” indicates death certificates with one infec-
tious cause reported in the underlying and contributing causes of death,
and “coinfection death” indicates death certificates with more than one
infectious cause reported.
Other data from the death certificates used here were sex and age at
death (age categorised as 0−20 then in decadal intervals up to 80+). This
type of categorisation of age is common in patient studies, and reflects the
different care services accessed by different age cohorts (Freeman Jr, 1987),
and ageing-associated diseases. All other information were removed by the
Office for National Statistics to comply with data protection regulations.
In addition to the death certificate data, independent data on the
number of notifiable infections in England and Wales from 2005 to 2008
(notifiable infections are those of interest to the government and reported
by doctors) were obtained from the Health Protection Agency. This sec-
ond dataset comprises the best data with national coverage on number
of cases of certain infections, but only include a restricted number of in-
fections: 10 notifiable infections did not appear on any death certificate,
and 83 infectious causes of death were not notifiable infections. There
were 96 infectious causes of death on death certificates, thus there were
13 infectious causes of death that were also notifiable infections.
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Statistical analysis
All analyses were done in R version 2.15.1 (R Development Core Team,
2012).
Hypothesis 1: prevalence and mortality rate for certain infec-
tious diseases
Spearman’s rank correlation was used to test for a positive correlation
between the number of reported cases of each notifiable infection and the
number of single infection deaths. This analysis was done separately for
males and females, because both datasets included information on sex and
this is relevant for hypothesis 2.
Hypothesis 2: age, sex, and coinfection death
The relationship between age, sex, and coinfection death was modelled
by logistic regression (generalised linear model (glm) with binomial error
structure and a logit link function). The response variable in these models
was the number of “successes” (coinfection death) and “failures” (single
infection death). Age was fit as an eight level factor (described above)
and sex was a two level factor. I tested for an interaction between age
and sex in the glm. To aid interpretation, a binomial generalised additive
model (gam) with a spline for age was also used. Splines with age have
shown a good fit in other coinfection studies, e.g. Fenton et al. (2010).
Analysis of deviance (χ2 ) tests showed whether the interaction between
age and sex should be dropped from the glm, or whether the age spline in
the gam should be modified by sex or dropped from the model.
Hypothesis 3: distribution of infectious causes of death
The observed distribution of the number of infectious causes reported per
death certificate was compared to a null expectation of independence fol-
lowing a Poisson distribution. I fit a Poisson distribution to the counts of
each number of infectious causes per death certificate using the pois.exact
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function in the R package epitools (Aragon, 2010). If the observed frequen-
cies of number of infections per death certificate was beyond the values
expected from this distribution (greater or lesser than 95% CI) then the
chance of a death certificate having a given number of reported infections
was non-randomly distributed.
Hypothesis 4: associations between pairs of infections
To test for associations between pairs of infectious causes of death, a two-
way contingency test was performed for each pair of infections. A Fisher’s
exact contingency test was used because for many pairs of infections there
were low numbers of occurrences (< 5). A negative association using
this analysis (odds ratio< 1) indicates lower occurrence of coinfection
than expected by chance, a positive association (odds ratio> 1) indicates
a higher occurrence of coinfection than expected by chance. Here the
critical value for determining a significant association was corrected for
multiple comparisons using a Bonferroni correction of α = 0.05
k
, where k
is the number of pairs of infections, and hence the number of comparisons,
that were tested.
Each pair of coinfections was categorised as having a positive asso-
ciation (significant OR> 1), negative association (significant OR< 1),
or no association (OR not significantly different from 1). The observed
proportions of these categories were compared to two null models using
Chi-squared tests. The first null model had equal proportions of positive,
no, and negative associations. The second null model was that coinfec-
tions do not interact, allowing for a 5% error rate (hence 2.5% negative,
2.5% positive, and 95% neutral reported effects). These tests use the
same methods as those used and described in greater detail in Chapter 2.
Hypothesis 5: are similar pairs of infectious causes associated with coin-
fection death?
The above analyses for hypothesis 4 provided an estimate of the associa-
tion between pairs of infections (i.e., the odds ratio). Linear models with
log10 odds ratio as a response variable were used to test whether the asso-
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ciation of a pair of infectious causes of death was related to the similarity
of the biology of the pair.
Biological characteristics used were taxonomic group, transmission
route, tropism, or timescale. Each infectious cause was assigned a cat-
egory for each characteristic using a PubMedHealth (NCBI, 2012) search
for its name in ICD-10 (World Health Organization, 2005), and two exist-
ing sources: a database of known human parasites (Taylor et al., 2001),
and a database of characteristics of RNA viruses of humans (Brierly (in
prep)). Taxonomic groups of infectious causes were: viruses, bacteria,
fungal parasites, protozoa, helminths, or other (where the ICD code could
refer to more than one of those five types, e.g. A09 diarrhoea or gas-
troenteritis of presumed infectious origin). Categories used for transmis-
sion routes were: contaminated food/water, inhalation, insect bites, via
open wounds, contact with animals, skin contact, sexual contact, or en-
vironmental pathogens (following Taylor et al. (2001)). Tropisms were
grouped into: neuronal, respiratory, circulatory, gastrointestinal, geni-
tal, skin, glandular, or multiorgan (following Brierly (in prep)). Lastly,
timescales of infection were acute, chronic, or both (for diseases with both
short- and long-term infections like Chlamydia, Q fever, or Nocardia).
Next the similarities between every pair of infections reported together
on the death certificates was described in terms of four binary variables,
one for each of the characteristics described above. In these four binary
variables, a 1 indicates a match between the two infections, and a 0 no
match. The lowest similarity was, therefore, four zeros, and highest four
ones.
Parametric multiple regression was used with the four binary variables
as explanatory variables, and the log odds ratio as the response variable.
Starting with the full model (including the four way interaction), terms
were removed in a stepwise manner using analysis of deviance (χ2 ) tests.
The final model showed large deviations from the assumptions of linear
regression, even with other transformations of the response variable, re-
moval of outliers, or removal of pairs of infections where no association was
observed (OR= 1). For this reason, localised non-parametric regression
was used, with one explanatory variable that was a single index of sim-
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ilarity combining all four binary explanatory variables (i.e. one variable
ranging from 0 to 4).
Results
From the 2, 028, 734 death certificates in England and Wales between 2005
and 2008, 130, 758 (6.4% out of 2, 028, 734, 72, 080 female, 58, 678 male)
death certificates attribute death to single infection, while 8, 695 (0.4%,
4, 623 female, 4, 072 male) listed multiple infections as causes of death.
All other death certificates contained only non-infectious causes of death
and were excluded from the analysis. In total there were 96 different
infectious causes listed on the death certificates.
Hypothesis 1: prevalence and mortality rate for certain infec-
tious diseases
There was no significant relationship between the number of death cer-
tificates with a particular infectious cause reported and the number of
notified cases of that infectious disease for either sex (paired Spearman’s
Rank correlation for males ρ = −0.14, P > 0.64, df = 12 and for females
ρ = −0.02, P > 0.93, df = 12, Fig. 4.1).
Hypothesis 2: age, sex, and coinfection death
The proportion of deaths that were coinfection deaths rose from < 20
years old to a peak in the 30− 39 age category, subsiding to lowest levels
in the over 60s (Fig. 4.2, binomial gam with age spline by sex, deviance
explained = 99.2%). Sex modified the effect of age so that the rate of
decline in the proportion of coinfection deaths from the peak in ages 30−39
was greater in females than males (grey vs. black solid lines > 2 standard
errors apart for ages 40 − 49 and 50 − 59 on Fig. 4.2). There was a
significant increase in residual deviance when sex or age were removed
from gam (deviance −46 and −978 respectively, both P < 0.001 using
χ2 -test).
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Fig. 4.1: Number of reported deaths from the 13 infectious causes of death
for which there was data on the number of reported cases in England and
Wales for (A) females, and (B) males.
Hypothesis 3: distribution of infectious causes of death
Out of 8, 695 reported coinfection deaths, 7, 980 (91.8%) had two infec-
tions, 609 (7.0%) had three, and 106 (1.2%]) had four or more (Fig.
4.3). This observed distribution is broadly consistent with expectations
based on independent and random distribution of infectious causes across
the death certificates (bars for 3 to 6 reported infectious causes over-
lap with 95% CI from Poisson density function where λ was the observed
mean number of reported infections per death certificate (1.07), Fig. 4.3).
However, there were slightly more single and dual infection deaths than
expected (bars for 1 to 2 reported infections higher than 95% CI, Fig.
4.3).
Hypothesis 4: associations between pairs of infections
The majority of pairs of infectious causes showed no association on death
certificates (197/366, 53.7%, odds ratio (OR) not significantly different
from zero using Bonferroni correction where α = 1.37× 10−4 , neutral bar
on Fig. 4.4). Next most common were positive associations (144/366, 39.3%,
Fig. 4.4, OR significantly > 1). Only 25 infectious pairs were negatively
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Fig. 4.2: Proportions of death certificates in the dataset that were coinfec-
tion deaths in decadal age categories and sex (female=grey, male=black).
Points are the observed proportions, solid lines are the model predictions
from a binomial gam P(multiple infection)=s(age):Sex, dotted lines are
±2s.e. around the model prediction.
84
4. Coinfection mortality
1 2 3 4 5 6
Number of reported infections
Lo
g 1
0 
nu
m
be
r o
f d
ea
th
 c
er
tif
ic
at
es
 +
 1
0
2
4
6
8
10
12
Fig. 4.3: Frequency distribution of reported infections on death certificates
between 2005 and 2008 from England and Wales. Black lines are 95%
confidence intervals from a Poisson distribution with λ = 1.068371.
associated (6.8%, Fig. 4.4, OR significantly < 1)
The distribution of these associations was significantly different from
both the random and no-effect null hypotheses (χ2 = 127, df = 2, P <
2.2 × 10−16 and χ2 = 2080, df = 2, P < 2.2 × 10−16 respectively, bars
significantly different heights from grey and black lines on Fig. 4.4).
Hypothesis 5: are similar pairs of infectious causes associated
with coinfection death?
Among the 311 pairs of infectious causes, there was no relationship be-
tween the similarity in biology of the pair (in terms of taxonomy, trans-
mission mode, tropism, and timescale of infection) and the odds of both
infectious causes being reported on the same death certificate (horizontal
regression line, Fig. 4.5). Other modelling approaches were attempted
but flouted statistical assumptions (see Methods).
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Fig. 4.4: Associations between every possible pair of infectious causes cat-
egorised into positive, negative, or neutral. Associations were derived from
two-way contingency tests on the number of deaths reported with neither
infection, each single infection, or both infections. Neutral indicates odds
ratio not significantly different from one. Lines indicate null hypotheses
(grey=random, black=no-effect).
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Fig. 4.5: Similarity in biology of pairs of infectious causes and the log10
odd ratio of their association on death certificates (from two-way contin-
gency tests). The x-axis is the sum of four factors indicating whether the
infectious causes shared the same tropism, transmission route, timescale
of infection, or taxonomic group. For each factor, 1 denoted a shared
characteristic (e.g. two chronic infectious causes would share the same
timescale of infection), and 0 denoted different characteristics (e.g. a bac-
terial and a viral coinfection would have different taxonomic groups), so
a pair of infectious causes with 4 on the x-axis had all four characteris-
tics in common, while 0 means the infectious causes were different in all
four characteristics. Points are transparent such that ten or more over-
laid points are black. Black line is the locally smoothed non-parametric
regression line with degree of smoothing α = 0.5 Grey polygon is ±2se.
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Discussion
A four-year long dataset of human mortality in England and Wales, com-
prising almost 140,000 deaths with reported infectious causes, yielded
the first ever national cross-sectional analysis of coinfection as a cause of
death. The infectious causes reported on these death certificates allowed
estimation of whether pairs of infectious causes are more or less likely to
be reported together. Adults between the ages of 20 and 40 had the high-
est probability of coinfections being reported on their death certificates.
This probability of reported coinfection decreased into older age groups,
but until age 60 was slightly higher in males than females. Positive as-
sociations of pairs of infectious causes co-occurring on death certificates
were found for almost 40% of pairs. The strength of association between
these pairs of infectious causes was not related to the number of biologi-
cal characteristics shared by the pair. I now discuss the factors that may
contribute to these patterns, before considering the limitations of the data.
Possible causes of observed patterns
There was a hump-shaped relationship between age and the proportion
of infectious disease deaths that had multiple infectious causes reported.
This early-to-mid adulthood peak in coinfection death contrasts with theo-
ries that the immune system’s ability to respond to antigens declines in old
age (Goodwin et al., 2006; Weinberger et al., 2008), and with noninfectious
diseases where the risk of multiple simultaneous diseases (comorbidities)
increases with age (Valderas et al., 2011). One possible explanation is that
older adults are more frail from the inevitable decay of their complex bod-
ily system (Topolski, 2009) and so have a higher risk of death from just a
single infection, whereas younger adults are generally stronger so it takes
multiple infectious diseases to kill them. Alternatively, those who survive
to old age may have immune phenotypes that enable them to effectively
respond to coinfections, but they eventually die from a single virulent in-
fection, perhaps in conjunction with other diseases that are more common
with age (Campbell et al., 1985), like cancer (Ferlay et al., 2007). There is
evidence that young adults are more prone to severe immunopathologies
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following infection. For example, critically ill hospitalised patients in the
USA and Canada with influenza A(H1N1) tended to be 20− 30 years old
(Jhung et al., 2011; Kumar et al., 2009) and had deficient adaptive im-
mune responses (Bermejo-Martin et al., 2010). In coinfected individuals
parasite abundance may also peak at intermediate age in rabbits and sheep
(Fenton et al., 2010), which may translate to a higher risk of coinfection
mortality in early adulthood in humans.
The number of death certificates with one or two reported infectious
causes of death was higher than expected from random, but the number
of deaths with three or more infectious causes was within expectations.
This could be because infectious diseases with high virulence tend to com-
petitively exclude other infections (as seen with higher virulence malaria
strains outcompeting others Bell et al. (2006); De Roode et al. (2005)).
In contrast, deaths from three or more infectious causes may be more of
a random-draw process involving lower virulence infections. Reductions
in the number of deaths reported from more than two infectious causes
could also be explained by competition for resources suppressing parasite
abundance (Dobson, 1985), coinfections of diverse taxa triggering immune
responses that are less damaging to the host (Graham, 2001), or patients
with many coinfections receiving closer medical attention.
While more than half of pairs of infectious causes of death were not
associated with being reported together on the same death certificate,
positive associations were four times more common than negative associa-
tions. These results are consistent with the skew toward positive interac-
tions between parasites found in published reports of coinfection morbidity
in humans (Fig. 2.2C). This skew could suggest that interspecific competi-
tion discussed above tends not to be strong enough to prevent coinfection
of individuals before death, and that facilitation between pairs of infec-
tious causes is more common. Such corroboration of findings suggests
that medical care of coinfected patients is more problematic than those
with single infections, being associated with higher parasite abundance,
worse health outcomes, and often higher risk of multiple infectious causes
of death.
More than four fifths of pairs of infectious causes were positively asso-
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ciated, many with odds of reported coinfection death over three orders of
magnitude greater than reported single infection death. Pairs with these
higher odds ratios included: mycobacteria and gastrointestinal protozoa
(A31 and A07, OR= 1795), mycobacteria and measles (A31 and B05,
OR= 1570), streptococcal sepsis and malaria (A40 and B54, OR= 1212).
Some of these same taxa also had significantly lower odds ratios when
paired with other infectious causes, including respiratory tuberculosis and
streptococcal sepsis (A40 and A16, OR= 0.244), and acute encephalitis
and septicaemia (A41 and A86, OR=0.006). The direction of association
for each taxon is therefore not consistent, but the strength of these as-
sociations means finding whether there are general causes behind these
associations is important.
The odds of pairs of infectious causes being reported together was
not associated with whether or not the pair shared the same transmis-
sion route, taxonomic group, timescale of infection, or tropism. This does
not rule out the role of biological characteristics of parasites in modifying
coinfection mortality risk. Further analyses could consider the particular
categories within each factor rather than a binary variable of whether or
not the pair shared the same category. Other biological characteristics
could also be studied with continuous variables, for instance measuring
generation time of the infecting organisms, time to transmission, average
time infecting one host, etc. Further analysis could also compare the char-
acteristics of the 20 out of 96 infectious causes that were never reported
in coinfection deaths against the infectious causes that only occurred in
coinfection deaths (e.g. B20− 23 denoted HIV infections).
Quality of data available for studying coinfection mortality
As with any results based on reported disease, it is important to consider
the influence of potential biases in reporting. There may be underreport-
ing of coinfection death on death certificates if other infectious diseases
were undetected, deemed not to have contributed to death, or reported
using an ambiguous code. For example, some codes may conceal multiple
species infecting the same individual (e.g. Streptococcus and Staphylo-
coccus both in B95, Klebsiella, Clostridium, and others in B96). Using
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multiple infectious causes (and code B20 as HIV coinfection) as indicators
of coinfection therefore probably underestimates the number of coinfection
deaths. Nevertheless death certificates offer novel insight into coinfection
mortality, and there is no evidence that reporting of infectious causes of
death is biased by age, sex, or infectious cause. Underreporting of mul-
tiple causes of death and wrong attribution of the cause of death was
highlighted as a problem in the 1990s (James and Bull, 1996; Leadbeat-
ter and Knight, 1993; Maudsley and Williams, 1996), and there have since
been legal and education reforms for doctors completing the certificates
(Aung et al., 2010; Swift and West, 2002; Tuffin et al., 2008). Inaccuracies
on death certificates can be subject to legal challenge and lead to medical
malpractice claims (Waldman and Spector, 2003). The Office for National
Statistics also issues official guidance to doctors completing death certifi-
cates (Devis and Rooney, 1999; Tuffin et al., 2008). For all these reasons
we can be confident that, in large causes of death datasets from recent
years like the one used here, relationships among the number of reported
causes of death, biological characteristics of infections, and host character-
istics (age and sex) are detectable. Even if the extent of underreporting of
infectious causes were known there is no reason to expect that this would
detract from the patterns presented here.
There was no association between reporting of a subset of infectious
causes on death certificates and the number of cases of those infectious
diseases reported in England and Wales. This suggests that infections
differ in their background risks of causing death. It is difficult to assess
whether the number of reported coinfection deaths was proportional to
the number of coinfection cases without data on coinfection prevalence
in the wider population. To test for variation in the risk of coinfection
death (coinfection mortality rate weighted by coinfection prevalence) be-
tween coinfections, we would need a coinfection dataset from a different
cutoff in the infection cycle, such as recovery rates after hospitalisation,
hospital diagnosis rates, symptomatic coinfection in doctors clinics, or
the prevalence of asymptomatic coinfection surveyed in the population.
Unfortunately none such data is currently available.
At a time when there are calls for greater reporting of causes of death
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globally (Editorial, 2013), it should be noted that multiple causes of death
must be reported in order to study interactions between different diseases
(Chamblee and Evans, 1982; Goodman et al., 1982; Redelings et al., 2005,
2007). Adding to these calls for data on multiple causes of death to be
more widely collected, this study has shown the utility of these data for
studying coinfection mortality by inferring associations among infectious
causes of death. Further such analyses are needed for accurate assessment
of infectious disease mortality burden in countries with different parasite
communities, human demographics, and health systems. Other oppor-
tunities for further research include estimating the sensitivity of results
to different disease coding systems (Wilson and Bhopal, 1998) and death
certificates from other years. Longitudinal studies can often reveal effect
of ageing on disease better than cross-sectional data with chronological
age categories (Hofer and Sliwinski, 2001). Tracking individuals with sin-
gle infection or coinfection could also help control for parasite abundance,
which is one of the key determinants of the type of immune response
(Menon and Bretscher, 1998).
Causes of death can be associated with various factors including health-
care, socioeconomic status, family structure, geography, behaviour, host
physiology, infectious dose, or virulence. Determining what factors con-
trol patterns of causes of death using national observational data alone is
therefore difficult (Hansen et al., 2007). It is especially difficult as other
health conditions, diagnostic tests, and treatment were not included in
the dataset used here. The above discussion of causes of the observed
patterns in single infection and coinfection deaths is therefore speculative,
but raises many hypotheses to be tested in future. This study is the first
of its kind to study coinfection mortality across the range of parasite types
(from viruses to helminths). Several patterns have never been described
before in humans or indeed any other host species, namely the distribu-
tion of coinfection deaths across age and sex cohorts, the distribution of
number of infectious causes reported at death, and the odds of reported
co-occurrence of hundreds of pairs of infectious causes. Understanding
how coinfection modifies mortality risk will help target health resources
to prevent deaths from multiple infectious causes.
92
Chapter 5
Indirect effects of treatment
on non-target parasites under
different one-way interactions
Abstract
There is potential for interactions among coinfecting parasites to under-
mine treatment efforts because treating one parasite species could indi-
rectly exacerbate untreated parasites. To study how interactions among
parasites modify treatment outcomes, an agent-based model of mass drug
administration in a village-sized human population with two endemic
macroparasites was developed.
The abundance of both parasite species was monitored in simulations
with and without targeted drug treatment of one species, with three lev-
els of coinfection. Simulations included one-way immune- or resource-
mediated interactions of varying strengths and directions in coinfected
hosts where target parasites affected the non-target parasite population.
In each scenario the effects of either single or repeat treatments on non-
target parasite abundance, and host morbidity (target plus non-target
species abundance) were recorded. Simulations were repeated for each
scenario using randomly generated initial conditions to test for variability
in non-target parasite abundance. A sensitivity analysis of total treatment
effects using half and double the original value of each parameter was also
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done.
As may be expected, treating positively interacting parasites tended
to also reduce non-target parasite abundance, whereas treating negatively
interacting parasites generally increased non-target parasite abundance.
However, the magnitude of this effect was sometimes negligibly or non-
monotonically related to interaction strength, with the shape of this rela-
tionship depending on whether the interaction was resource- or immune-
mediated. Indirect effects of treatment were amplified by higher coinfec-
tion prevalence and higher treatment frequency.
These results indicate that the direction of interspecific parasite in-
teractions may be a good indicator of whether species-specific treatment
programmes will have greater or lesser benefits for coinfected individu-
als. However, other within-host processes, such as resource- or immune-
mediated intraspecific density dependence, can mask the effects of inter-
action direction such that the size of the indirect treatment effect may
be less predictable. The model is theoretical, in that it represents a sim-
plified and generalised one-host two-parasite system. Nevertheless, this
model provides valuable insight into the potential indirect effects of tar-
geted drug treatment under coinfection, and highlights areas where such
future work may be directed, including quantifying the most influential
parameters like rates of immune killing, and refining models of the rela-
tionships among parasites within coinfected humans.
Introduction
Parasite infections have been traditionally studied in isolation (Anderson
and May, 1985; Cox, 2001), but coinfection by multiple parasite species
is commonplace in humans (Buck et al., 1978a; Crompton, 1999; Petney
and Andrews, 1998), and animals (Budischak et al., 2012; Ezenwa et al.,
2010; Lello et al., 2004). Coinfected patients tend to have higher parasite
abundance and worse health than those with one infection (Chapter 2).
Thus we need to better understand the factors affecting the abundance
of coinfecting parasites to help improve treatment of coinfected patients
(Bruce et al., 2000; dos Santos et al., 2010; Hotez et al., 2010; Lello et al.,
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2004; Lustigman et al., 2012).
Most treatment programmes are parasite-specific and therefore im-
plicitly assume that parasite species can be managed independently (Cox,
2001; Gibson et al., 2010; Singer, 2009; Wenzel and Edmond, 2010). Here,
I focus on drug treatments, but similar principles apply to other species-
specific interventions like vaccination or prophylaxis. Successful parasite-
specific drug treatments improve host health by suppressing target par-
asite abundance by using drugs to reduce or clear the target parasites.
Drugs often vary in their efficacy against parasite species in the same or
different phyla. For example, praziquantel is effective against schistosomi-
asis, but not directly on hookworm (Utzinger et al., 2002), and combined
treatment of ivermectin and albendazole in cattle is effective against gas-
trointestinal nematodes except the resistant Cooperia genus (Entrocasso
et al., 2008). Since many infections overlap in distribution (Brooker and
Clements, 2009; Brooker and Utzinger, 2007; Brooker et al., 2000b, 2007,
2010; Molyneux et al., 2009; Soares Magalha˜es et al., 2011), there is high
potential for drugs to indirectly affect other, non-target parasite species
(Basa´n˜ez et al., 2012; Pasman, 2012). In such cases, the effect of drug
treatment on non-target parasite abundance depends on how the target
and non-target species interact within coinfected hosts. The health bene-
fits of drug treatment will be reduced, or even overturned, if species not
directly affected by the drug (non-target parasites) increase in abundance
after treatment.
Interactions between parasite species can affect treatment outcomes,
such as deworming treatments worsening HIV and tuberculosis epidemics
(Bentwich et al., 1999, 2008; Elias et al., 2006; Nacher, 2002; Rafi et al.,
2012; Sangare´ et al., 2011; Wolday et al., 2002). There are new, integrated
parasite treatment programmes for humans (Crompton, 2006; Fenwick,
2006; Hotez et al., 2008), but the effects of combining these drugs are only
beginning to be explored (Gryseels, 2006; Lammie et al., 2006; van Gen-
deren and van Hellemond, 2012), and the within-host interactions of most
parasites are poorly understood (Alizon et al., 2013). Although rarely
tested for, the occurrence, direction and magnitude of such interspecific
parasite interactions could profoundly alter the net effects of targeted drug
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treatment programmes.
Direction, magnitude, and mechanisms of parasite interaction
Within-host interactions between parasite species can be negative (antag-
onistic) from processes like resource competition, or positive (synergistic)
from mutualisms or immunosuppression. Treating a positively interacting
parasite will further reduce host morbidity because the non-target para-
site population will also decline in coinfected hosts. Conversely, treating a
negatively interacting parasite might bring reduced benefits to host health
because the non-target parasite population will grow.
Parasites can interact directly with one another, for example by releas-
ing an exoproduct that repels another species, or by consuming or infecting
the other parasite. However, there appears to be greater capacity for in-
direct interactions mediated by resources available to the parasites, or the
coinfected host’s immune system (Chapter 3). Immune-mediated interac-
tions include cross-reactivity, where one host antibody type or lympho-
cyte receptor binds to multiple parasite antigens, resulting in a negative
interaction between parasites (Tanaka and Feldman, 1999), and trade-
offs, where an immune reaction to one parasite reduces the reaction to a
coinfecting parasite (a positive interaction, such as immunosuppression;
see, for example, Austin et al. (1996)). Immune-mediated interactions are
one cause of ineffective vaccines (De Bruyn, 2010), and has been observed
in vaccines for Vibrio cholerae (Cooper et al., 2000, 2001; Harris et al.,
2009), tetanus (Cooper et al., 1998, 1999), Mycobacterium tuberculosis
(Elias et al., 2001; Wammes et al., 2010), and HBV (van den Berg et al.,
2009), crossreactivity in influenza-HCV coinfection (Kasprowicz et al.,
2008), and for gastrointestinal helminth-malaria coinfection in lab mice
(Fairlie-Clarke et al., 2009, 2010).
Resource-mediated interactions involve parasites altering the space,
energy, and nutrients available to coinfecting parasites. Where data on
resource availability are lacking, resource-mediated interactions can be
modeled by density dependent feedback loops. Negative density depen-
dence means every additional parasite reduces the availability of resources
(Anderson and May, 1978; Dietz, 1988), which can affect the stability of
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the parasite population after chemotherapy (Churcher et al., 2006; Duerr
et al., 2005; Nasell, 1976). Positive density dependence represents facilita-
tion where population growth rates increase the more parasites there are
(Basa´n˜ez et al., 1995).
Indirect effects of treatment on a non-target parasite population are
likely to depend on the direction, strength, and mechanism of the interspe-
cific parasite interaction (positive or negative, from weak to strong, and
immune- or resource-mediated respectively). Furthermore, interactions
within individual coinfected hosts can affect treatment outcomes at the
population level, depending on how interactions affect parasite fecundity,
how parasites transmit between hosts, and the proportion of hosts that
are coinfected (coinfection prevalence). The indirect effects of treatment
on coinfecting parasites will likely increase with coinfection prevalence be-
cause coinfected hosts, within which the parasites interact, are at higher
density. Coinfection prevalence is enhanced by common risk factors in-
cluding shared transmission routes, poor host hygiene or environment, and
genetic susceptibility. Conversely, different risk factors for target and non-
target parasites, such as environmental preferences, will lower coinfection
prevalence.
Focus on coinfecting helminths
To explore the effect of treatment on non-target parasite abundance and
host health (total parasite abundance) in different interaction scenarios, I
focus on perhaps the most common coinfection globally. One billion indi-
viduals worldwide are estimated to be coinfected with multiple helminths
(Crompton, 1999). Finding the most successful treatment options for
helminths is important because they aﬄict the world’s poorest (Bonds
et al., 2010; King, 2010), and have a larger health burden than malaria or
tuberculosis (Hotez et al., 2008). World Health Organisation guidelines
recommend drug treatment for helminth infections (there are no vaccines,
McSorley and Maizels (2012)). Treatment should be repeated at least
annually depending on political will, budgetary constraints, attitudes, ex-
perience, and parasite prevalence in the population (Crompton, 2006).
Differences in treatment frequency could affect non-target parasite dy-
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Fig. 5.1: Treatment at t = 1 perturbs the host-parasite system. Re-
peat treatment will move parasite abundance to a lower equilibrium (solid
line), whereas after a pulse treatment parasite abundance will return to
its former equilibrium (dotted line).
namics; a large or long-term indirect effect on the non-target parasite
might only occur if the target parasite is treated repeatedly. One-off treat-
ments can cause short-term, transient dynamics where the system reacts
to treatment with an initial deviation that dampens over time (damp-
ing oscillation), before returning to its original equilibrium and closely
matches the dynamics of an untreated system (Fig. 5.1 dashed line).
Repeat treatments, if strong and long enough, also cause damping oscil-
lations, but cause the system to move to a new equilibrium that is also
dependent on species interactions (Fig. 5.1 solid line, see Bender et al.
(1984)).
A mathematical modeling approach
Studies into how treatment frequency, coinfection prevalence, and inter-
specific interactions affect treatment outcomes at the population level are
rare, even though understanding indirect effects is crucial for effective
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treatment (Brooker et al., 2012; Lafferty, 2010). The complexity of coin-
fection in terms of the range of interactions described above, difficulties
in ascertaining how parasites interact (Fenton et al., 2010; Hellard et al.,
2012; Johnson and Buller, 2011), and the diversity of parasites that could
simultaneously infect an individual means identifying particular coinfec-
tions and epidemiological contexts with significant indirect treatment ef-
fects is formidable. Meanwhile, projections from mathematical models can
suggest optimal treatment strategies under different scenarios (e.g. Stolk
et al. (2003); Winnen et al. (2002)), and offer useful opportunities for
understanding within-host interactions and guiding policies for helminth
treatment (Antia and Lipsitch, 1997; Michael et al., 2006, 2007; World
Health Organization and TDR Disease Reference Group on Helminth In-
fections, 2012).
The effects of direct and indirect parasite interactions and are impor-
tant in explaining patterns of host health (Bottomley et al., 2005), con-
trolling energy flows in an estuarine ecosystem (Lafferty et al., 2006), and
for increasing virulence and destabilising parasite dynamics (Eswarappa
et al., 2012). There are models of treatment for specific coinfections in-
cluding gonorrhea and HIV (Mushayabasa et al., 2011), and malaria and
trypanosomiasis (Nannyonga et al., 2012), and of multiple untreated geno-
types interacting via immunity or resources (Hellriegel, 1997). Lello et al.
(2004) present an ordinary differential equation model with vaccination
and immune-mediated interactions among three helminth species. How-
ever, the impact of immune- or resource-mediated interactions on drug
treatment outcomes in a host population infected by two helminth species
has not yet been modeled.
Here I develop a mathematical model to explore how different forms
of interspecific parasite interaction mediate the effects of targeted anti-
parasite treatment. The model represents two helminth species in a human
population, where the target parasite species can be treated, and the non-
target parasite species is never treated. Although interactions between
parasite species can be reciprocal, and can be among three or more species,
for simplicity I assume only a one-way interaction where one species, the
target species, interacts with a coinfecting, non-target parasite species. I
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also assume that parasite abundance is positively related to host morbidity
(following Eswarappa et al. (2012)).
Hypotheses
The following hypotheses relate to the mean abundance of the non-target
parasite in the host population across ten years:
1. Non-target parasite abundance with and without treatment will de-
pend on the sign of the interaction between target and non-target
parasite species.
a. With a positive interaction and no treatment of the target par-
asite, there will be higher non-target parasite abundance, and
when there is a negative interaction abundance will be lower.
b. After the target parasite is treated, when there is a positive
interaction non-target parasite abundance will decrease, and
when there is a negative interaction abundance will increase.
2. Stronger interactions will have greater effects on non-target parasite
abundance both with and without treatment.
3. The effects of the interspecific interaction and of treatment will also
depend on whether the interaction is mediated by resources or im-
munity.
4. The effects of treatment on non-target parasite abundance will be
proportional to the coinfection prevalence.
5. Repeat treatments will have greater effects on non-target parasite
abundance than single treatments.
I also hypothesise that:
6. Treatment effects on host morbidity (assumed to be proportional to
combined abundance of target and non-target parasites) will depend
on the type, sign, and strength of the parasite interaction. Assuming
the two species have equal virulence, host morbidity will be lower
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when a positively interacting parasite is treated because non-target
parasite abundance will also decrease.
Modeling framework
These hypotheses are tested using an agent-based model of two co-endemic
helminth species in a notional human village-sized population. Agent-
based models are suited to modeling complex biological systems (Grimm
and Railsback, 2005; Holcombe et al., 2012), and have three advantages for
modeling parasite coinfection: (i) they can readily include variation among
hosts, such as aggregated distributions of parasite abundance, which are
fundamental to parasite dynamics and treatment success (Brogden et al.,
2005; Grenfell et al., 1995; Johnson et al., 2012; King, 2010; Sabatelli
et al., 2008; Schur et al., 2012; Soares Magalha˜es et al., 2011; Stein, 2011;
Woolhouse et al., 1997), (ii) they simulate across scales, i.e. within and
between-host infection dynamics (Bauer et al., 2009; Sabatelli et al., 2008),
for example parasite abundance in each host, and transmission in the pop-
ulation (Plaisier et al., 1990), and (iii) they can have short-term, transient,
nonequilibrium dynamics that often follow treatment.
Using this framework, different treatment regimes (single vs. repeated)
are applied to the target parasite when target parasites have different ef-
fects on non-target parasites (immune- or resource-mediated, from strongly
negative to strongly positive), in populations with different coinfection
prevalences (low, moderate, or high). Some simulations had higher vari-
ability around mean non-target parasite abundance, prompting additional
investigation of the contribution of stochastic processes.
Methods
Model overview
Each timestep of the discrete time model included an entire life cycle
for each parasite species, including transmission, establishment, repro-
duction, and death of parasites, and possible death of a host. Target
parasite abundance was reduced by treatment applied once or repeatedly,
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and the indirect effect of treatment on non-target or total parasite abun-
dance was measured. Simulations covered every unique combination of
magnitude, direction (positive to negative), and mechanism (immune- or
resource-mediated) of the interaction between the treated “target” para-
site and the other “non-target” parasite, and repeat or single treatment.
Individual hosts varied in their exposure to infection, and setting different
correlations of exposure to the two parasites gave coinfection prevalence
ranging from low (< 20%), medium (35%) to high (> 50%). Target
and non-target parasites interacted either via resources (facilitation as a
positive interaction, competition for resources as a negative interaction,
modeled as a density dependent process based on contemporary parasite
abundances), or via immune responses (crossimmunity as a negative in-
teraction, an immune tradeoff as a positive interaction, modeled via an
explicit immune component for each parasite species).
Each simulation recorded each parasite species’ abundance and fecun-
dity, and magnitude of the immune response specific to each parasite
species in each host at each timestep for ten years after the first treatment.
Parasite abundance was recorded at the end of each timestep, i.e. after
establishment of new larvae, and after immune attack. Each timestep
is roughly a year long, incorporating all parasite life stages. The mean
and variability of non-target parasite abundance across the host popula-
tion were calculated. Morbidity was the total abundance of both parasite
species in each host, and the mean was calculated across hosts. There
were 50 replicate simulations for each parasite interaction scenario. The
agent-based model is described in more detail in the Appendix using an
established and recommended protocol (Grimm et al., 2006).
Analysis
To show the effects of treatment, parasite abundance time series can be
analysed in various ways (Chen and Cohen, 2001; Grimm and Wissel,
1997; Neubert and Caswell, 1997; Stott et al., 2011). Mean abundance
across the ten timesteps after treatment was used as a proxy for how large
a net effect treatment has. Ten timesteps was long enough to include
the initial direct effects of treatment, rebound, and, in most simulations,
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Fig. 5.2: Life stages of the target and non-target parasites (subscripted as
species 1 and 2 respectively). Variables recorded within each host at each
timestep are: specific immune response of host (I) that is stimulated by
and kills adult parasites (P) infecting the host that reproduce and release
eggs (black circles) that contribute to the environmental pool of larvae
(E). The parasite species can interact within a coinfected host through
immunity or resources (black lines). We model resources available for adult
parasites (R) implicitly as interspecific density dependence. Eggs hatch
into larvae that survive in the environmental pool and can be ingested by
susceptible hosts next timestep.
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equilibration. Ten years is also the timescale of many long-term helminth
treatment programmes. The hypotheses focus on non-target and total
parasite abundance because abundance was used in many original stud-
ies, and remains a good indicator, of interspecific interactions (Goldberg
et al., 1999; Hutchinson, 1978; Poulin, 2001). Mean abundance in a hu-
man population is also used to evaluate helminth treatment programmes
(Brooker et al., 2000a).
All simulations and analyses were done in R version 2.15.1 (R Devel-
opment Core Team, 2012).
Sensitivity analyses
Results from model simulations can be sensitive to stochasticity, initial
conditions, model structure, and the choice of parameter values. The
50 replicates using different sets of random numbers reveal uncertainty
regarding stochastic dynamics and initial conditions assigned from prob-
ability distributions (i.e. host exposure). The model presents a basic
macroparasite life cycle so there is little structural uncertainty. In terms
of parameter values, global sensitivity analyses of other individual based
ecological models of particular infections have sampled all variables within
known confidence intervals to inform further experiments to refine pa-
rameter estimates of the most sensitive (Magori et al., 2009; Xu et al.,
2010). The model presented here represents no specific coinfection, and
consequently there are no empirical confidence intervals within which to
sample parameter values for sensitivity tests. Nevertheless, even over ar-
bitrary parameter ranges, sensitivity analyses are still useful to find the
parameters relating to within-host interactions that most strongly control
treatment effects on the non-target parasite.
Sensitivity tests were done for each parameter that related to the
resource- or immune-mediated interactions. The metric used to assess
sensitivity to changes in parameter values was total treatment effect on
mean non-target abundance (the different in mean non-target parasite
abundance between treatment and non-treatment runs), which was mea-
sured by taking the mean treatment effect across 50 simulations for each
interaction value (from −1 to +1 in decimal intervals), and then calculat-
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ing the absolute sum across those interaction values. This was repeated
in turn for each parameter using half and double its original value (see
Appendix table 6.1) under resource- and immune-mediated interactions.
The only exception to this was the parameter for the proportion of the
population treated where the upper parameter value was 1, since the orig-
inal value of 0.7 could not be doubled (no more than the whole population
can be treated). Press treatment and populations with medium coinfection
prevalence were used for all sensitivity tests. By subjecting each parame-
ter to the same treatment in turn allows the parameters to be ranked in
terms of their relative sensitivities under each interaction type, and also
provides insight into the impact of uncertainties in estimates of the effect
of treatment in the model given particular within-host conditions.
Results
The model was simulated to test hypotheses that the (1) sign, (2) strength,
and (3) type of interaction affected the mean abundance of the non-target
parasite across ten timesteps with or without treatment of the other para-
site. The effects of (4) coinfection prevalence and (5) treatment frequency
on mean non-target parasite abundance were also tested, and how these
interaction and treatment scenarios affected (6) host morbidity (total par-
asite abundance).
Hypothesis 1a: mean non-target parasite abundance in the ab-
sence of treatment depends on the sign of the interaction
Without treatment the target parasite generally led to lower non-target
parasite abundance when there was a negative, immune-mediated interac-
tion, and higher abundance when there was a positive interaction (treat-
ment effect below and above y = 0 when interaction negative and positive
respectively, Fig. 5.3A), supporting hypothesis 1a. However, the effects
of resource-mediated interactions were sometimes the reverse of hypoth-
esis 1a (Fig. 5.3B). Here, non-target abundance increased under weakly
negative resource-mediated interactions before subsiding and going ex-
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Fig. 5.3: Mean abundance of non-target parasite in the absence of treat-
ment with either an interspecific immune- (A) or resource-mediated inter-
action (B).
tinct under strongly negative interactions (positive gradient for interaction
strengths between 0.5 and 0, subsiding at interaction strengths around
−0.5, and reaching zero for interaction strengths ≥ −0.9 Fig. 5.3B).
Positive resource-mediated interactions did not alter parasite abundance
(horizontal line for all interaction strengths > 0, Fig. 5.3B).
Hypothesis 1b: mean non-target parasite abundance in the
presence of treatment depends on the sign of the interaction
Treatment of the target parasite generally increased non-target parasite
abundance when there was a negative interaction, and decreased it when
there was a positive interaction (treatment effect above and below y = 0
with negative and positive interaction respectively, Fig. 5.4), supporting
hypothesis 1b. Treatment exacerbated the effect of resource-mediated
interactions on non-target parasite abundance; the shape of the treatment
response with a resource-mediated interaction (Fig. 5.4A, C, and E) is
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similar to abundance without treatment (cf. Fig. 5.3B).
Treatment of a negative immune-mediated interaction consistently in-
creased non-target parasite abundance (treatment effect on mean non-
target abundance greater than 0 when interaction strength < 0, Fig.
5.4B, D, and F). Under positive immune-mediated interactions the treat-
ment effect was negative, more stochastic, than seen under negative in-
teractions, and non-linear (spoon-shaped), showing recovery of the non-
target parasite under very strong positive interactions (Fig. 5.4B, D, and
F).
Hypothesis 2: stronger interactions have greater effects on
non-target parasite abundance
In untreated simulations the strength of the immune interaction resulted
in a gentle S-shaped curve in non-target parasite abundance in untreated
simulations (Fig. 5.3A), supporting the hypothesis that stronger interac-
tions have greater effects on the non-target parasite. However, this is the
only result consistent with hypothesis 2 across the interaction parameter
space in either untreated or treated scenarios.
In treated scenarios under immune-mediated interactions (Fig. 5.4B,
D, and F), the peak reduction in non-target parasite abundance was not at
the strongest positive interaction, but at intermediate strength, with the
effect diminishing at higher interaction strengths. Increasing the strength
of negative immune-mediated interactions led to slightly higher non-target
abundances after treatment.
For resource-mediated interactions, in both treated and untreated sim-
ulations, the highest levels of non-target parasite abundance occurred at
intermediate negative interaction strength. Under strong negative inter-
actions the non-target parasite went extinct before treatment was applied,
so no treatment effect was observed here (abundance = 0 when interaction
strength ≥ 0.9 in Fig. 5.3B corresponds with no change in abundance af-
ter treatment in Fig. 5.4A, C, and E). Increasing the strength of positive
resource-mediated interactions caused little change in mean non-target
parasite abundance either with or without treatment.
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Fig. 5.4: Difference in mean non-target parasite abundance between
treated and untreated simulations (red=single treatment, blue=repeat
treatment) in low, medium, and high prevalence populations (top, middle,
and bottom respectively) for resource- and immune-mediated interactions
(left and right columns respectively).
108
5. Treatment effects on non-target parasites
Hypothesis 3: interaction and treatment effects depend on
whether the interaction is mediated by resources or immunity
As seen in the contrasts made above, immune- and resource-mediated
interactions produced different patterns of non-target abundance, both
under untreated and treated scenarios (Fig 5.3 A vs. B, and Fig. 5.4
left vs. right column). Both mechanisms of interaction had some areas of
negligible response of non-target parasite abundance to varying interaction
strength (positive resource-mediated interactions, and negative immune-
mediated interactions) or non-monotonicity (negative resource-mediated
interactions, and positive immune-mediated interactions). Only immune-
mediated interactions, particularly under strongly positive interactions,
saw increased variability between simulations, with variability between
simulations involving resource-mediated interactions remaining constant
across the interaction parameter space (see Discussion).
Hypothesis 4: treatment effects on non-target parasite abun-
dance are proportional to coinfection prevalence
As hypothesised, increasing the prevalence of coinfection in the host popu-
lation accentuated the indirect effects of treatment on non-target parasite
abundance for both interaction types (values stretch along y-axis from low
to high prevalence from Fig. 5.4A to C to E, and from Fig. 5.4 B to D to
F).
Hypothesis 5: repeat treatments have greater effects on non-
target parasite abundance than single treatments
Again, as hypothesised, repeat treatments enhanced the effects on non-
target parasite abundance compared with single treatments (blue points
further from y = 0 than red points, Fig. 5.4).
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Hypothesis 6: treatment effects on host morbidity depend on
the type, sign, and strength of the parasite interaction
Treatment of the target parasite always reduced host morbidity (assumed
to be proportional to total parasite load, with equal virulence of the par-
asite species, y < 0 for all interaction strengths, Fig. 5.5). However, in
accordance with hypothesis 6, the size of this reduction was moderated by
the interaction between target and non-target parasite, and by treatment
frequency: repeat treatments (Fig. 5.5, red points) brought greater reduc-
tions in morbidity than single treatments (Fig. 5.5, blue points), and host
morbidity was further reduced where there was a positive interaction, and
not reduced as greatly when there was a negative interaction. The great-
est reductions in morbidity were seen under positive immune-mediated
interactions, although there was substantial variation in treatment effects
by this criterion between replicate simulations under immune-mediated
interactions (Fig. 5.5B, D, and F show wide distance between blue and
especially red points).
Sensitivity analysis results
The ranking of the variables from the sensitivity tests is shown in Fig. 5.6
where higher absolute treatment effects indicate a greater deviation be-
tween treated and untreated simulations across the relevant interaction.
Treatment causes the biggest changes in non-target parasite abundance
for parameters with lines higher up the y-axis on Fig. 5.6, and steeper
lines indicate greater sensitivity to the value of that parameter. For both
interactions, total absolute treatment effect was most sensitive to the pro-
portion of the population treated (T ), the effect of parasites on the host’s
specific immune response to them (γi ), and the effect of immunity on
parasite survival (SI ). Total absolute treatment effect was relatively in-
sensitive to changes in virulence (V ), parasite survival (S ), the effect
of immunity on parasite fecundity (FI ), and intraspecific density depen-
dence (Dhalf ). The ranking of the parameters depended on the interaction
type (Fig. 5.6A vs. B), and on whether the parameter was half or double
its original value.
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Fig. 5.5: Difference between mean total parasite abundance in treated and
untreated simulations (red=single treatment, blue=repeat treatment) in
low, medium, and high prevalence populations (top, middle, and bottom
respectively) for resource- and immune-mediated interactions (left and
right columns respectively).
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Fig. 5.6: Sum of the absolute difference between treated and untreated
mean total parasite abundance across interaction parameter values for
resource- (A) and immune-mediated (B) interactions. Each parameter
is indicated by a label next to its line: δ = rate of decay of immune
memory (red line), Dhalf = parasite density for half of larvae to establish
(orange), FI = effect of immunity on adult parasite fecundity (olive),
γi = species-specific immune stimulation (dark blue), M = maximum
life expectancy (light blue), S = survival rate of adult parasites (medium
blue), SI = effect of immunity on adult parasite survival (bright green),
T = proportion of population treated (purple), V = virulence of parasites
(magenta), and X = inflexion point of logistic virulence curve (teal). See
Appendix table 6.1 for original parameter values corresponding with this
notation.
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Discussion
To test the indirect effects of treatment on coinfecting parasites, I sim-
ulated the population dynamics of two endemic helminth species in a
village-sized population of humans with and without treatment of a tar-
get species, and with a range of interactions between the target and non-
target species. Treatment either increased or decreased non-target parasite
abundance, in a manner largely consistent with whether the underlying
interaction between the species was negative or positive. However, this
indirect effect of treatment was amplified by repeat treatments and higher
coinfection prevalence, and modified by interaction type and strength in a
complex manner, sometimes resulting in negligible and sometimes in non-
monotonic relationships between interaction strength and the effect of
treatment. As I will discuss, these responses have important implications
for predicting or evaluating the outcomes of species-specific treatment pro-
grammes in coinfected populations. The results also prompt consideration
of how parasite interactions can be inferred from perturbation studies, and
highlight opportunities for future research.
Implications for treatment
In the model, the mean abundance of the non-target parasite was both
raised and lowered when the target parasite interacted with the non-target
parasite. Similarly, the change in morbidity in a treated population de-
pends not just on how the targeted species is treated, but also on the
presence of coinfecting species not directly affected by the drug. These
results suggest that the net health benefits of the treatment programmes
may be over- or under-estimated unless we account for the indirect effects
of treatment on non-target parasites. Therefore surveys need to monitor
for co-occurring species as well as target parasites before initiating treat-
ment, and close attention paid to their responses following treatment. The
implications of non-target parasites for the health of treated individuals
should also be assessed.
To help predict or evaluate how non-target parasites are likely to mod-
ify treatment outcomes, the model highlights various factors that deter-
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mine the indirect effects of treatment on non-target parasites, and condi-
tions under which these effects do or do not arise. Key factors to consider
are coinfection prevalence, treatment frequency and coverage, and the di-
rection of the underlying one-way interspecific interaction. For example,
in the model, when two species interacted, the longer treatment continued,
or the higher the coinfection prevalence, the greater the deviation between
treated and untreated simulations. The sensitivity tests also showed the
proportion of the population receiving treatment to also be correlated with
treatment effect. Another possible indicator is that the direction of a one-
way interaction often corresponds to indirect effects of treatment of the
opposite direction (e.g., a negative underlying interaction often results in
a positive treatment effect, such that non-target parasite abundance in-
creases post-treatment). Increases in non-target parasite abundance after
treatment reliably reflected negative resource- or immune-mediated inter-
actions, and decreases in non-target abundance reliably reflected positive
resource- or immune-mediated interactions. However, some interactions,
e.g. positive resource-mediated interactions, did not alter treatment out-
comes. Thus, treatment may not necessarily affect non-target parasites
despite the presence of an interaction. Such non-responsiveness happens
when the effects of the interspecific interaction were obscured by intraspe-
cific regulation (e.g. resource-mediated interspecific interactions were of-
ten obscured by intraspecific immune-mediated regulation). To under-
stand the impact of parasite interactions on treatment success, interac-
tions should therefore be understood in the context of other within-host
processes. However, the nonlinear nature of the intraspecific processes
produced non-monotonic relationships between post-treatment non-target
abundance and interaction strength, so interaction strength may be an un-
reliable indicator of indirect effects of treatment programmes.
Studying parasite interactions
Intraspecific processes like species-specific density dependent immune re-
sponses affected the abundance of non-target parasites so strongly that
they obscured the effects positive interspecific resource-mediated interac-
tions. It is therefore important to know the form (direction, mechanism,
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and magnitude) of all interactions among parasite species within coin-
fected individuals in order to predict treatment outcomes. In particular
the sensitivity tests suggest that precise parameterisation of the stimula-
tion of immunity by adult parasites and the effect of immunity on parasite
eggs is particularly important. However, detection of interspecific interac-
tions is known to be difficult from perturbed time series in general (Bender
et al., 1984), and between coinfecting parasites in particular (Fenton et al.,
2010; Hellard et al., 2012; Johnson and Buller, 2011). Appropriate models
for many within-host processes are also unclear. How the rate of immune
killing responds to parasite abundance is rarely discussed, but is crucial to
indirect treatment effects when species interact via immunity in this and
other coinfection models (e.g. Fenton and Perkins (2010)). The feeding
relationships between parasites and host resources are perhaps discussed
even less frequently, except in rare cases like the relationship between
malaria and red blood cells (e.g. Savill et al. (2009)). The results from
the sensitivity analysis suggest that estimating the inflexion point of any
resource competition curve can have a large influence on the indirect of
treatment on non-target parasites. Without quantified measurements of
these relationships among parasites and host components, especially those
parameters that treatment effects are most sensitive to, it will be difficult
to predict the effects of treatment on communities of interacting parasites.
Further to these challenges to understanding the dynamics of coin-
fection within hosts, various model results suggest that inferences of in-
teraction strength from mean treatment responses are uncertain because
increases or decreases in treatment effects are not always correlated with
interaction strength. The model results give at least three reasons for such
uncertainty: wide regions of non-response, non-monotonic relationships,
and high variability in treatment effects between replicate simulations.
First, negligible treatment effects were observed at various interaction
strengths, including from very weak to very strong resource-mediated in-
teractions. When effects of drug treatment were observed these tended
to reliably reflect the direction of underlying interactions. However, the
absence of a treatment response does not necessarily indicate the ab-
sence of an interspecific interaction. While certain interactions may be
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occurring, as often occurred under resource-mediated interactions, other,
stronger within-host processes like immune-killing can counteract these
effects. Similar compensatory immune responses have also been shown to
mask interspecific interactions in other multi-parasite systems (Bull et al.,
2012).
Second, the largest treatment effect under positive immune interactions
occurred at intermediate interaction strength; either side of this value
treatment indirectly lowered mean non-target abundance, but to a lesser
extent. When a negative treatment effect is smaller than this peak value
there is therefore ambiguity in whether the immune interaction was weak
or strong. Hence, a larger treatment effect is not necessarily indicative of
a stronger interaction between the parasites.
Third, replicate host populations of identical size with identical pro-
cesses, but with different randomly-selected values of host exposure, varied
in the size of the treatment effect on mean non-target abundance. Indeed,
the between-simulation variability under positive immune-mediated in-
teractions (immunosuppression) was so high as to create a large area of
ambiguity where the same treatment effect could have been caused by a
wide range of interaction strengths.
These three possibilities need to be considered when interpreting the
results of future studies of parasite communities. Indeterminacy of long
term (equilibrial) effects of press perturbations in multi-species commu-
nities has long been known (Yodzis, 1988). In addition, the simulations
presented herein show that there are areas of indeterminacy in the disequi-
librium phase in the years after single or repeat treatment for a community
of two parasite species.
Variability in non-target parasite abundance
Of particular interest in the model results were some immune-mediated
interaction strengths that increased variability in mean non-target abun-
dance between populations. To further understand what contributes to
variation in mean parasite abundance, variability around the mean was
measured in high prevalence simulations in two ways: (i) the amplitude of
parasite dynamics (taken as the difference between the minimum and max-
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imum mean parasite abundance per host in ten timesteps after treatment),
which indicates temporal variability, and (ii) the distribution of non-target
parasites across the host population (taken as the 95% confidence interval
of the non-target abundance ten-year mean), which indicates between-host
variability.
Post-treatment variability under resource-mediated interactions fol-
lowed the same pattern as mean abundance for both temporal and inter-
host variability (5.7A and C, cf. Fig. 5.4A, C, and E), with greater
increases when treatment was repeated (red vs. blue points), and greatest
increases at negative interactions up to −0.7, before parasite extinction
reduced variability to zero.
Variability was larger for immune- rather than resource-mediated in-
teractions (note same scales on Fig. 5.7A-B and C-D). For immune-
mediated interactions, repeat treatments increased temporal variability
more than single treatments when there was a positive interaction (blue
points further from zero for positive interactions, Fig. 5.7B). Conversely,
negative interactions increased temporal variability after single treatment
more than repeat treatments (blue points closer to zero for negative in-
teraction values, Fig. 5.7B). In terms of variability between hosts, nega-
tive immune-mediated interactions resulted in very little variability (Fig.
5.7D), whereas variability greatly increased under positive interactions,
and these effects were magnified under repeat treatments.
These results (Fig. 5.7B and D) indicate that the observed increased
stochasticity between replicates under positive immune-mediated inter-
actions (Fig. 5.4 right column) is caused by increasing fluctuations in
the parasite dynamics through time, and that inter-host variability con-
tributes less to stochasticity because immunity tends to homogenise the
host population by reducing the number of high burden hosts. It seems
that positive immune interactions (immunosuppression) and the loss of
immune memory as parasite populations decline contribute to delayed
density dependence resulting in unstable population cycles. This con-
trasts with the more stable equilibrium observed even after treatment
when immune interactions were weaker or negative. The potential for
both stability and instability from delayed density dependence is known
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Fig. 5.7: Difference in variability in non-target parasite abundance
between treated and untreated simulations (red=single treatment,
blue=repeat treatment) in medium prevalence populations with a resource
(A and C) or immune interspecific interaction (B and D). Variability is
measured by the difference between minimum and maximum mean abun-
dance in ten timesteps after treatment (temporal variability: A and B),
and 95% CI in the abundance of non-target parasites among hosts (inter-
host variability: C and D).
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from lagged predator-prey systems (Sih, 1987; Turchin et al., 1999). The
possibility of these dynamics being present within coinfected hosts is per-
haps a new observation, though whether this is an artefact of the discrete
model used here, or whether this is a real feature of immune interactions
between parasites needs further testing.
Further research
In this chapter I have begun to explore how interactions among parasite
species and variability between hosts affects population-level treatment
outcomes. I developed an agent-based model with treatment of one par-
asite species that interacted via shared resources or immune responses.
Further scenarios could be tested with small modifications to this model.
• How individual variation in interaction strengths affects ecosystems
is a growing area of research (Wells and O’Hara, 2012), but how
interactions between coinfecting parasites vary among hosts, and
what impact it has on treatment programmes, is largely unknown.
Components involved in immune- or resource-mediated interactions
that vary between individuals, such as different parasite epitopes and
immune receptors, nutritional status, or tissue repair rates, could
easily be included in the model as another source of agent-based
variation.
• Parasite communities are far more complex than presented in the
model, and how these complexities alter the indirect effects of treat-
ment need to be explored. For instance, greater parasite diversity
exponentially increases the number of interactions and treatment op-
tions to be considered. Two-way interactions where both parasites
affect one another, or where resource- and immune-mediated inter-
actions occur simultaneously are also possible. And there are also
evolutionary feedbacks, for instance drug treatments are likely to
select for drug-resistant parasite strains, which adds to the parasites
responding indirectly to treatment.
• The model should be parameterised for a specific pair of parasites,
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and could be used to compare between real treatment options, for
instance nutrition or environmental improvements as well as drug
treatment.
Perhaps most importantly, to test whether these simulations are re-
alistic, we need more monitoring of the effects of specific treatments on
the wider parasite community, and studies of interactions among parasite
species. More empirical studies of interactions in coinfected populations
have been called for by other authors too (Basa´n˜ez et al., 2012; Righetti
et al., 2012). Would a metanalysis of treatment effects on non-target
parasites experiencing different interactions look like Fig. 5.4? The simu-
lation presented here is just the beginning of research into how health in
treated human populations is affected by interactions among the parasite
community.
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Discussion
Infectious diseases pose a serious challenge to global health (Hopkins, 2013;
Sanders et al., 2008), but the contribution of coinfection to this morbidity
and mortality burden is only beginning to be investigated (Pullan and
Brooker, 2008). This thesis has expanded the typical approaches used to
study particular parasite coinfections to instead study the range of inter-
actions among the diverse parasite community of humans using various
cross-disciplinary methods. I have compiled three of the largest datasets
of coinfection in humans, covering hundreds of species combinations and
hundreds of thousands of individuals. I also developed a unique model
representing treatment of a small human population infected by two in-
teracting parasite species.
My research shows that coinfection is not rare, nor does it have ran-
dom or negligible effects on human health. Rather, the published reports
that I collated showed coinfection to be a diverse problem involving hun-
dreds of parasite species. Coinfections reportedly have a tendency towards
higher abundance infections, and towards worse host health than single
infections. Most of the data contributing to these results comes from pa-
tients already receiving healthcare. Therefore, we can make, for the first
time, a general conclusion about treatment of coinfected patients, namely
that coinfection appears to have worse health outcomes than for those
with only one infection, likely contributed to by the difficulties of tackling
multiple species.
My research also revealed some other previously unknown general pat-
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terns of reported interactions among coinfecting parasites, most notably
that they are mostly indirect and often mediated by shared resources. My
simulations of treatment effects on two parasite species in a heterogeneous
host population suggested that the direction of a one-way interaction could
inform decisions of the optimal treatment program in coinfected popula-
tions. Together these results suggest that, while treatment of coinfected
patients appears to be more difficult than for those with one infection,
treatments could be improved if parasite interactions were better under-
stood. The findings from each research chapter are now discussed in turn,
before considering shared themes and issues highlighted by the research
chapters, and finally considering opportunities for advancing knowledge
of this important global health issue.
Findings from research chapters
Patterns of human coinfection
Prior to this thesis many fundamental patterns of coinfection were not
known, such as the different nutritional or pathological consequences for
single- and co-infected hosts (Pullan and Brooker, 2008). The research
in Chapter 2 collated data from recent publications on coinfecting para-
sites, and their reported effects on host health and parasite abundance.
Reported coinfections included all kinds of parasites, but were most likely
to involve viruses and bacteria. The most commonly reported coinfect-
ing parasites differed from those causing highest global mortality, with a
notable lack of serious childhood infections in reported coinfections. Coin-
fected individuals were generally reported to have worse health (78% pub-
lications) and higher parasite abundance (57% publications) than those
with single infections.
Given the large and very significant effects observed, I am confident
that these general findings are robust. It is still worthwhile to consider
possible biases in and limitations of the data. The results do suggest bi-
ases in the coverage of coinfection research. For example helminth coinfec-
tion is estimated to affect between 800 million and one billion individuals
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(Crompton, 1999; Hotez et al., 2007), but there were relatively few re-
ports of this in the sampled publications. Also, most publications showed
negative effects of coinfection on host health, but grouping the same data
by the pair of coinfecting parasites led to most effects being negligible
(though positive effects where parasite abundance was higher than single
infections still exceeded negative ones, Fig. 2.2). Another caveat is the in-
sufficient and inconsistent reporting of quantitative data, which precluded
full meta-analysis. Nevertheless, having analysed the reported direction
of associations and found a tendency toward reported negative effects of
coinfection on human health (and positive effects on parasite abundance),
the question emerges of how this arose.
The observational nature of the dataset from Chapter 2 means we
can only speculate on the likely cause of this skewed distribution. Three
explanations are plausible. (1) Coinfected individuals may have had worse
health to begin with, such as a weakened immune system. Thus, the lower
health status reported for coinfected individuals was the cause, rather than
the consequence, of their coinfection. (2) The multiple infections could
have had an additive effect where one infection causes a health burden, and
a coinfection causes further health burden. Accordingly coinfection simply
causes more damage to the host. (3) Coinfecting parasite populations
might not have been independent and were interacting by some mechanism
so that the presence of a parasite of another species alters the life history
of a coinfecting parasite. To assess the interactions among parasites that
may cause the statistical associations observed in published reports, the
frequency of different interaction types was tested in Chapter 3.
Summary network of coinfecting parasites
The parasites infecting a host, the host’s immune system, and the re-
sources used by the parasites (e.g. host tissues) can be viewed as a network
of interacting components, in the same way as one can characterise trophic
relationships among species in a free-living community as a network (i.e. a
food web). Just as in free-living communities, it is possible that communi-
ties of coinfecting parasites are controlled by top-down (immune control)
or bottom up (resource control) processes (Pedersen and Fenton, 2007).
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While some studies have collated all the host-parasite interactions for par-
ticular parasite species (e.g. Raman et al. (2010)), or included parasites in
free-living food webs (Lafferty et al., 2006), in Chapter 3 I made the first
attempt to construct a summary coinfection network for humans. Data
on host-parasite interactions from the same set of recent publications used
in Chapter 2 were assembled into a within-host network comprising direct
and indirect interactions among parasites, resources, and immune com-
ponents. Inclusion of resources consumed by coinfecting parasites as well
as their immune interactions offered a novel comparison of the number of
known routes for either top-down or bottom-up control.
Analyses of the structure of this network showed that interactions
between pairs of parasites were more often mediated indirectly through
shared resources than through immune components or other parasites.
Interacting components of the network were also grouped into modules
that were each associated with particular body parts. This structuring of
the network by resource relationships offers the first indication that phys-
ical compartments within the body and bottom-up processes most often
influence how, where, and which coinfecting parasites interact.
These findings underline the importance of studying resource-mediated
interspecific interactions, and raises further questions. For example, these
patterns originate from the same publications from Chapter 2 where coin-
fection was associated with worse host health, so does bottom-up control
determine the health burden of coinfection? Although resource-mediated
interactions were relatively common reported mechanisms for interactions
between pairs of parasites, these interactions do not necessarily have the
strongest effects on the parasite community. Measuring the strength of
parasite interactions and their pathological consequences would enable
further tests of the importance of resource-associated modules via new
methods such as quantitative analyses of compartmentation via Bayesian
clustering methods (Bogich et al., 2013; Tsuda and Georgii, 2013), and
simulations to estimate the resilience and resistance of the parasite com-
munity of humans. There are various methodological difficulties in how
to measure the strength of interactions between parasites and host com-
ponents, and directly between parasites. For instance, how the rate of
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consumption of host resources by parasites changes with parasite abun-
dance or resource availability is rarely discussed. Even relationships be-
tween host immunity and parasites are difficult to model, especially as
there is insufficient data for parameter estimation (Fenton and Perkins,
2010). The network I developed in Chapter 3 is an initial step towards
studying all the interactions among parasites known to coinfect humans,
and opens the door for future research.
Coinfection deaths in England and Wales
As well as not knowing how strongly coinfecting parasite species interact,
the cohorts most at risk of coinfection were little studied. Risk factors for,
and prevalence of, coinfection have so far been studied in narrow datasets,
such as three gastrointestinal helminths and fever among 350 children
in Tanzania (Lello et al., 2013), sexually transmitted infections among
teenage girls in the USA (Forhan et al., 2009), and two tick-borne bacterial
species in humans and other hosts (Nieto and Foley, 2009). Until now no
study had considered the full range of parasites or the number of people
coinfected across any national population. Moreover some studies implied
coinfection was a problem of poorer countries (e.g. Lello et al. (2013)),
though the mortality burden of coinfection in countries that invest heavily
in universal access to healthcare was unknown.
Using data on reported causes of death from England and Wales, I
showed in Chapter 4 that from 2005 to 2008 more than 135, 000 people
died from infectious causes, and 6% of these were associated with coin-
fection. By analysing the first national-level distribution of coinfection
deaths across age and sex cohorts, I showed that adults between their 20s
and 40s were most likely to have coinfection reported on their death cer-
tificate, and relatively high proportions continued to slightly later ages in
males. I found no consistent relationship between pairs of infections and
the similarity of their biological characteristics. Most pairs of parasites
co-occurred on death certificates at rates comparable with what was ex-
pected if the two infections caused death independently. However among
the pairs of parasites where the odds of coinfection death were significantly
different, the odds were most often higher than expected (Fig. 4.4). In
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other words, the odds of coinfection death were, for more than half of pairs
of infectious causes of death, based on the additive probability of having
two infections. For two fifths of pairs, there were significantly higher odds
of deaths reported as being from both causes. Referring back to the three
potential drivers of association between coinfection and host health (page
123), for coinfection mortality in England and Wales we can conclude that
pairs of infections mostly have additive effects on host mortality, but often
the odds of coinfection were higher than the sum of their parts. Whether
this association is because of host susceptibility, parasite interactions, or
a mix of the two warrants further examination.
The network I assembled in Chapter 3 demonstrates that there is much
evidence in publications that coinfecting parasite species have the poten-
tial to interact with one another within a human host. There is also
evidence that host factors can affect the way individuals respond to their
infections, and for those with weak, inappropriate, or pathological immune
responses, worse health outcomes may be more likely (Ingram et al., 2011;
Meyrelles et al., 2013). Generally speaking we would expect the propor-
tion of coinfection deaths to be higher in older individuals because ageing
of the immune system leads to higher susceptibility to infections (Wein-
berger et al., 2008) and lower immune responses (Goodwin et al., 2006).
The results of Chapter 4 showed instead that the proportion of coinfection
deaths was highest in early adulthood. People in this age bracket could be
viewed as being in their prime, and that the higher proportion of coinfec-
tion deaths are indicative of highly pathological within-host interactions.
This explanation is preferred among many infectious disease researchers
nowadays, but wider anthropological factors should still be considered
Singer (2009), especially as the dataset in Chapter 4 only revealed age,
sex, and causes of death. Also in the analyses undertaken, the biologi-
cal characteristics of co-occurring infections were not associated with the
odds of coinfection death, so the nature of any within-host interactions is
unclear. Whether those aged 20− 40 had characteristics that made them
more susceptible to coinfection, or whether their immune response makes
them more likely to die from coinfection remains to be seen.
While it is not possible, at least at this stage, to attribute the skew
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towards higher odds of coinfection being reported on death certificates
to individual characteristics, parasite interactions, or both, these results
corroborate the finding from Chapter 2 that coinfection is associated with
worse host health. Moreover the lack of coinfections reported in the litera-
ture that involve childhood infections can be attributed to a lack of study;
coinfections involving varicella zoster virus (chicken pox) and measles were
reported on death certificates in England and Wales, and had a higher
odds of coinfection death than deaths reported as being caused by either
infection alone (infectious causes B01 and B05 had an odds ratio of 2096).
Certain childhood infections are therefore associated with higher odds of
coinfection death.
The lack of association between pairs of infections with similar biolog-
ical characteristics, particularly shared tropisms, casts doubt on whether
consuming the same host resource confers greater risk of coinfection and
damage to health, as had been suggested when the results of Chapter 2
and 3 were taken together. However, more nuanced analyses of the biolog-
ical characteristics of infections on death certificates and of relationships
between coinfecting parasites and host resources are required. Neverthe-
less, my initial analysis of reported infectious causes of death shows that
coinfection could have significant, detrimental health implications even in
richer countries with universal healthcare.
Modelling indirect effects of treatment on coinfecting parasites
The fact that coinfection was associated with higher reported parasitemia
(Chapter 2), worse health (Chapter 2), and higher odds of death (Chapter
4) despite most of the individuals in this dataset having access to health-
care suggests that current treatments developed to target single infections
may be impeded by interactions among coinfecting parasites. This has
been previously suggested in papers about coinfection in animals (Behnke
et al., 2001; Lello et al., 2004). There were some models of vaccination
and immune interactions (Lello et al., 2004), and of treatments for spe-
cific coinfections (Alemu et al., 2013; Mushayabasa et al., 2011). Yet there
were no tests of how the indirect interactions among coinfecting parasites,
that were so common in the network in Chapter 3, affect treatment of
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parasite communities in humans. In Chapter 5 I developed a theoret-
ical model of mass drug administration in a village-sized population to
test how immune- or resource-mediated interactions between two endemic
helminth species altered treatment outcomes.
I found that the indirect effect of treatment on non-target parasites
was consistently related to the direction of the interaction between tar-
get and non-target parasite. Indirect treatment effects also increased in
magnitude the higher the coinfection prevalence, and the more frequently
treatment was applied. These results suggest that, for a two-parasite one-
host species system, the direction of treatment outcomes on non-target
parasites at the population level could be predicted using the direction
of an interaction, the proportion of individuals coinfected, and treatment
frequency. This indicates, at least theoretically for a one-way interaction,
that understanding parasite interactions could help design better treat-
ment programs for coinfected populations.
However, at certain interaction strengths I also found that the non-
target parasite was unaffected by treatment, and where variability between
simulations increased. These phenomena would hinder either precise pre-
diction of treatment effects from interaction parameters, or inference of in-
teraction parameters from observations of perturbed systems. This raises
the question of how well we can understand the direction and strength
of statistical associations and any underlying mechanistic interactions be-
tween coinfecting parasites.
Shared themes from the research chapters
Are observational patterns of coinfection meaningful?
For parasite interactions to be translated into clinical applications that
could improve patient health, data about the presence and strength of in-
terspecific interactions among parasites needs to be reliable. Using reports
in the published literature and reports on death certificates, I showed that
the overall effect of coinfection on human health appears to be negative.
The extent to which such patterns are biologically meaningful rather than
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artefacts of processes by which the data was produced and assembled, is
crucial, but often unclear (Sutherland et al., 2013). Errors in the collec-
tion and presentation of empirical data can arise from random variation
or structural biases at various stages: choice of system, sampling, mea-
surement, statistical analysis, reporting of particular results, and biased
publication of research (Levitt et al., 1993). Such errors may occur in
the three datasets in this thesis (Chapters 2-4), though I have shown that
results are robust to certain sources of error. The structure of the network
that I collated from published papers in Chapter 3 is robust to the method
used for sampling publications and the aggregation of node names, but it
was not possible to assess the extent of publication or reporting bias in the
source data. The key results in Chapter 2 were similarly robust to pairs
of parasites where the presence (or absence) of an effect on host health
or parasitemia was not reported in the reviewed publications. Tests for
robustness were not done for the reported causes of death in Chapter 4.
The sensitivity of all these Chapters’ results to sampling by the original
investigators is difficult to determine, but can be speculated upon. Such
consideration is crucial if we are to have confidence in the main conclusion
of this thesis that coinfection is commonplace and, in general, has nega-
tive effects on host health. While trends among biomedical publications
(discussed below) might indicate biases that undermine this thesis’ con-
clusions, this is counteracted by the diverse data sources presented herein
corroborating one another.
Biomedical publications, like the infectious disease publications sur-
veyed in Chapters 2 and 3, may report conclusions that are rarely sup-
ported by repeat studies or reanalysis (Easterbrook et al., 1991). Biomed-
ical papers tend to report significant results, but between 14% and a
majority contain false positives (Ioannidis, 2005; Jager and Leek, 2013).
Accordingly, there could be consistent bias among infectious disease re-
searchers to report data that show negative health effects, or to focus their
research on more pathogenic parasites. There could also be a persistent
bias towards, say, authors tending to describe the sites of infection rather
than immune responses (Loscalzo, 2011).
Death certificates are very different sources of information compared
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to published articles. Death certificates are legal documents signed by
two doctors and collated by the state to study all causes of death, not just
particular infectious diseases of research interest. The dataset in Chapter
4 includes a subset of all death certificates in England and Wales for
which any infectious cause of death was reported. It is therefore unlikely
that these data contain the same potential biases as in published articles,
such as reporting biases toward worse coinfection outcomes, or biased
documentation of sites of infection compared to immune responses.
Recently published studies using still other methods also suggest a
general detrimental effect of coinfection on host health. For example,
Schistosoma spp. coinfections (Abruzzi and Fried, 2011), polymicrobial
Staphylococcus aureus infection (Park et al., 2012), and reported coinfec-
tions in non-human hosts (Manenti, 2011) have overall negative effects on
host health. With increasing evidence, and a variety of data sources, we
can reasonably conclude that coinfected hosts tend to suffer more from
infectious disease than those with one infection.
How do parasites interact within a coinfected human?
Having established that coinfection often has general negative effects on
human health, the interactions that could produce these effects need con-
sideration. The network presented in Chapter 3 showed parasite feeding on
shared resources to be the most commonly reported indirect interaction in
coinfected humans. While the frequency of occurrence of this interaction
type may be inflated by infection being often described in terms of host
resources (Loscalzo, 2011), this finding should provoke greater consider-
ation of non-immune interactions. Prior to this thesis immune-mediated
interactions had been proposed as the major type of interaction in empir-
ical and modelling studies (see citations and discussion in Graham (2008)
and Tompkins et al. (2011), and Fenton and Perkins (2010) respectively),
though the possibilities of bottom-up control had been discussed partic-
ularly in relation to coinfected mice (Fairlie-Clarke, 2011; Knowles, 2011;
Pedersen and Fenton, 2007). The network shows that indirect interac-
tions sharing a resource are relatively common in published reports; it
is unclear whether publications fairly represent within-host interactions,
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or how large an effect resource-mediated interactions have on coinfection
dynamics relative to other interaction types. Nevertheless the network
adds to existing calls for resource-mediated interactions to be considered
alongside immune-mediated ones.
There are various options for how to develop methods to measure the
strength of interactions among parasite species and their host. There are
some computer and lab models of physiological changes caused by coin-
fection in host cells and parasites (Lutermann et al., 2012; Romano et al.,
2013), but further work is needed. Where immune responses to parasites
can be modeled using predator-prey models, there is uncertainty over how
to model coinfection (Fenton and Perkins, 2010). How parasite popula-
tions respond to the availability of host resources is only discussed for
certain parasites, like malaria (Savill et al., 2009), and no general model
for within-host coinfection has been described. As an extension includ-
ing theories of foraging in free-living systems (e.g. Petchey et al. (2008)),
mechanistic functions of immune components attacking parasites, and par-
asites feeding on their resources (potentially being immune components)
could be developed. Thus, foraging of parasites on host cells and tis-
sues could explain rates of parasite growth within the host. While body
size of consumers and their prey are important determinants of interac-
tions in free-living ecological networks (Eklo¨f et al., 2013), they are yet
to be applied to within-host parasite interactions. It is unclear how one
would measure body size, handling time, or gape size of, say, cytotoxic
T-cells fighting liver cells infected with hepatitis virus. Another compli-
cation is the wide range of within-host scales, with interactions involving
components from molecules to tissues to populations of organisms. How
descriptions of interactions among parasites should account for biologi-
cal scale and different processes compared with free-living systems needs
further work.
The typology I have presented in terms of direct, or resource- or
immune-mediated also needs to be critically examined. The dichotomy
this thesis has posed between resources and immunity as bottom-up and
top-down respectively is blurred in at least five ways. First, many globally
serious infections inhabit immune components, such as HIV infecting CD4
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T-cells, or Mycobacteria infecting macrophages. Second, definitions of the
immune system are broad, with some researchers considering anti-parasite
behaviour relating to their offspring’s food source to be immunological
(Kacsoh et al., 2013). Third, both immune and resource components
are limited by the host’s energy intake so that there is a tradeoff be-
tween immune investment and tolerance of metabolic losses (McFall-Ngai,
2007; Rauw, 2012). Fourth, parasites’ resource use can be determined
by the host’s immune phenotype, such as interferon type determining
whether leprosy produces small, localised lesions or more disseminated
disease (Teles et al., 2013), or Salmonella attracting neutrophils that lyse
the red blood cells inhabited by malarial parasites (Cunnington et al.,
2012). Fifth, immune components can be restricted to particular body
parts, such as regulatory immune cells being specific to an organ (Mal-
chow et al., 2013). Distinguishing between resources and immunity is
therefore a non-trivial matter.
These ambiguities between immunity and resources affect the inter-
pretation of Chapter 3’s results in two ways. First, nodes like CD4 cells
and macrophages are only classified as immune, even though they may be
inhabited by many parasites. Consequently, the undirected links between
immune components and parasites could reflect energy flows in either di-
rection. Second, the module detection algorithms used in Chapter 3 mean
that immune components like T-cells, macrophages, or antibodies are only
assigned to a single module, even though they circulate around many parts
of the body.
Future research could overcome some of these limitations by assigning
direction(s) to indicate whether it is the immune component reacting to
the parasite, or the parasite infecting the immune component (or both,
in a bidirectional link). If the strength as well as the direction of each
interaction were estimated, prediction of treatment effects would likely be
more accurate (Novak et al., 2011), and the Bayesian clustering meth-
ods mentioned above could be used to allow nodes to appear in multiple
modules. However, inferring interaction strength is particularly problem-
atic for coinfecting parasites because, as mentioned above, there is no
consensus on the functions and parameters to describe them. Even with
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appropriate functions, gathering data to quantify the strength of hundreds
of links in the network presented in Chapter 3 would be arduous. An ini-
tial option is to quantify interaction strength for a subset of the network.
Even so, detecting interactions between parasite species is nontrivial.
How to detect parasite interactions
When publications report interactions between parasite species, this is of-
ten based on statistical associations (e.g. higher than expected rates of
coinfection) rather than one species causing changes in the population size
of coinfecting parasites (Poulin, 2001). However, establishing whether this
association is caused by an interaction within a coinfected host is nontriv-
ial. Much evidence is needed before concluding a particular interaction
is occurring, as seen with debates over HIV-Mycobacterium leprae inter-
actions (Hohmann and Voss-Bo¨hme, 2013; Massone et al., 2011), inter-
actions between sexually-transmitted viruses (Bollen et al., 2008; Cohen,
2006; Rotchford et al., 2000), and why differences in between single- and
co-infected hosts appear at certain times post infection (Fairlie-Clarke,
2011). Furthermore, appropriate statistical methods for studying parasite
interactions are strongly debated (Fenton et al., 2010; Hellard et al., 2012;
Johnson and Buller, 2011).
My thesis work adds two further considerations for research into par-
asite interactions: potential non-response of perturbed systems, and vari-
ability through time and between hosts. I found in Chapter 5 that treat-
ment effects on non-target parasites depended on the direction of an in-
teraction, but that the absence or dampening of such a treatment effect
did not necessarily indicate the absence or weakening of an interaction.
Even when treatment effects were observed, the strength of the under-
lying interaction was sometimes obscured by temporal and demographic
stochasticity. While binary questions of whether or not there is an asso-
ciation, or categorisation of coinfection effects into positive, negative, and
neutral seems intuitive and is the focus of much debate, my research shows
that we also need to consider the identity of the parasites involved, the
mechanisms that link them, and how variable parasite populations are.
Understandably coinfection in humans is often described as complex.
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Coinfection is a complex system: how much do we under-
stand?
Complex systems, such as the global climate system, brains, and human
economies, have diverse and aggregated components, stable states, and
locally intense, often nonlinear, interactions (Levin, 1998). Throughout
the thesis I have shown that coinfection in humans, like communities of
free-living species, has many if not all these characteristics of complex sys-
tems. Previously, the potentially overwhelming diversity of parasites and
interactions among them had been spoken of, but evidence of complexity
was lacking.
In terms of diversity, a survey of known human parasites numbered
> 1400 species (Taylor et al., 2001). Further to this, the dataset collected
in a single year of publications demonstrated that there are hundreds of
different reported species co-occurrences, and in the human coinfection
network built from these publications the number of nodes (infections)
was still linearly increasing. In addition to the great diversity of parasites
found, the network I analysed in Chapter 3 showed elements of robust-
ness, such as an exponential distribution, weak, if any, assortativity, and
compartments, which suggest that perturbations, such as drug treatments
or vaccination, will affect few other nodes. Stability in terms of resistance
was also found in the model of a two-species parasite community in Chap-
ter 5, in that parasites were resilient to one-off treatment, and resistant to
extinction even under repeat treatment. Lastly, the network had localised
parasite interactions with 10 modules of interacting nodes largely centred
around certain bodily sites. This thesis has advanced understanding of
coinfection as a complex system, but treatments based on interactions
among parasites are still rare.
Challenges to treating the complex system
Translating studies of complex systems into treatments is challenging for
many reasons (Schadt and Bjo¨rkegren, 2012). For coinfection in humans
these include: (i) many components performing the same functions, (ii)
multiple, nonlinear processes occurring simultaneously, and (iii) many in-
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direct interactions confounding predictions of treatment effects. Studies
of coinfection need to recognise that these three issues are inherent to
complex systems, and find ways to deal with them.
In the immune system, different components perform the same func-
tion, such as multiple cytokines causing the same response in target host
cells (Segel and Cohen, 2001). There is also the possibility that elimi-
nation of one parasite could simply open a niche for a different parasite
to invade. Ideally treatments should be robust to this, but knowing that
two or more nodes in a network share the same function is difficult a pri-
ori without experiments that knockout each node in turn. Such tests are
often precluded in humans on ethical grounds, but the use of laboratory
animals could be model systems.
I attempted to overcome these difficulties by representing coinfection
within humans in silico using a network and a simulation. As mentioned
above, there is no consensus over which functions should describe within-
host interactions either in the model developed in Chapter 5, or for quanti-
fying interaction strength in any future version of the network in Chapter
3. Where nonlinear functions for within-host processes are posited, as
in the model in Chapter 5 following the models of Fenton et al. (2010)
and Hauzy et al. (2010), the necessary data to parameterise models in
humans are lacking. Thus I developed a theoretical model for a range
of helminths species with different interspecific interactions. The results
from this model showed that complex treatment responses are possible
including non-monotonic or flat relationships with increases in the inter-
action parameter. When multiple nonlinear processes like density depen-
dent establishment, fecundity, and immune attack occur simultaneously,
perturbations like drug treatment might have counterintuitive effects. Im-
proving our understanding of within-host biology, modelling it, and using
the models to make predictions for treatment programs is therefore vital.
To translate model simulations into recommendations for real treat-
ments the model presented in Chapter 5 is only the beginning. Future
versions of the model could include more diverse parasite communities
and species with different life histories, say varying in virulence, or having
other hosts or vectors. Other treatment types could be modeled, such as
135
6. Discussion
vaccination, nutritional improvements, or only treating high burden hosts.
Two-way interactions can also be modeled where both species affect the
another, as has been done for HIV and malaria coinfection (Alemu et al.,
2013). However, the major caveat to such work is that, as I showed in
Chapter 5, the simulated effects of treatment are sensitive to nonlinear-
ities. Establishing the nonlinear functions of within-host processes, and
collecting data to infer parameters are crucial.
Another potential caveat is that prediction might be difficult even when
interspecific interactions are quantified. Perturbations of models of eco-
logical communities of more than two species where the only process is
population growth are predicted to often have effects of indeterminate
direction and size (Yodzis, 1988), even with recent technical and comput-
ing advances (Novak et al., 2011). Nevertheless, this thesis indicates that
whether non-target parasite populations in patients coinfected by a pair
of parasites are higher or lower after treatment might be predictable when
there is one-way interaction between the parasite species. While the im-
pact of treatment on the wider parasite community of humans might be
difficult to determine, decisions about target or integrated treatment that
are informed by parasite interactions could be made for pairs of parasites
and in individuals.
Personalised networks of coinfection
To test the potential for treating pairs of coinfecting parasites in terms of
their interspecific interaction, first we would need to observe such coinfec-
tion systems in individuals, and then compare their outcomes with what
was simulated by a computer model. Simulations of a realistic model could
suggest the optimal treatment of coinfected patients that could then be
tested by a medical trial. This could be part of a translational math-
ematical modelling branch alongside current efforts to incorporate new
information for more personalised medical decisions (Auffray et al., 2009;
Loscalzo, 2011; Ma et al., 2011; Milgrom and Tran, 2010). This could also
extend the findings from the summary network in Chapter 3 to reveal the
variability between individuals and their disease progression, which may
require more flexibility in coinfection treatment strategies.
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A move towards personalised networks would also incorporate esti-
mates of interaction strength and various possible interventions, enabling
evaluation of different treatment options. For example, many studies of
hepatitis focus on interactions between HBV and HCV, but HDV coinfec-
tion and alcohol consumption have bigger effects on liver damage (Sagnelli
et al., 2012). Hepatitis would be a good coinfection for developing net-
works to predict the outcomes of different treatment options, given that I
found in Chapter 2 that almost two fifths of 2009 coinfection publications
included hepatitis coinfection.
How could treatment of coinfection be improved?
Commensal parasites are being targeted by treatments to benefit host
health (e.g. Wolbachia, Taylor et al. (2010)). Whether interactions be-
tween pathogenic parasites can be translated into treatments is still un-
clear. However, having reduced the complexity down to a theoretical
model involving only two parasite species, I can make some of the first
predictions of the general outcomes of species-specific treatment in coin-
fected populations. Results of simulations from Chapter 5 showed that
reductions in non-target parasites can occur when a positively interacting
parasite is treated. Coinfection, even at high prevalences, is therefore not
sufficient justification for an integrated treatment program because tar-
geting treatment at a positively interacting parasite can indirectly reduce
the burden of coinfecting parasites.
Deciding on integrated treatment based solely on parasites co-occurring
is therefore questionable; the presence of positive interspecific interactions
should also be tested for. Treatments that target facilitatory parasites
would be expected to indirectly reduce morbidity from non-target para-
sites. Extrapolating this finding from the model of helminth coinfection
in Chapter 5 to other parasite types that are thought to interact posi-
tively, such as bacterial coinfection being fostered by malaria or influenza,
this calls into question recommendations for integrated treatments. Such
recent recommendations included giving antibiotics for suspected bacte-
rial coinfections in malaria or influenza patients (Sandlund et al. (2013)
and Davies (2011) respectively). Further tests for interactions and new
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models of treatment of microparasite coinfection are needed. Ideally ran-
domised trials comparing the outcomes of targeted and integrated treat-
ments should be done before such medical guidance is given. At a mini-
mum, data recording the multiple diseases that simultaneously affect pa-
tients should be collated (Sa´nchez et al., 2010; Schur et al., 2011). With
more data on the disease trajectory of coinfected patients and their treat-
ments, we could compare infected and coinfected patients, and coinfected
patients receiving different treatments with fewer sampling, reporting, or
publication biases.
Future research opportunities
The research in this thesis pioneered a broader approach to coinfection
research, and has identified many avenues for future research.
Patterns of coinfection and related diseases
To further evaluate the general effects of coinfection on human health,
more datasets are needed. The analytical approach of Chapter 4 could
be extended by comparing coinfecting parasites in living patients with
those reported on death certificates, analysing death certificates from
other countries and years, or looking at other causes of death. For ex-
ample, coinfection deaths could be associated with noncommunicable dis-
eases because there are similarities between health services for infectious
and noncommunicable diseases (Bygbjerg, 2012), the human immune sys-
tem fights parasites, cancer, and autoimmune disease (Thompson, 1995;
Vincent, 2006), and various infections can lead to cancer (Parkin, 2006).
In addition, more systematic reviews of the human coinfection literature
for years before and beyond 2009 would likely expand the database of
parasites known to coinfect humans.
Evolution and treatment of complex systems
Studying complex systems often means a move toward big data and large
networks, but these can be technically challenging, and, perhaps more im-
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portantly, the biological understanding is often lacking (Anderson, 1994;
Callebaut, 2012). Theory of coinfection as a complex system could be
particularly advanced by study of evolution. This thesis has only con-
sidered the population dynamics arising from parasite interactions, but
how the parasites, and, in turn, their interactions, evolve should also be
studied. The evolution of resistance to drugs is a particular challenge for
treatment of infectious diseases (Baquero, 1997; Hirsch et al., 1998; Koul
et al., 2011). Pertinent to coinfection treatment, broad-spectrum drugs or
combinations of drugs used in integrated control programs may select for
parasites resistant to the most widely used drugs. For instance, applying
antibiotics that target diverse coinfecting bacteria has been attributed to
severe infections like necrotising fasciitis being increasingly dominated by
single bacterial strains resistant to multiple antibiotics (Tsitsilonis et al.,
2013). The double complication of coinfection with two differently re-
sistant bacterial types is also increasingly common (Meyer et al., 2011).
Whether administering multiple treatments to coinfected patients selects
for resistance at a different rate from patients with single infections or
coinfected patients receiving a single treatment needs further monitor-
ing and modelling. While adding evolution to parasite interactions often
makes the problem less tractable (Woolhouse et al., 2002), evolutionary
feedbacks such as the evolution of resistance to drugs could easily be added
to the model I developed in Chapter 5. This research is urgently needed
to inform prudent drug treatments in coinfected patients.
Coinfection diagnosis and treatment in practice
The possibility that current treatments might be unnecessary or counter-
productive must be tempered, given the dearth of data on how coinfected
patients are being treated. The datasets used in Chapters 2 to 4 included
treated individuals, but how their parasite communities were changed by
treatment is unclear. Studies of how coinfected patients are diagnosed
and treated in clinical practice would enable assessment of how parasite
communities are being perturbed. Diagnosis of coinfection is often re-
ported as occurring solely by symptoms, or once a patient’s condition did
not improve after initial treatment (Alavi et al., 2012; Baba et al., 2013;
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Xuefei et al., 2013). How often does this occur? Which diagnostic tests
are done first? Once diagnosed, how are coinfection treatments decided?
What is the relative importance of patient condition, patient characteris-
tics like age and sex, and guidelines for treatment of the infections? What
are the strategies used by physicians treating patients with multiple dis-
eases besides infection (Fortin et al., 2007), and can they be applied to
coinfection?
As well as understanding parasite interactions within coinfected pa-
tients, we also need to find how social and clinical environments affect
parasite communities parasites (Utzinger et al., 2011; Waldman et al.,
2013). The model presented in Chapter 5 could be made more relevant
to public health by considering societal inequalities, risky behaviours, and
poor environments. Coinfected individuals are often from marginalised
groups like criminals or drug abusers, and these social factors contribute to
the particular vulnerabilities of these individuals to coinfection (Freuden-
berg and Galea, 2006; La Fleur et al., 2012; Ruan et al., 2004; Singer,
2009; Tshikuka Mulumba et al., 2012; Zhou et al., 2012). Reducing so-
cial inequalities and risk factors is one of the most promising avenues for
reducing HIV-HCV coinfection (Klein et al., 2012). Models could thus
be expanded to consider the role of altered social structure, sanitation,
or needle exchange in coinfection dynamics. These models often rely on
biomedical indicators (e.g. parasite abundance) to indicate health, but so-
cial attitudes to health will affect the behaviour of coinfected patients and
their clinicians and the use of model findings in treatment programmes.
Research into biological systems like coinfection often dehumanises and
objectifies coinfection, but social factors like emotion, culture, and stigma
around diagnoses are important for patients (Daftary, 2012; Farrell and
Comiskey, 2013; Hansen et al., 2007; Ro¨dlach et al., 2012; Singer, 2009;
Singer and Clair, 2003), and can affect compliance with treatment (Allen
and Parker, 2011; Parker and Allen, 2011; Parker et al., 2008; Soriano
et al., 2004). How can compliance with multiple treatments for multiple
infections be maximised? What is the effect of patients’ noncompliance
on health outcomes? While health is defined in this thesis as the presence
of disease causing morbidity or mortality, in other discourses “health” in-
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cludes more social aspects to mean either complete wellbeing, or, increas-
ingly, how resilient individuals are to changes in their lives (Jadad and
O’Grady, 2008). There is considerable disagreement within and among
patients and professionals how to define health (Tikkinen et al., 2012).
How do coinfected individuals view their health? Do other measures of
health also differentiate between coinfected and single infected individuals,
and for which kinds of parasites? Exploring social aspects of coinfection
is an important next step because human behaviour affects individual
health, treatment compliance, and the parasite community.
Final conclusions
Through the varied datasets, methods, and investigations presented in this
thesis, I have shown that coinfection, while diverse and complex, tends to
have detrimental effects on the morbidity and mortality of human hosts.
By building a network of parasites, host resources, and host immune com-
ponents, I was able to show that most interactions among coinfecting
parasites appear to be indirect, and are clustered around shared sites of
infection. Simulations of an agent-based model showed that, despite the
indirect nature of resource- and immune-mediated interactions, if we knew
the direction of an interaction, we could often predict treatment outcomes
of non-target parasites. This opens the way for recommendation of op-
timal treatment regimes based on interactions between pairs of parasite
species. If there is a positive interaction between the parasites then spe-
cific treatment of the facilitatory species may be sufficient. If there is a
negative interaction, co-treatment may be advisable. Most pairs of para-
sites appear to not be associated, but given the severe harm to host health
in terms of morbidity and mortality we need to find the types of parasites
that do co-occur more frequently than expected and that interact to dam-
age host health. Taking a broader view of interspecific interactions in
coinfected humans has opened up many more avenues for study of this
complex system, including how treatment can be improved to maximise
host health.
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Appendix: Agent-based model
from Chapter 5
Purpose
The purpose of this model was to explore how treating one parasite affects
non-target parasite abundance, and overall host morbidity, under a range
of interaction scenarios. Specifically the model explores the effects of an-
tihelminthic drug treatment applied singly or repeatedly across a range of
parasite interaction strengths, mechanisms, and directions in populations
with low, medium, and high coinfection prevalence.
State variables
State variables were: each host’s exposure to two parasite species, the
number of adults of each species (parasite abundance), size of the specific
immune response to each species, number of eggs released by each parasite
population into the environment (Fig. 5.2). The size of the environmental
pool of each parasite species, and each host’s age and mortality risk were
also calculated each timestep.
Processes
The model represents a village-sized human population living in a common
environment with two direct-transmitted endemic helminth species. Each
timestep includes a full parasite life cycle comprising transmission from
environment to hosts, establishment in hosts, immune response of hosts
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to parasites contributing to parasite mortality and reduced fecundity, and
reproduction of surviving parasites releasing eggs from hosts into the envi-
ronment. This model structure reflects a typical macroparasite life history
where host exposure, establishment of parasites, and density dependence
regulate helminth infections in sheep (Grenfell et al., 1987) and humans
(Basa´n˜ez and Boussinesq, 1999).
The host population is assumed to be at equilibrium, with every host
having the chance of dying each timestep, calculated from a background
age-dependent mortality rate and the combined burden of both parasite
species. Dead hosts were immediately replaced by identical, but unin-
fected new hosts (age 0). 70% of randomly selected hosts received treat-
ment during treatment timestep(s), reflecting treatment coverage similar
to other repeated mass drug administration programs (Mathieu et al.,
2006; Wanji et al., 2009). The model was iterated for 500 hosts until
state variables and host age distribution reached equilibrium (timestep
45).
Permanent residence in dense populations has been an important driver
of infectious disease dynamics in human history (Dobson and Carper,
1996), but I chose a village-sized population because mass drug admin-
istration to a majority of the host population is more feasible here, and
such settlements represent nearly half of the world population who live
outside large urban areas. Modeling a population of 500 hosts is large
enough to include a range of parasite susceptibilities, while also being
computationally tractable. Submodels (see below) of parasite life stages
were iterated in the same order every timestep for each host (e.g. infec-
tion, establishment within host, immune stimulation, death and immune
attack on worms, parasite reproduction, immune attack on eggs, then pos-
sible host death). The order of hosts to which this sequence of submodels
was applied was randomized in each iteration. Once at equilibrium the
hosts were treated with antihelminthic drug for either one timestep (one-
off treatment) or each timestep (repeat treatment) until the model run
ended 10 timesteps later. Each parameter set was simulated 50 times,
after which point the mean of all state variables was at equilibrium.
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Design concepts
The model is a double-programmed, updated R version of the Fenton
et al. (2010) Mathematica model of two macroparasites interacting within
a mammalian host population. Such independent rewriting of code im-
proves confidence in model features and results (e.g. Magori et al. (2009)).
Parasite life history stages and their order are unchanged between the two
models. Modifications include adapting the method for correlating host
exposure rates for both parasites to allow for negative correlation, adding
resource-mediated interactions, increased host longevity and increasing
risk of host death with age (to represent typical human survivorship rather
than the constant higher mortality rates of the original shorter-lived rab-
bits or sheep), and including treatment in the model.
Correlated exposure to infection
Each host has a lifelong exposure score to each parasite species that is
a probability of that host encountering parasite larvae in the environ-
ment, reflecting fixed genetic, environmental, or behavioural risk factors
to infection (Bensted-Smith et al., 1987; Bundy et al., 1987; Hall et al.,
1992; Jong-Wook, 2003; Quinnell et al., 2001; Schad and Anderson, 1985).
Host exposure to the two parasite species could be correlated (positively or
negatively) to represent hosts with certain tendencies or environs that fos-
ter coinfection of similar parasite species like shared transmission routes
(positive correlations in exposure) or differential exposure to the para-
sites like asynchronous parasite phenology (negative correlations). The
values of the correlated exposure parameter were −0.9 (strong negative
correlation, for low coinfection prevalence), 0 (no correlation, medium
prevalence), and +0.9 (strong positive correlation, high prevalence). Cor-
related exposure is an association based on between-host parasite ecology,
and is not a within-host interaction between parasite species. In other
words although infection rates can be correlated in the host population,
they behave independently within individual hosts unless an interaction
is added.
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Host immunity and immune-mediated parasite interactions
Immune responses associated with helminth infection are complex and
some may be defective (Schweitzer et al., 1992). Following other mod-
els of immunity to parasites, details like particular cell types are ignored,
and the size of an overall immune response is modeled. This immunity
increases with parasite density (Kepler et al., 2009), and with cumulative
experience of infection, albeit with some decay of immune memory with
time post infection (Anderson and May, 1992). Immunity to each parasite
accumulated over each host’s lifespan at a rate determined by that par-
asites cumulative population size within that host (Haswell-Elkins et al.,
1989), but immune memory decayed slowly over time so that immunity
diminished without parasite stimulation (see Bleay et al. (2009)). Host
immunity had a large negative effect on parasite numbers by increasing
adult parasite mortality and reducing per capita fecundity, concuring with
macroparasite infections in mammalian models (Bleay et al., 2007; Pater-
son and Viney, 2003; Roberts, 1999; Stear et al., 2007).
In simulations where the parasite species interacted via immunity, the
crossimmunity parameter ranged from −1 (immunosuppression propor-
tional to entire abundance of target parasite) to +1 (enhancement of
immune response proportional to entire abundance of target parasite),
reflecting differences in immune affinity caused by one parasite species
(following Fenton et al. (2010)).
Parasite density and resource-mediated interactions
The model also included the possibility of a resource-mediated interaction.
Progression of parasite life stages can change with parasite abundance
(density), affecting establishment, growth, survival, and reproduction of
each parasite species (Medley and Anderson, 1985; Paterson and Viney,
2003; Shostak and Scott, 1993). In the model non-target parasite species’
density could also affect target species’ density. This mimics one-way re-
source availability without tracking resources explicitly (Krebs, 1995). A
density-dependent function was used where the rate of parasite establish-
ment or fecundity of parasite species i at timestep T (Ei,T ) varied with
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total parasite density either positively or negatively using equation 2 from
Hauzy et al. (2010):
Ei,T = Emax · DT
xi
Dhalf
xi +DT
xi
(6.1)
where Emax is the highest proportion of larvae that can establish or
worms that can reproduce, Dhalf is the density of total parasites when
half the maximum establishment or reproductive rate is reached, DT is
the total parasite density at time T , and xi is the shape parameter, that
is the effect of parasite density either positive or negative on parasite i .
The shape of the function can represent competitive (−1 < xi < 0), fa-
cilitative (0 < xi < 1), or no interaction between the parasites (0, Fig.
6.1). As well as allowing the density of the target species to affect the non-
target species, intraspecific density dependence is modeled so that mortal-
ity rates increase and fecundity decreases at higher conspecific densities
(following studies of hookworm, Kotze and Kopp (2008); Norozian-Amiri
et al. (1994)).
Treatment
Single (“pulse”) and repeated (“press”) treatments (sensu Bender et al.
(Bender et al., 1984)) were simulated. Sometimes treatments are slightly
effective at killing coinfecting parasites (e.g. Waikagul et al. (2005)), but
for simplicity I assumed that a drug only directly affects the target par-
asite and has no effect on non-targets. Treatment was applied at speci-
fied time(s) to a random sample of 70% of hosts after parasite dynamics
had equilibrated. Treated hosts were assumed to clear their adult worms
for that timestep, representing a totally effective dose of antihelminthic
drugs, like praziquantel for schistosomiasis, ivermectin for onchocerciasis,
or albendazole for hookworm. The effect of treatment was instantaneous
(i.e. same timestep, not persisting to the next timestep); consequently
susceptible hosts can be reinfected. Mass drug administration was mod-
eled because this is WHO-recommended practice (Crompton, 2006) and
is generally more effective than selective or targeted treatments at reach-
ing infected individuals and reducing mean worm abundance (Richardson
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Fig. 6.1: Response of the establishment rate (E ) of the non-target larvae
to the abundance of adult target parasites depending on the shaping co-
efficient, x . Follows equation 6.1. This density dependent function is also
applied to fecundity.
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et al., 2011), even when subtotal enrollment is accounted for (Asaolu et al.,
1991; Olsen, 1998).
Stochasticity
There were four stochastic aspects to the model that enable tests of treat-
ment in varying host populations: (i) the initial assignment of host sus-
ceptibilities, (ii) the order of hosts at each timestep, (iii) demographic
stochasticity by rounding population size of parasite adults and eggs to
integer values, and (iv) host death. The demographic stochasticity from
discretising numbers of adult parasites and their progeny is especially im-
portant for modeling infections at the individual host scale when parasite
numbers within each host are small (n < 100), such as gastrointestinal
helminths of humans. All parasite dynamics were deterministic, i.e. trans-
mission, reproduction, parasite mortality, and interspecific interactions.
Initialisation
The model was first parameterised with the values of Fenton et al.’s the-
oretical model (Fenton et al., 2010). New parameters, such as for host
mortality, were set at biologically realistic values (Table 6.1). Host ex-
posure was assigned from the negative binomial distribution, which is a
good statistical model for worm burden (Crofton, 1971; Richardson et al.,
2011), of which host genetic susceptibility is a major driver (Holland, 2009;
Wilson et al., 2002).
Input
The model was simulated for each parasite interaction term in intervals of
0.05 between −1 and +1. All functions were applied at every timestep to
every host, except for treatment, which was applied at specified time(s).
Each set of parameters was simulated 50 times.
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Table 6.1: Values of parameters used in the Individual Based Model. No-
tation corresponds with the equations in the Supplementary Methods,
with - denoting that there is no relevant equation presented.
Parameter Notation Value
Number of hosts - 500
Number of parasite species - 2
Number of timesteps - 100
Replicate simulations - 50
Host exposure P
Mean for negative binomial distribution - 1
Dispersion for negative binomial distribution - 6000
Coexposure to both species - −0.9, 0, 0.9
General parasite dynamics -
Initial environmental egg pool 1000
Density dependent shaping parameter x −1 to +1
Maximum fecundity and establishment rate Emax 1
Parasite density for half density dependent rate Dhalf 40
Adult parasite survival rate S 0.8
Immune decay rate δ 0.5
Adult parasite fecundity F 200
Immune effect on adult parasite survival SI 0.001
Immune effect on adult parasite fecundity FI 0.001
Environmental egg pool decay rate - 0.75
Parasite-specific immune responses
Impact of parasite 1 on immune response to parasite 1 γ1,1 +1
Impact of parasite 2 on immune response to parasite 2 γ2,2 +1
Impact of parasite 1 on immune response to parasite 2 γ1,2 −1 to +1
Impact of parasite 2 on immune response to parasite 1 γ2,1 0
Host mortality
Maximum host life expectancy M 70
Virulence inflexion point X 2000
Treatment
Effect of drug on adult parasite number - 1
Proportion of hosts treated T 0.7
Timestep when treatment started - 50
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Submodels
Parasite life history stages and host mortality were calculated for each
host at each timestep in the same order as the following submodels. These
submodels correspond to those of Fenton et al. (2010), with some modifi-
cations detailed below.
Host exposure to parasites
Individual host exposure to parasites is modeled by a probability of in-
fection sampled from a negative binomial distribution (X ∼ NB(µ, k),
with mean µ and dispersion parameter k ). I converted each integer into
a probability by dividing by the total. These randomly assigned probabil-
ities were shuﬄed to create coexposure using the Iman Conover method
until exposure was rank correlated as close as possible to a target cor-
relation (Iman, 1982) (using the R package mc2d version 0.1-8 (Pouillot
and Delignette-Muller, 2010; Pouillot et al., 2010)). This alteration to the
method of Fenton et al. enables negative and positive correlation.
Larval parasite transmission
The number of parasite larvae of parasites species i ingested by a host
(NU ) at timestep T is given by:
NUi,T = Pi · Li,T (6.2)
where Pi is host exposure to species i , and Li is the number of parasite
larvae of species i remaining in the environmental pool from the previous
timestep. In this function larvae remaining in the environment do not die
between timesteps. Larvae of nematodes infecting sheep like Ostertagia
spp. are known to live on pasture into the following year (Boag and
Thomas, 1970; Gibson and Everett, 1972; Gibson et al., 1967; Gulland
and Fox, 1992), and, depending on climate, larvae can survive round the
year (Gupta et al., 1987; O’Connor et al., 2006).
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Establishment of parasite larvae
The number of ingested larvae of species i establishing and reaching ma-
turity within a host at timestep T (NAi,T ) is given by:
NAi,T = N
U
i,T · Ei (6.3)
where E is the larval establishment rate for species i .
Specific host immune responses
The magnitude of a host’s specific immune response (I ) of species i at
time T is given by:
Ii,T = Ii,T−1(1− δ) + γi,i ·NAi,T + γj,i ·NAj,T (6.4)
where δ is the decay rate of immunity per unit time, j is the other
parasite species (i.e. not species i), γ is the effect of the first subscripted
species on the immune response to the second subscripted species, and
NA is the number of adult parasites infecting the host.
Adult parasite survival
The number of adult parasites of species i in a host at the end of timestep
T (Ni,T ) is given by:
Ni,T = (N
A
i,T +Ni,T−1) · Si.e−Si·Ni,T−1−SI·Ii,T (6.5)
where Si is parasite survival rate of species i , SI is the effect of
immunity on parasite survival.
188
Appendix
Adult parasite fecundity
The number of parasite eggs (faecal egg count, FEC of species i released
from a host in timestep T is given by:
FECi,T = Ni,T · Fi.e−F,·Ni,T−FI·Ii,T (6.6)
where F is the reproductive rate (per capita fecundity) of an adult
parasite of species i and FI is the effect of immunity on fecundity. In
each timestep the model predicts that the more adult worms in an in-
dividual, the more eggs produced, although the relationship is nonlinear
and variable (Fig. 6.2). Hosts die after parasite reproduction so some in-
fected hosts release eggs, but subsequently die and lose all their parasites
(eggs> 0 when worms= 0 on Fig. 6.2). Many publications report wide
variation in individual fecundity and worm abundance relationships, with
hosts with few worms releasing many eggs, and hosts releasing few eggs
having many worms. The model does not exhibit such wide variation (few
points along the axes on Fig. 6.2) because it represents a year, rather than
the shorter daily to weekly timescales of most empirical data. Studies of
nematodes in sheep show egg counts close to animal death are positively
correlated and that eggs and adult parasites follow similar distributions
across hosts (Grenfell et al., 1995).
Host mortality risk
The risk of a host’s death P (dYT ) related to its age Y at timestep T is
given by:
P (dYT ) = 1− 0.5
1
(M−YT )/2 (6.7)
where M is the maximum host life expectancy. This is the Gompertz-
Makeham model and replaces the constant background host mortality risk
in the original model (Fenton et al., 2010) with one where mortality risk
increases exponentially with host age (Milne, 2008).
Mortality risk was also associated with parasite burden (reflecting im-
munopathology like inflammation (Finch and Crimmins, 2004), severe
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Fig. 6.2: Number of eggs produced in one timestep by adult parasites of
the target species for 500 hosts.
malnutrition, organ failure etc.) by a sigmoidal relationship (Equation
6.8). The shape of this sigmoidal curve was equal for both parasite species
so that the parasites had equal virulence. The probability of a host’s death
related to total parasite burden N at timestep T (P (dNT )) is given by:
P (dNT ) =
1
1 + e(−V ·(
∑n
i (Ni,T )−X)
(6.8)
where n is the number of the parasite species, V is the virulence of
adult parasites, and X is the inflexion parameter for the sigmoid curve.
Mortality risks associated with age (Equation 6.7) and parasite burden
(Equation 6.8) each contributed to two separate failure functions with a
single-draw process determining host death P (death) = mortality risk.
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